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ABSTRACT OF THE DISSERTATION 
 
Indole scaffolds are incorporated in a plethora of clinically useful natural products like 
ergotamine, reserpine, vincristine. Indole alkaloids have been fascinating chemists and 
biologists alike because of its diverse biological activity and intrinsic structural 
complexity. N-alkylated tryptamines, along with their analogs, are recognized as potent 
SHIP inhibitors and are considered privileged structures due their binding properties and 
diverse biological targeting. Also, the pyrrolo[2,3-a]indoline frameworks have been 
recognized as key structural motifs in many anticancer and psychoactive compounds. 
Thus, the development of a simple, inexpensive, efficient, safe, and environmentally 
friendly method of accomplishing indole alkylation constitutes an important synthetic 
goal. This dissertation describes modular approaches to constructing densely 
functionalized indoles, fused heteroaromatic natural products and alkylated tryptamines. 
The first chapter of the dissertation gives a detailed account of reactions of glycosyl or 
alkyl trichloroacetimidates with various indole derivatives substituted at N-, 2- and 3- 
position. While Friedel Crafts reactions of indoles with trichloroacetimidates are known, 
regioselectivity of these reactions is not very clear. The relative utility of all the known 
reactions is reviewed in order to gauge the potential of this new technology. 
Trichloroacetimidates make excellent electrophiles when activated with Brønsted or 
Lewis acids, and therefore were good substrates for the elaboration of the nucleophilic 
indole heterocycle. Intriguingly, the primary product of these transformations depends on 
both the structure of the imidate and the indole nucleophile, with N-alkylation, C2-
alkylation, and C3-alkylation products being readily attainable. This transformation is 
discussed in the second chapter. By exploring modular approaches to constructing these 
compounds, we envision that this methodology will aid the preparation of densely 
functionalized tryptamines. 
 
Dearomatization reaction is a powerful tool that converts planar aromatic compounds into 
interesting highly functionalized three-dimensional structures. The reactions discussed 
herein include the alkylative dearomatization through activation of trichloroacetimidates 
for the syntheses of 2,3,3’-trisubstituted indolenine cores. Dearomatization / Cyclization 
cascade sequences that involve dearomatization as the key step useful in the syntheses of 
pyrrolo[2,3-a]indoline frameworks are also described in the third chapter. 
 
Phosphatidylinositol 3’-kinase (PI3K) is an important component of an important 
signaling pathway, which regulates cell growth and cell proliferation. The SH2 
containing inositol 5'-phosphatase (SHIP) also plays a regulatory role in the PI3K 
signaling pathway. Inhibition of SHIP using small molecules has been shown to result in 
decreased cell growth in a number of cancer cell lines. Thus, SHIP inhibitors are being 
investigated as potential anti-cancer drugs. In this chapter, synthesis of a tryptaimine 
based SHIP inhibitor and some analogs is discussed. 
 
Fifth chapter discusses protection of carboxylic acids converted to the corresponding 4-
methoxybenzyl (PMB) esters with 4-methoxybenzyl-2,2,2-trichloroacetimidate in the 
absence of an acid catalyst.  This operationally simple procedure is an effective method 
for the formation of PMB esters.  The reaction is promoted by the carboxylic acids 
themselves in excellent yields (78-99%).  No racemization is observed in the case of 
carboxylic acids bearing a α-stereocenter.   
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The Use of Trichloroacetimidates as Electrophiles in the 
Friedel–Crafts Alkylation Reaction 
Abstract 
The first chapter of the dissertation gives a detailed account of reactions of glycosyl or 
alkyl trichloroacetimidates with various indole derivatives substituted at N-, 2- and 3- 
position. While Friedel Crafts reactions of indoles with trichloroacetimidates are known, 
regioselectivity of these reactions is not very clear. The relative utility of all the known 
reactions is reviewed in order to gauge the potential of this new technology. 
Introduction 
Charles Friedel and James Mason Crafts published on the alkylation of benzene with 
amyl chloride in the presence of Al2Cl6 in the year 1877 from the Sorbonne Laboratory in 
France.1 Despite the fact that the original studies date back to nearly 140 years, the 
Friedel Crafts reaction (F-C Alkylation) still remains a corner stone of organic 
syntheses.2-20 Like the Grignard reaction, this transformation represents one of the most 
versatile (in terms of both catalysts as well as reactants) and most frequently used tool in 
organic chemistry. Over the years, the number of chemists and the amount of material in 
terms of scientific publications and patents continues to grow exponentially. Friedel and 
Crafts continued their research in this field and found that ferric chloride, zinc chloride 
and sodium aluminum chloride could also catalyze the alkylation reaction. A large 
number of investigators following their work found many other Lewis acids like 
BF3.Et2O, TMSCN and SnCl4 were active promoters for the F-C alkylation reaction.2 In 
2	
	
due course, Brønsted acids like HCl, H2SO4 and H3PO4 were also found to catalyze these 
reactions.  
 Despite the usefulness and versatility of the F-C alkylation reaction, it has some 
drawbacks. Typically the transformations require stoichiometric and sometimes even 
super stoichiometric amounts of promoter reagent. In recent years, chemists have been 
successful in developing true catalysts for the transformation, and the research has moved 
to lowering the catalyst loadings using more exotic reagents like TeCl4, Nd(OTf)3, 
Yb(OTf)3, HAuCl4, TfOH and Pd(PPh3)4.2 Chiral Lewis and Brønsted acids have also 
been used to activate electrophilic reagents and thus catalytic asymmetric versions of F-C 
alkylation have been developed.3 These strategies have facilitated a marked drop in the 
formation of side products and significantly improved disposal of waste products.4 
 The alkyl halide coupling partners are also known to be toxic to the environment as 
they need to be activated by heavy metals and in turn form metal salts as byproducts. 
Utilizing modern conditions and with enough effort, nearly all-organic compounds with 
electrophilic character have been made to react with arenes in Friedel Crafts reaction. 
Alkenes, alkynes and alcohols may now be used as alkylating agents. Research into more 
environmentally benign alkylating agents continues, with the exploration of alternatives 
like epoxides,21-31 aziridines,32-34 allenes,35-38 doubly allylic systems, π-alcohols,39-42 and 
other electrophiles in catalytic F-C alkylation processes being an active area of 
investigation.5-8  Intermediates that are reasonably stable with leaving groups that do not 
require activation by stoichiometric promoters or heavy metals are highly desired.5-8 
 Trichloroacetimidates meet many of these leaving group requirements. They are 
easily accessed from the corresponding alcohols by base catalyzed addition to 
3	
	
inexpensive and commercially available trichloroacetonitrile. They can be activated by 
catalytic amounts of Lewis acids or Bronsted acids and do not require drastic reaction 
conditions. Upon activation, either the trichloroacetimidates are displaced directly or the 
carbocation intermediates are formed, which can then react with the aromatic 
nucleophile. Displacement of the imidates is facilitated by rearrangement of the imidate 
to the more stable trichloroacetamide, which provides an additional thermodynamic 
driving force.43 
 While trichloroacetimidates are ready participants in FC alkylations, they are 
primarily known for their roles in other organic transformations. Schmidt made 
trichloroacetimidates popular as glycosylating agents44-46 and Overman showed that they 
were useful intermediates in synthesis of allylic amines.47, 48 Trichloroacetimidates have 
also been heavily used in installation of protecting groups under acidic conditions.49-51 
Sporadic findings on F-C alkylation reactions using trichloroacetimidates have been 
appearing since the 1980s. In this context, all the examples of such alkylation reactions 
have been gathered and presented in this chapter. They have been described here mostly 
in chronological order. 
O-Glycosyl trichloroacetimidates for the synthesis of C-glycosides 
The availability of a general procedure for synthesis of glycosides and polysaccharides is 
of paramount importance since such bonds are present in a wide variety of biologically 
and clinically active substances like antibodies and antigens. Schmidt and co-workers 
discovered a highly chemoselective and stereoselective method to synthesize α- and β- 
disaccharides, trisaccharides and tetrasaccharides using trichloroacetimidates. These 
reactions form the glycosidic ether linkage mainly by inversion of configuration at the 
4	
	
anomeric center.52 Since the late 1970s, Schmidt and his group have been dedicated to 
finding new methodologies for synthesis of glycoside bonds. They introduced O-glycosyl 
phosphites, O-glycosyl nitroglycals and O-glycosyl trichloroacetimidates as glycosyl 
donors. These methodologies provided easy and efficient accesses to O-, N-, S- and P- 
glycoside bonds.53-56 During this time, they also extended their work to the syntheses of 
aryl C-glycosides by F-C reactions between anomeric trichloroacetimidates (glycosyl 
donor) with aromatic rings (glycosyl acceptor) in presence of a promoter (Scheme 1).57,58 
The ring size of the carbohydrate partner was found to be important in the 
stereoselectivity of the transformation. Glycosylation of pyranoses tend to be 
stereoselective whereas glycosylation of furanoses are not stereoselective.26,27 Protecting 
groups at C-2 did not necessarily control selectivity since β- anomer is sterically more 
stable. Furanoses were found to generate mixtures of α- and β- aryl furanoses.  
Scheme 1.1: Pictorial representation of the Friedel–Crafts alkylation of pyranoses/ 
furanoses 
 
Shown in Table 1 are the yields and stereoselectivity in the reaction of 
trichloroacetimidates with a large variety of aromatic acceptors. That includes aromatic 
compounds containing electron-donating groups, heteroaromatic compounds and 
aromatic compounds containing hydroxyl groups. 
O
O
NH
Cl3C
O
Ar
Promoter
+ ArH
Glycosyl
Donor
Glycosyl
Acceptor
1 2
3
5	
	
Table 1.1: Summary of trichloroacetimidate donors in C-glycoside formation 
 
Starting 
Anomer 
(R) OR1 ArH Product Promoter % 
Yield 
Ratio 
α:β  
Ref 
α OBn OBn 
 
10 
 
22 
BF3.Et2O 55 1:100 61 
β OBn Olp 
 
11  
23 
ZnCl2 53-65 1:1 61 
α OBn β-Olp 
 
10 24 
BF3.Et2O 63 100:1 61 
α OBn OBn 
 
12 
 
25 
ZnCl2 44 1:1 62 
α OBn OBn 
 
13 
 
26 
ZnCl2 40 1:100 62 
α OBn OBn 
12 
27 
BF3.Et2O 40 1:100 62 
ORORO
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NH
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O ArH
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9
TrO O
NH
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6 7
8
Ar
O O
O
TrO
Ar
OMe
MeO OMe
OBnOBnO
OBn
OBnMeO OMe
OMe
OMeMeO
O O
O
TrO
OMe
OMe
OMe
MeO OMe H
O O
O
H
O O
MeO
OMe
OMe
OSiMe3
OBnOBnO
OBn
OBn
O
OMeO
OBnOBnO
OBn
OBnMeO O
OSiMe3
OAcOAcO
OAc
OAc O
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α OAc NTCP* 
 
11 
 
28 
BF3.Et2O 54-77 0 63 
β OAc NTCP* 
 
14 
 
29 
SnCl2 71 0 63 
β OAc NTCP* 
 
10 
 
30 
SnCl2 62 0 63 
α OBn OBn  
15  
31 
ZnCl2.Et2O 68 100:1 64 
α OBn OBn  
16 
 
32 
ZnCl2.Et2O 30 100:1 64 
α OBn OBn 
 
17 
 
33 
ZnCl2.Et2O 59 1:100 64 
α OBn OBn 
 
18 
 
34 
TMSOTf 53-55 1:100 57 
α OBn OBn 
 
19 
 
35 
TMSOTf 69 1:100 57 
α OBn OBn 
 
20 
 
36 
TMSOTf 59 1:100 57 
α OBn OBn 
 
21 
 
37 
TMSOTf 59 1:100 57 
* NTCP stands for sodium taurocholate co-transporting polypeptide 
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In the table above, R stands for the protecting group at positions C-3, C-4, C-5. R1 stands for the 
participating group or protecting group at C-2. 
 
Several glycosidic systems with a free hydroxy group at C2 were also shown to have a 
directing effect.65 For these cases, it was hypothesized that the coupling first proceeds via 
the corresponding O-glycosides, which in presence of promoter arranges to ortho 
hydroxyl C-glycosides. 
 
Friedel-Crafts Alkylation with trichloroacetimidates in Total Synthesis 
Schmidt used this method of forming C-glycosides in the syntheses of visnagin,66 vitexin, 
isovitexin and isoembigenin.58 Opatz used this method in syntheses of glycosylated 
templates for the construction of saccharide mimetics.67 These syntheses will be 
discussed next. 
 
Figure 1.1 Structures of Natural Products isoembigenin, visnagin, vitexin and isovitexin 
 Synthesis of the natural product visnagin 39 by Schmidt and co-workers66 is shown in 
Scheme 1.2. Phenol 42 was treated with O-benzyl protected trichloroacetimidate glycosyl 
donor 43 in the presence of TMSOTf. This reaction afforded single anomer of α-linked 
glycoside 44 which, when reacted with the aldehyde 45 produced chalcone 46. Chalcone 
O
HO O
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O
O
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O
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O
OH
OH
HO OH
40
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46 underwent ring closure under oxidative conditions using SeO2 and furnished O-benzyl 
protected flavone 47. The benzyl protecting groups were then removed under reductive 
conditions to produce the product 39. 
Scheme 1.2 
 
Synthesis of C-glycosides to explore their use as glycoside mimics 
 The synthesis of structurally defined oligosaccharides is an emerging field as they 
play a very important role in communication between cells. In principle, these molecules 
may be useful as drugs in numerous medical conditions like psoriasis, asthma or 
repurfusion syndrome, however, they are plagued by poor pharmacokinetics. So, various 
types of oligosaccharide mimetics (including C-glycosides) having higher metabolic 
stability and better binding affinity have been developed.67, 68 Reaction of glycosyl donors 
with electron rich phenols permits a straightforward synthesis of O-hydroxyaryl C-β-D-
glucopyranosides (a metabolically stable oligosaccharide mimetic) regio- and stereo- 
selectively as shown above in Table 1.57 
O O
MeO O
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O O
MeO O
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MeO O
OMeO
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MeO O
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O
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O OH
MeO O
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77%
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OBnOBn
O
OBn
OBn
OBnOBn
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 An example of the use of trichloroacetimidates in C-glycoside formation is shown in 
Scheme 1.3 below. 2-Naphthol was reacted with galactosyl trichloroacetimidate 48 in the 
presence of TMSOTf. This reaction produced β-C-glycoside 50. Subsequently, 50 was 
reacted with acetyl protected mannosyl trichloroacetimidate 51. Deprotection of product 
52 provided the C-glycoside 53, which was hypothesized to be a good mimic of a 
branched polysaccharide.  
Scheme 1.3 
 
 C-Glycosides possess a high stability against ubiquitous glycosidases and hence are 
considered privileged structures for saccharide mimicry. Indoles have high electron 
density making them a good template for direct C-glycosylation and have been viewed as 
mimetics of trisaccharides.70 As shown in Scheme 1.4, BF3•etherate promoted reaction 
with acetyl protected trichloroacetimidate donors furnished the single anomers of the 1,3-
diglycosylindoles 56 and 59. 
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Scheme 1.4 
 
Imidomethylation of C-nucleophiles using O-phthalimidomethyl 
trichloroacetimidate 
Introduction of amido/ aminomethyl groups to aromatic systems has found a multitude of 
applications in organic chemistry. The most important and widely used reaction, which 
involves an enolizable aldehyde or ketone as the nucleophile, is R-aminomethylated by 
an iminium ion to generate an α-amino carbonyl compound (also known as a Mannich 
base).71 Schmidt and coworkers developed a modification of this reaction in which 
phthalimidomethyl (Pim) trichloroacetimidate reacts with a wide variety of C-
nucleophiles, forming a new C-C bond while also introducing phthalimidomethyl group. 
This transformation serves as an alternative method for imidoalkylation. The phthalimido 
group also acts as amine protecting group. As shown in Scheme 5, Schmidt and co-
workers found that phthalimidomethyl (Pim) trichloroacetimidate, when reacted with 
aromatic rings in the presence of TMSOTf as promoter, furnished compounds 62, 63 and 
64 in good yields.72 
O
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NH
OAc
O
AcO N
OAc
OAcOAc
O
AcO N
OAc
OAc
AcO
mol seives 4Å
BF3  Et2O,
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O
AcO N
OAc
OAcOAc
56
O
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OAc
OC(NH)CCl3
O
OAc
AcO
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O
+
+
O
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OAc
OAcO
AcO N
OAc
OAc
AcO
59
-15 oC to 8 oC
33%
mol seives 4Å
BF3  Et2O,
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55%
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Scheme 1.5 
	
	
	
 
Synthesis of diarylmethane derivatives using substituted O-benzyl 
trichloroacetimidates 
Diarylmethane derivatives are precursors to several dyes and pharmaceuticals.73-75 These 
compounds are also used in syntheses of macrocycles, catenanes and rotaxanes.76 
Schmidt and co-workers have also reported the synthesis of diarylmethane derivatives 
utilizing the FC alkylation reactions of trichloroacetimidates..77 Many alcohols which can 
form stabilized carbocations (like allyl, propargyl, benzyl, cyclopropylmethyl, 
cyclobutyl, oxyallyl, etc.) can be transformed into trichloroacetimidates easily. Acid 
catalyzed activation of these imidates and their subsequent F-C reaction with C-
nucleophiles has been reported and is summarized in Scheme 1.6 and Scheme 1.7 O-
Benzyl trichloroacetimidate derivatives were reacted with 1 equivalent of 1,3-
dimethoxybenzene to provide the diarylmethane products in good yields.  
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Scheme 1.6 
 
 When 2.5 equivalents of the trichloroacetimidate were used with respect to the 
acceptor of 1,3-dimethoxybenzene, dialkylated products could be obtained (as shown for 
74 and 75 in Scheme 1.7). The 74% yield of 68, produced with an electron deficient 
benzylic trichloroacetimidate, is remarkable as the electron poor aromatic electrophiles 
typically give low yields in FC alkylations. With 2.5 equivalents of imidates, synthesized 
from benzyl groups with electron withdrawing groups such as 1,3–
dinitrobenzyltrichloroacetimidate, monoalkylated product 76 was obtained in 72% yield. 
The regioselectivity in these displacement reactions is controlled both by steric effects 
and the electron densities at different positions on the 1,3-dimethoxybenzene, thus 
leading to the 4-monoalkylated or 4,6-dialkylated products, rather than to those alkylated 
at the sterically hindered 2-position or electron-poor 5-position. Benzene was an effective 
acceptor in the FC alkylation reactions when it is used as solvent (in excess), producing 
the substituted aromatic systems 77, 78 and 79. This is notable as benzene is not a 
O
NH
CCl3
TMSOTf (0.2 equiv)
DCM
Donor
O
CCl3
NHTMSR
R'
Acceptor
65 66
CCl3CONH2
R
R'
67
R
Acceptor Used =
OMe
OMe
Method A
1 equivalent
OMeMeOO2N OMeMeO OMeMeOBO
O74% 64% 77%
68 69 70
Br
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particularly active reactant in most FC alkylations. Compounds 70 and 79 are of value as 
they can be employed in Suzuki cross-coupling reactions.77 
Scheme 1.7  
	
 
 
 
 
Lewis Acid Catalyzed Propargylation of Arenes with O-Propargyl 
Trichloroacetimidates 
1,3-Diarylpropynes are of high synthetic value because of the presence of alkyne 
functionality, which can be transformed to a number of high value materials. These 
O
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intermediates are generally synthesized Friedel-Crafts propargylation of aromatics using 
propargyl halides. This reaction is typically more difficult to achieve since the 
intermediate propargyl cation is in equilibrium with the corresponding allenylium cation, 
which can undergo side reactions leading to product mixtures.2,79,80 Alternatively, the 
highly desired 1,3-diarylpropynes 81 were obtained in good yields from imidates like 80 
when boron trifluoride etherate (0.3 equivalents) was used as the promoter. The reaction 
was fast and various arenes and heteroarenes, including toluene, xylene, thiophene or 
furan were tolerated well as nucleophiles as shown in Scheme 1.8.16 
Scheme 1.8 
 
	
Activation of π- alchohols of hydroxy lactam/ Carbon-Carbon bond forming 
sequence using a Brønsted Base/Brønsted Acid System 
 Dalla and co-workers developed an efficient and reliable tandem reaction sequence in 
which the π- alcohol in a hydroxy lactam (derived from phthalimide) is converted into a 
R
O
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ArH
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Ph Ph Ph
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trichloroacetimidate, making the alcohol a good leaving group which can then be 
displaced by a variety of nucleophiles. While the imidate was somewhat unstable to 
chromatography, it could be formed and displaced in one pot operation using a catalytic 
amount of triflimide as Brønsted Acid catalyst to facilitate the substitution. The reaction 
is summarized in Scheme 9.49  
Scheme 1.9 
 
	
	
	
Thiourea-catalyzed ring opening of episulfonium ions with indole derivatives by 
means of stabilizing non-covalent interactions 
Jacobsen and Lin demonstrated the use of urea-based catalyst stabilizing the 
episulfonium ion, which is highly electrophilic in nature. The episulfonium ion in the 
presence of chiral catalyst undergoes diastereotopic bond formation with nucleophiles. 
Trichloroacetimidates were used as episulfonium ion precursor. Trichloroacetimidates 
were ideal because they underwent protonolysis and substitution with a variety of 
N N
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Brønsted Acids and thus formed meso-sulfonium ion. Thiourea catalysts were found to 
introduce reactivity and high levels of stereoselectivity with aromatic compounds as 
shown in Scheme 1.10.80 These catalysts form a complex with sulfonic acid, providing a 
chiral counterion that controls the stereochemistry of reaction products. A similar system 
has been developed by Toste and co-workers with chiral phosphoric acid catalysts,81 
although they utilized only heteroatom nucleophiles and did not perform any FC 
alkylation reactions.  
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Scheme 1.10 
	
	 	
 
Synthesis of 3,3-disubstituted oxindoles by one-pot integrated Brønsted base-
catalyzed trichloroacetimidation of 3-hydroxyoxindoles and Brønsted acid-catalyzed 
nucleophilic substitution reaction 
3,3-Disubstituted oxindoles are found in several naturally occurring compounds like 
mitraphylline, marcfortine C and N-methylwelwitindolinone C isothiocyanate. Although 
a variety of methods have been developed for their synthesis, simple and efficient access 
to this type of heterocycle is still in high demand.  
N
H
SBn
Ph Ph
N
N
N SBn
Ph Ph
N
Me
SBn
Ph Ph
77 78 79
N
H
SBn
Ph Ph
80
N
H
SBn
Ph Ph
81
N
H
SBn
Ph Ph
82
N
H
SBn
Ph Ph
83
93% yield
93% ee
92% yield
85% ee
57% yield
1% ee
MeO
F
97% yield
91% ee
93% yield
93% ee
92% yield
85% ee
95% yield
79% ee
O
SBnPh
Ph
CCl3HN
N
O N N
St-Bu
CF3
CF3H H
S OO
O R
S Ph Ph
H H
Ph
H H
+δ
N
H
+δ
++
selective transition state-stabilization 
via attractive, non covalent interactions
(-RSO3H) N
H
SBn
Ph Ph
93% ee
76
75
thiourea
RSO3H
indole
(-CCl3CONH2)
18	
	
 
Figure 1.2 Structures of natural products mitraphylline, marcfortine C and N-methylwelwtindolinone C 
isothiocyanate 
 3-Hydroxyoxindoles are less effective starting materials for the synthesis of 3,3-
disubstituted oxindoles and in general, as a strong acid is needed to promote the 
substitution reaction, the alcohol being a poor leaving group.47 Zhu and coworkers 
reported the conversion of 3-hydroxyindoles to 3,3-disubstituted oxindoles utilizing a 
substitution reaction of the corresponding trichloroacetimidate followed by its 
substitution with a diverse set of nucleophiles as shown in Scheme 1.11. Again, the 
imidate was formed first and was found to be unstable to chromatography, but formation 
in situ followed by addition of a nucleophile and an acid catalyst was quite effective. Use 
of chiral phosphoric acid was attempted but provided low enantioselectivity.47 
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Scheme 1.11 
 
 
 
 
Syntheses of Dictyodendrins 
Dictyodendrins (A-E) are natural products extracted from marine sponge Dictyodendrilla 
verongiformis.82 They are known to inhibit telomerase enzyme which is expressed in 
most tumor cell lines and are seen as potential targets for cancer chemotherapy.83 They 
possess a highly substituted pyrrolo[2,3-c]carbazole core. Fukuyama and coworkers 
synthesized dictyodendrins A-E. They demonstrated that p-methoxybenzyl 
trichloroacetimidate when made to react with indole in presence of lewis acid catalyst 
produced a mixture of 2 and 5-benzylated products. A variety of lewis acid catalysts were 
surveyed in order to improve the regioselectivity of the reaction. They succeeded in 
obtaining a mixture of products in ratio 2.2:1.84  
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Scheme 1.12 
 
 
 
Conclusion 
 In summary, this brief review presents explorations into the utilization of 
trichloroacetimidates in Friedel-Crafts alkylation reactions. These procedures are mild 
and require only a catalytic amount of Lewis/ Brønsted acid. Reactions tend to tolerate a 
wide array of aromatic rings as nucleophiles. Imidates provide a useful solution to 
catalytic Friedel-Crafts alkylation reactions, operate with electron poor electrophiles and 
relatively unreactive nucleophiles like benzene. In the future advances in the use of 
imidates in regioselective, stereoselective and enantioselective F-C alkylation will be 
pursued. The goal of these studies is to provide a reliable and practical solution to F-C 
alkylation reactions. 
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A Modular Approach to Highly Functionalized Indole 
Derivatives. 
Abstract 
 
Polysubstituted indole scaffolds that possess biological and pharmacological activity are 
widely distributed in nature. In addition, polysubstituted indoles are often considered 
privileged pharmaceutical structures due to their diverse biological targeting, which 
include serotonin agonist activity and hallucinogenic properties. More recently N-
alkylated tryptamines have been found to be potent inhibitors of the inositol phosphate 
SHIP. Thus, the development of simple, inexpensive, efficient, safe, and environmentally 
friendly methods of synthesizing polysubstituted indoles constitutes an important 
synthetic goal. Recently we began to investigate some reactions of trichloroacetimidates 
and indoles to address the challenges of functionalizing substituted indoles. 
Trichloroacetimidates are excellent electrophiles when activated with Brønsted or Lewis 
acids, and therefore were good substrates for the elaboration of the nucleophilic indole 
heterocycle. Intriguingly, the primary product of these transformations depends on both 
the structure of the imidate and the indole nucleophile, with N-alkylation, C2-alkylation, 
and C3-alkylation products being readily attainable. By exploring modular approaches to 
constructing these compounds, we envision that this methodology will aid the preparation 
of densely functionalized indoles and related structures. 
Background and Significance 
 Studies on the heterocyclic chemistry of indole have been proceeding for generations. 
Adolf von Baeyer prepared indole in 18661 and then Baeyer proposed the correct 
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chemical structure in 1869.2 The dye and pigment industry was booming at the end of the 
19th century and indole based colorants played a major role in the dyestuff industry. 
During the 20th century, indoles garnered great interest because of their presence in many 
natural products. In modern times, indole and carbazole nuclei are used in medicine for 
their antibacterial, antimicrobial, and anti-inflammatory effects and occupy a relevant 
role in the discovery of antitumor drugs.3-5 Carbazole derivatives also find applications in 
organic materials as chromophores and photoconductors.6-9 Indole-based structures have 
found additional uses in materials science10 and agrochemistry.11 Shown below in Figure 
2.1 are some indole containing psychedelics, triptan drugs (used in the treatment of 
migraine headaches) and antitumor compounds. Psilocybin 1 and lysergic acid 
diethylamide 2 are hallucinogens well known for psychological effects typically by 
agonizing serotonin receptors.12 Ergotamine 3, sumatriptan 4 and rizatriptan 5 are 
examples of vasoconstrictors that are used for treatment of acute migraine attacks. These 
alkaloids constrict extracerebral blood vessels through 5-HT1B receptors and also inhibit 
trigeminal neurotransmission through 5-HT1D receptors. 13 Ondasteron 6 is an example of 
5-HT1B receptor agonist that is known to be a highly effective antiemetic.14, 15 Brivanib 7 
and cediranib 8 are examples of angiokinase inhibitors that are undergoing phase III 
clinical trials for the treatment of various cancer.16, 17 
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Figure 2.1: Examples of indole containing hallucinogens, triptans and antitumor drugs 
 A large number of reactions have been developed to form the indole heterocycle, and 
these have been reviewed.18-23 Attention has now turned to methods that allow the rapid 
decoration of the indole core so that the parent system can be formed rapidly and in high 
yield.24 One of the most promising transformations for the direct functionalization of 
indoles with carbon electrophiles is the Friedel-Crafts alkylation. 
 The Friedel–Crafts (F–C) alkylation is one of the archetypical acid catalyzed C–C 
bond-forming reactions for introducing side-chains onto an aromatic compounds via alkyl 
electrophiles.25 Indole is commonly referred to as an electron-rich heteroaromatic system 
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that shows enhanced reactivity, compared to benzene, in electrophilic aromatic 
substitutions. Although the high reactivity of indoles for alkylation facilitates organic 
reactions that are unfeasible for benzene and similar less reactive arenes, a careful 
assessment of the reaction conditions and additives must be carried out to avoid 
undesired poly-substitution events on the indolyl ring. 
 The pyrrole ring is the most reactive portion of the indole. Site C3 (enamine position) 
is the most reactive position of indole towards electrophilic substitution (about 1000 
times more reactive then benzene).25-27 One can synthesize C3 substituted indoles using 
electrophilic alkylations in an aqueous buffer with iminium electrophiles. C-2 Alkylation 
in unsubstituted indoles is generally carried out by lithiation of the indole 2-position after 
protection of the nitrogen followed by electrophilic alkylation.28, 29 The C-2 position can 
also be alkylated if a group is already present at the C-3 position, as is often demonstrated 
in the Pictet Spengler reaction.30 The reduced nucleophilicity of the indole N–H 
functionality typically allows N-substitution only when the N–H proton of indoles is 
removed under irreversible conditions in a polar aprotic solvent to generate a strongly 
charged nucleophilic nitrogen25 (Fig. 2.2, equation (3)). This reduced nucleophilicity is 
due to the lone pair of the nitrogen participating in the aromaticity of the heterocycle, 
which diminishes its nucleophilicity. Synthesis of N-alkylated indoles is usually 
performed by deprotonation of the indole NH with strong bases like NaH or KH in ether, 
DMSO, or THF followed reaction with an alkyl halide.31-35 Alkali hydroxides have also 
been used in presence of crown ethers and phase transfer catalysts. 
36	
	
 
Figure 2.2: Numbering in indoles. Equations 1 & 2 represent electrophilic attack on indoles at C3 and C2 
respectively. Equation 3 represents deprotonation on indole NH 
 Most of these reactions that favor N-alkylation require a toxic polar aprotic solvent or 
co-solvent to stabilize the intermediate anion. Also, typically, strong bases must be used 
with alkyl halides, which limits functional group compatibility.  These substitution 
reactions also form stoichiometric amounts of metal salts as by-products since these 
reactions are not catalytic in nature. 
 To avoid many of these disadvantages, chemists have been prompted to find 
alternatives to organohalides as alkylating agents in FC alkylations. The use of allylic and 
benzylic alcohols activated by Lewis acids or Brønsted acids can also provide alkylated 
indoles, but most of these reactions require vigorous conditions except for the most 
highly activated cases (typically doubly allylic systems).36-39 The use of transition metal 
catalysts has been explored for allylation, benzylation and propargylation, but these 
catalysts are expensive, often air-sensitive, and in many cases an additional Lewis acid 
must also be added.29,40-54 Thus, the development of simple, inexpensive, efficient 
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electrophile that can provide a general method of accomplishing indole alkylation 
constitutes an important synthetic goal.  
 Trichloroacetimidates are best known for their role in the synthesis of allylic amines 
(the Overman rearrangement), 55,56 as alkylating agents for the formation of glycosidic 
bonds (the Schmidt glycosylation), 57-59	 and for the formation of ethers under mild 
conditions, particularly useful for the installation of the 4-methoxybenzyl60, 61 and t-butyl 
protecting groups.62 Trichloroacetimidates can also function as electrophiles in the 
alkylation of aromatic systems63-69	 and electron rich alkenes.70,71 Use of 
trichloroacetimidates provides several advantages over alkyl halides. The imidate 
structure possesses basic nitrogen, which can be activated under mild conditions by a 
catalytic amount of either a Brønsted or Lewis acid. Displacement of the imidate is 
facilitated by rearrangement to trichloroacetamide, which provides an additional 
thermodynamic driving force. 
 Inspired by the skeletal diversity of naturally occurring indole alkaloids and the rich 
potential of chemistry trichloroacetimidates can offer, we conceived a pathway entailing 
three modes of intermolecular reactions between the indoles and trichloroacetimidates in 
presence of mild Brønsted acid catalysts leading to indole alkaloid-like skeletons. N-
Alkylation, C-2 Alkylation and C-3 Alkylation are discussed in this report.  
A few examples of the reactions of indoles and imidates have been described in the 
literature. They are shown below in Scheme 2.1 and Scheme 2.2.  
Scheme 2.1. Literature examples of alkylation at the C-3 position of indoles with 
trichloroacetimidates 
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Scheme 2.1 
 
 
Scheme 2.2 shows examples of N-alkylation of indoles in the literature using a variety of 
trichloroacetimidates. Schmidt and coworkers demonstrated N-glucosylation of 2,3-
diphenyl indoles to produce 27 in the presence of boron trifluoride in diethyl ether. 
However, they also observed C-glycosylation at the 7-position. In 2004, Schnabel et al 
published the synthesis of tryptophan N-glucoside in the presence of TMSOTf as an 
activator. 
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Scheme 2.2 
 
Scheme 3 shows an examples of C2- and C5- benzylation of indoles in the literature 
using a p-methoxybenzyl trichloroacetimidate as demonstrated by Fukuyama and 
coworkers.  
Scheme 2.3 
 
 
Results and Discussions 
As seen in Scheme 2.1-2.3, no general trend is apparent, sometimes C-3 alkylation is 
observed while sometimes N-alkylation is preferred. So, a systematic approach to 
understand the reactions between simple indoles and simple trichloroacetimidates was 
undertaken. Initial experiments involved reacting a number of imidates with the ethyl 
ester of indole-3-acetic acid (34) in presence of 10 mol % camphorsulfonic acid (CSA) at 
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in moderate to good yields as shown in Scheme 2.3. Benzyl imidate, 4-methoxybenzyl 
(electron rich), 4-bromobenzyl (less electron rich) and 3-nitrobenzyl (electron deficient) 
products were all obtained in good yields, although the electron deficient 3-nitrobenzyl 
imidate had to be heated to reflux in order for the reaction to proceed. Similar reactions 
between substituted benzene rings and trichloroacetimidates have shown a similar pattern 
of reactivity.79 Synthesis of 2-tert-prenyl indole (2-methyl-3-but-2-ene), 15 was 
attempted because of the presence of this carbon skeleton in a number of natural 
products.48 However, only prenyl indole 37 was obtained in low yield. Similar 
etherification reactions have been reported in the literature with this imidate and oxygen 
nucleophiles. 80 
Scheme 2.4 
 
In order to access the tert-prenyl product 38 an alternative strategy was obviously 
required. So, it was envisaged that the reaction of indole 34 with the tertiary imidate 
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formed from 2-methyl-3-butyn-2-ol followed by hydrogenation would furnish 38. 
However, surprisingly only N-alkylation was obtained. A number of reactions with other 
sterically hindered imidates and ethyl ester of indole-3-acetic acid 34 were attempted. In 
each case only alkylation at the N-position was observed. One explanation of these 
results was that hindered imidates were stopping at N-alkylation as a kinetic product, but 
in less hindered cases the alkyl group continues to the C-2 position, which represents the 
thermodynamic product. To test this hypothesis, compound 47 was heated to reflux in 
presence of acid, and the benzyl group migrated to the 2-position to furnish product 49. 
No migration was observed in refluxing toluene without the addition of CSA. 
Scheme 2.5 
 
A search of the literature revealed several reports on the migration of alkyl groups from 
the nitrogen to the C2-position in indoles.80,81 Blechert studied this reaction in detail, and 
proposed that the N-benzyl group first migrates to the C3-position of the indole via a 1,3-
alkyl shift followed by a Wagner-Meerwein rearrangement to form the C2-alkyl product. 
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Figure 2.3: Blechert’s Proposed Mechanism for the Rearrangement of N-Benzyl Indole to 
2-Benzyl Indole 80 
Based on Blechert’s mechanism, a mechanism for the alkylation of the indole is proposed 
in Figure 4 below. The trichloroacetimidate reacts with CSA so that imidate is protonated 
58. Trichloroacetamide 60 leaves, forming trichloroacetamide, which is highly 
exothermic and provides an additional driving force for formation of the cation. The 
cation then alkylates the nitrogen of the indole, providing indole 61 as the kinetic 
product. Protonation of 61 then forms 64 through a 1,3-shift. The R group now shifts to 
the 2-position although a Wagner-Meerwein shift which in turn forms cation 65, which 
undergoes loss of a proton to provide indole 66, the observed thermodynamic product. 
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Figure 2.4: Proposed Mechanism for the Alkylation of 3-Substituted Indoles with 
Trichloroacetimidates 
 
Trapping of iminium ion 64 in an intramolecular reaction with nucleophilic R'-group 
would lead to interesting pyrroloindoline like structures. Pyrrolidino[2,3-b]indoline 
substructures are present in many bioactive natural products.68-71 In practice, reaction of 
carbamate 9 with imidates resulted in formation of the corresponding pyrrolidino[2,3-
b]indolines. This mode of reactivity is discussed in more detail in Chapter 3.  
	
As expected, 2-substituted indoles reacted at C3 to obtain 2,3-disubstituted indoles. This 
was mode of reactivity was also briefly explored (Scheme 5). 2-Methyl indole was 
reacted with several nitrobenzyl imidates as a route to tryptamine analogs, which may be 
useful as SHIP inhibitors (see Chapter 5). Alkylation of 2-methyl indole was also 
performed with a phthalimidomethyl imidate, providing 71 in 78% yield.  
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Scheme 2.6 
 
	
Summary and Future Work 
 
This Chapter is focused on exploring the reactions of indoles with trichloroacetimidate 
electrophiles. A number of cases with unusual reactivity, such as selective N- or C2-
alkylation with 3-substituted indoles have been demonstrated. 
The utility of the selective alkylation methods will be demonstrated in the future in the 
synthesis of indole based natural products. Many of these structures are decorated with 
prenyl or tert-prenyl groups, which may be introduced utilizing imidate chemistry. For 
example, synthesis of trypostatin (Scheme 7) could be envisioned where C2 prenylation 
would be the key step.  
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Scheme 2.7 
 
By exploring modular approaches to constructing these polycyclic compounds, it is 
envisioned that trichloroacetimidates would prove to be an indispensible technology for 
the preparation of densely functionalized tryptamines and fused heteroaromatic natural 
products.  
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Experimentals 
General Information. All anhydrous reactions were performed under a positive pressure 
of argon or nitrogen. All syringes, needles, and reaction flasks required for anhydrous 
reactions were dried in an oven and cooled under an N2 atmosphere or in a desiccator. 
Dichloromethane and THF were dried by passage through an alumina column following 
the method of Grubbs.43 Triethylamine was distilled from CaH2. All other reagents and 
solvents were purchased from commercial sources and used without further purification. 
Analysis and Purification. Analytical thin layer chromatography (TLC) was 
performed on precoated glass backed plates (silica gel 60 F254; 0.25 mm thickness). 
The TLC plates were visualized by UV illumination and by staining. Solvents for 
chromatography are listed as volume:volume ratios. Flash column chromatography 
was carried out on silica gel (40-63 µm). Melting points were recorded using an 
electrothermal melting point apparatus and are uncorrected. Optical rotations were 
measured at the sodium D line (589 nm) on a digital polarimeter and reported in 
reagent grade solvent. Enantiopurity was determined using chiral phase HPLC with 
an OD-H (0.46 × 25 cm) column. Elemental analyses were performed on an 
elemental analyzer with a thermal conductivity detector and 2 meter GC column 
maintained at 50 °C. 
Identity. Proton (1H NMR) and carbon (13C NMR) nuclear magnetic resonance 
spectra were recorded at 300 MHz and 75 MHz respectively. The chemical shifts are 
given in parts per million (ppm) on the delta (δ) scale. Coupling constants are 
reported in hertz (Hz). The spectra were recorded in solutions of deuterated 
chloroform (CDCl3), with  residual chloroform (δ 7.26 ppm for 1H NMR, δ 77.23 
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ppm for 13C NMR) as the internal reference. Data are reported as follows: (s = singlet; 
d = doublet; t = triplet; q = quartet; p = pentet; dd = doublet of doublets; dt = doublet 
of triplets; td = triplet of doublets; tt = triplet of triplets; ddd = doublet of doublet of 
doublets; brs = broad singlet). Where applicable, the number of protons attached to 
the corresponding carbon atom was determined by DEPT 135 NMR. Infrared (IR) 
spectra were obtained as thin films on NaCl plates by dissolving the compound in 
CH2Cl2 followed by evaporation. 
Representative Procedure for syntheses of 2-substituted indoles/ N-substituted 
indoles- Reaction of previously reported O-allyl 2,2,2- trichloroacetimidate92 with ethyl 
3-indoleacetate 34. Allyl imidate (0.40 g, 2.0 mmol) and 3-indoleacetate  (0.20 g, 1.0 
mmol) were added to a flame-dried round-bottom flask under argon. Dry 
dichloromethane (8 mL) was added to form 0.25 M solution, followed by 
camphorsulfonic acid (0.05 g, 0.10 mmol). The reaction was stirred at room temperature 
for 24 h. When no more indole is observed using TLC, the mixture is dissolved in ethyl 
acetate (20 mL) and washed with saturated, aqueous sodium bicarbonate (3 x 20 mL). 
The organic layer was then separated and dried over anhydrous sodium sulfate, 
concentrated and adsorbed on silica gel. Purification by silica gel chromatography 
(solvent system is the same as TLC Rf reported) 20% Ethyl acetate/80% hexanes to give 
190 mg (78%) of 2-substituted indole 36 as yellow oil.  
Ethyl-2-allyl-3-indoleacetate 36. 
  
N
H
EtO2C
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36. Prepared using representative procedure from ethyl 3-indoleacetate 34 and the 
previously known imidate,92 compound 36 was purified using silica gel chromatography 
(80% hexanes/20% ethyl acetate). Yellow oil (0.19 g, 78%); TLC Rf = 0.70 (80% 
hexanes/20% ethyl acetate); IR (thin film) 3407, 3001, 1720, 1656, 990 cm-1; 1H NMR 
(300 MHz, CDCl3) δ 7.99 (bs, 1H), 7.58 (d, J = 6.0 Hz, 1H), 7.26 (d, J = 8.3 Hz, 1H), 
7.17-7.06 (m, 2H), 6.00-5.89 (m, 1H), 5.22-5.16 (m, 2H), 4.13 (q, J = 8.0, 2H), 3.71 (s, 
2H), 3.53 (d, J = 6.4 Hz, 2H), 1.24 (t, J = 7.1 Hz, 3H); 13C-NMR (75MHz, CDCl3) δ 
172.3, 135.5, 134.8, 134.2, 128.7, 121.7, 119.8, 118.6, 117.6, 110.7, 105.0, 60.9, 53.7, 
30.9, 30.6, 14.5. Anal. Calcd for C15H17NO2: C, 74.05; H, 7.04; N, 5.76. Found: C, 74.00; 
H, 7.10; N, 5.85.  
Ethyl 2-(3-methyl-2-butenyl)-3-indoleacetate 37. 
 
 Depew, K. M.; Danishefsky, S. J.; Rosen, N.; Sepp-Lorenzino, L. Total Synthesis of 
Tryprostatin B:  Generation of a Nucleophilic Prenylating Species from a Prenylstannane. 
J. Am. Chem. Soc. 1996, 118, 12463–12464. 
37. Prepared using representative procedure from ethyl 3-indoleacetate 34 and the 
previously known imidate,93 37 purified using silica gel chromatography (70% 
hexanes/30% ethyl acetate). Yellow oil (0.18 g, 69%); TLC Rf = 0.65 (70% hexanes/30% 
ethyl acetate); 1H NMR (300 MHz, CDCl3) δ 7.80 (bs, 1H), 7.55 (dd, J = 6.6, 1.0 Hz, 
1H), 7.28-7.26 (m, 1H), 7.12-7.08 (m, 2H), 5.36-5.30 (m, 1H), 4.12 (qd, J = 7.1, 0.8 Hz, 
N
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CO2Et
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2H), 3.69 (s, 2H), 3.50 (d, J = 7.3 Hz, 2H), 1.77 (d, J = 9.8 Hz, 6 H), 1.24 (t, J = 7.1 Hz, 
3H); 13C-NMR (75MHz, CDCl3): δ= 171.7, 135.6, 135.5, 129.3, 121.5, 121.2, 119.9, 
118.9, 110.8, 104.7, 60.5, 30.7, 25.6, 25.5, 17.7, 14.1. 
 (2-Benzyl-1H-indol-3-yl)acetic acid ethyl ester 39. 
 
 
 
Bowman, R. W.; Fletcher, A, J.; Pedersen, J, M.; Lovell, P. J.; Elsegood, M. R. J.; Elena 
Lopez, E, H.; McKeea, V.; Pottsa, G. Amides as precursors of imidoyl radicals in 
cyclisation reactions. Tetrahedron 2007, 63, 191–203. 
39. Prepared using representative procedure from ethyl 3-indoleacetate 34 and the 
previously known imidate,94 39 purified using silica gel chromatography (80% 
hexanes/20% ethyl acetate). Yellow oil (0.23 g, 78%); TLC Rf = 0.40 (80% hexanes/20% 
ethyl acetate); 1H NMR (300 MHz, CDCl3) δ 7.72 (bs, 1H), 7.57-7.61 (m, 1H), 7.34-7.07 
(m, 8H), 4.15 (2 H, s, 2H), 4.11 (q, J = 7.2 Hz, 2H), 3.76 (s, 2H), 1.22 (t, J = 7.2 Hz, 
3H); 13C-NMR (75MHz, CDCl3) δ 172.0, 138.2, 135.4, 134.6, 128.8, 128.7, 128.3, 126.0, 
121.0, 119.8, 118.5, 110.5, 105.4, 60.8, 32.3, 30.5, 14.2. 
[2-(4-nitrobenzyl)-1H-indol-3-yl]acetic acid ethyl ester 40. 
 
N
H
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40. Prepared using representative procedure from ethyl 3-indoleacetate 34 and the 
previously known imidate,94 40 purified using silica gel chromatography (80% 
hexanes/20% ethyl acetate). Clear oil (0.20 g, 60%); TLC Rf = 0.53 (80% hexanes/20% 
ethyl acetate); IR (thin film) 3390, 2950, 1730, 1615, 1500, 1330 cm-1; 1H NMR (300 
MHz, CDCl3) δ 8.10-8.07 (m, 2H), 7.87 (bs, 1H), 7.62-7.41 (m, 3H), 7.25-7.09 (m, 2H), 
4.21 (s, 2H), 4.12 (q, J = 7.2 Hz, 3H), 3.75 (s, 2H), 1.22 (t, J = 7.2 Hz, 2H). 
[2-(4-bromobenzyl)-1H-indol-3-yl]acetic acid ethyl ester 41. 
 
 
41. Prepared using representative procedure from ethyl 3-indoleacetate 34 and the 
previously known imidate,94 41 purified using silica gel chromatography (80% 
hexanes/20% ethyl acetate). Clear oil (0.29 g, 80%); TLC Rf = 0.65 (80% hexanes/20% 
ethyl acetate); IR (thin film) 3395, 2922, 1732, 1600, 900 cm-1; 1H-NMR (300MHz, 
CDCl3) δ 7.84 (bs, 1H), 7.62-7.59 (m, 1H), 7.41 (d, J = 8.5 Hz, 2H), 7.22-7.11 (m, 3H), 
7.06 (d, J = 8.5 Hz, 2H), 4.11 (q, J = 7.1 Hz, 2H), 4.05 (s, 2H), 3.74 (s, 2H), 1.23 (t, J = 
7.1 Hz, 3H); 13C-NMR (75MHz, CDCl3) δ 172.2, 137.6, 136.0, 134.5, 132.0, 130.7, 
128.5, 122.1, 121.4, 120.0, 118.8, 110.9, 105.9, 61.1, 31.9, 30.7, 14.5. Anal. Calcd. for 
C19H18BrNO2: C, 61.30; H, 4.87; Br, 21.46, N, 3.76. Found: C, 61.60; H, 4.89; Br, 21.52; 
N, 3.77.  
N
H
CO2Et
NO2
N
H
CO2Et
Br
63	
	
[2-(3-nitrobenzyl)-1H-indol-3-yl]acetic acid ethyl ester 42. 
 
42. Prepared using representative procedure from ethyl 3-indoleacetate 34 and the 
previously known imidate,97 42 purified using silica gel chromatography (80% 
hexanes/20% ethyl acetate). Clear oil (0.22 g, 66%); TLC Rf = 0.15 (80% hexanes/20% 
ethyl acetate); IR (thin film) 3395, 2859, 1730, 1560, 1355, 860 cm-1; 1H-NMR 
(300MHz, CDCl3) 1H-NMR (300MHz, CDCl3) δ 8.10-8.07 (m, 2H), 7.87 (bs, 1H), 7.62-
7.41 (m, 3H), 7.25-7.09(m, 2H), 4.21 (s, 2H), 4.12 (q, J = 7.2 Hz, 3H), 3.75 (s, 2H), 1.22 
(t, J = 7.2 Hz, 2H); 13C-NMR (75MHz, CDCl3) δ 171.9, 138.3, 135.4, 134.9, 128.8, 
128.7, 128.3, 126.7, 121.6, 119.6, 118.5, 110.5, 105.4, 60.8, 32.3, 30.5. 
 
[N-(tert-butyl)-indol-3-yl]acetic acid ethyl ester 46. 
 
 
46. Prepared using representative procedure from ethyl 3-indoleacetate 34 and the 
commercially available imidate, 46 purified using silica gel chromatography (90% 
hexanes/10% ethyl acetate). Clear oil (0.13 g, 52%); TLC Rf = 0.83 (90% hexanes/10% 
ethyl acetate); IR (thin film) 2890, 1735, 1460, 1350, 1053 cm-1; 1H-NMR (300MHz, 
CDCl3): δ 7.65-7.60 (m, 2H), 7.27 (s, 1H), 7.20 (m, 2H), 4.17 (q, J = 7.1 Hz, 2H), 3.75 (s, 
2H), 1.73 (s, 9H), 1.28 (t, J = 7.1 Hz, 3H). 13C-NMR (75MHz, CDCl3) δ 172.5, 135.3, 
N
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129.6, 124.6, 121.1, 119.5, 118.9, 113.6, 106.0, 60.9, 55.9, 31.7, 30.0, 14.5. Anal. Calcd. 
For C, 74.10; H, 8.16; N, 5.40. Found: C, 74.47; H, 8.12; N, 5.37.  
[N-(tert-prenyl)-indol-3-yl]acetic acid ethyl ester 45. 
 
 
45. Prepared using representative procedure from ethyl 3-indoleacetate 34 and the 
previously known imidate,72 45 purified using silica gel chromatography (90% 
hexanes/10% ethyl acetate). Clear oil (0.16 g, 62%); TLC Rf = 0.79 (90% hexanes/10% 
ethyl acetate); IR (thin film) 2925, 2250, 1738, 1080 cm-1; 1H-NMR (300MHz, CDCl3): δ 
7.77 (d, J = 8.3 Hz, 1H), 7.55 (d, J = 7.7 Hz, 1H), 7.23 (s, 1H), 7.15-7.06 (m, 3H), 4.09 
(q, J = 7.1 Hz, 2 H), 3.67 (s, 2H), 2.49 (s, 1H), 1.88 (s, 6H), 1.22 (t, J = 7.2, 3H).  
 
[N-(o-toluyl)-indol-3-yl]acetic acid ethyl ester 47. 
 
 
47. Prepared using representative procedure from 3-indoleacetate 34 and the imidate 
(procedure shown below), 47 purified using silica gel chromatography (90% 
hexanes/10% ethyl acetate). Yellow oil (0.16 g, 62%); TLC Rf = 0.79 (90% hexanes/10% 
ethyl acetate); IR (thin film) 2885, 1718, 1613, 1100, 750 cm-1; 1H-NMR (300MHz, 
N
CO2Et
N
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CDCl3) δ 7.68 (dd, J = 6.6, 2.0 Hz, 1H), 7.23-7.15 (m, 7H), 5.81 (q, J = 6.9 Hz, 1H), 4.13 
(q, J = 7.1 Hz, 2 H), 3.88 (s, 2H), 2.21 (s, 3H), 1.59 (d, J = 6.0 Hz, 3H); 13C-NMR 
(75MHz, CDCl3) δ 172.4, 140.3, 136.5, 135.9, 131.0, 128.3, 127.9, 127.7, 127.0, 126.8, 
126.5, 126.0, 125.6, 124.3, 122.0, 119.7, 119.5, 110.0, 107.5, 107.2, 60.9, 52.0, 31.9, 
20.8, 19.7, 14.5. Anal. Calcd. For C, 78.47; H, 7.21; N, 4.36. Found: C, 74.10; H, 7.21; 
N, 4.58.  
[2-(o-toluyl)-1H-indol-3-yl]acetic acid ethyl ester 49. 
 
N-substituted indole 47 (0.1g, 0.31 mmol) is dissolved in 5 mL of dry toluene. When a 
homogeneous mixture is obtained, 7.5 mg of CSA is added and the resulting mixture is 
stirred under reflux conditions. When no more nucleophile is observed using TLC, the 
mixture is cooled and then dissolved in Ethyl acetate (20 mL) and extracted with 
saturated, aqueous sodium bicarbonate (3 x 20 mL). Organic extracts separated and dried 
over anhydrous sodium sulfate. Organic extracts are concentrated and adsorbed over 
silica gel. Crude product is purified by silica gel chromatography (70% hexanes/30% 
ethyl acetate) 
Yellow Oil, (0.09 g, 89% yield). TLC Rf = 0.63 (70% hexanes/30% ethyl acetate); IR 
(thin film) 3553, 2976, 1728, 1613, 1100, 750 cm-1; (300MHz, CDCl3): δ 7.62-7.59 (m, 
1H), 7.51 (bs, 1H), 7.43 (d, J = 7.5 Hz, 1H), 7.31-7.09 (m, 7 H), 4.64 (q, J = 7.2 Hz, 1H), 
4.12 (q, J = 7.1 Hz, 2H), 3.81-3.69 (m 2H), 2.20 (s, 3H), 1.70 (d, J = 7.2 Hz, 3H), 1.23 (t, 
J = 7.1 Hz, 3H); 13C-NMR (75MHz, CDCl3) δ 172.4, 140.3, 136.5, 135.9, 131.0, 128.3, 
N
H
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127.9, 127.7, 127.0, 126.8, 126.5, 126.2, 126.0, 125.6, 124.3, 122.0, 119.7, 119.5, 110.0, 
107.5, 107.2, 60.9, 52.0, 31.9, 20.8, 19.7, 14.5. 
Methyl-(2-tolyl)-trichloroacetimidate 
 
A mixture of alchohol (0.69 g, 5.0 mmol), trichloroacetonitrile (2.2 g, 15 mmol) and 1,8-
diazabicyclo[5.4.0]undec-7-ene (76 mg, 0.5 mmol) in dry dichloromethane(10 mL) was 
stirred for 3 h at room temperature. The reaction mixture was then concentrated in vacuo 
and the residue was purified by flash chromatography (80% hexanes/17% ethyl acetate/ 
3% triethylamine) to give the desired product. 
Yellow oil (0.96 g, 66%); TLC Rf = 0.79 (80% hexanes/17% ethyl acetate/ 3% 
triethylamine); IR (neat, cm-1) 3342, 1662, 1076, 796.1H NMR (300 MHz, CDCl3) δ 8.21 
(bs, 1H), 7.45-7.43 (m, 1H), 7.19-7.08 (m, 3H), 6.09 (q, 1H, J = 6Hz), 2.24 (s, 3H), 1.54 
(d, 3H, J = 6Hz): 13C NMR (75 MHz CDCl3) δ 172.1, 141.2, 139.5, 137.1, 136.6, 134.7, 
131.1, 128.8, 127.2, 126.7, 126.0, 125.8, 121.6, 119.9, 118.7, 110.8, 107.2, 104.2, 60.9, 
33.4, 30.9, 29.9, 20.6, 19.6, 14.4. 
 [N-(cyclohex-2-enyl)-indol-3-yl]acetic acid ethyl ester 46. 
O
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45. Prepared using representative procedure from ethyl 3-indoleacetate 34 and the 
commercially available imidate, 45 purified using silica gel chromatography (90% 
hexanes/10% ethyl acetate). Clear oil (0.16 g, 62%); TLC Rf = 0.79 (90% hexanes/10% 
ethyl acetate); IR (thin film) 2900, 1738, 1640, 1113 cm-1; 1H-NMR (300MHz, CDCl3) 
7.49 (d, J = 7.9 Hz, 1H), 7.37 (d, J = 8.1 Hz, 1H), 7.14 (s, 1H), 7.13-6.98 (m, 3H), 6.07-
6.02 (m, 1H), 5.71 (dd, J = 9.5, 1.5 Hz, 1H), 4.05 (q, J = 7.1 Hz, 2H), 3.66 (s, 2H), 2.11-
1.61 (m, 9H), 1.15 (td, J = 7.1, 1.3 Hz, 3H). 13C NMR (75 MHz CDCl3) δ 172.2, 140.7, 
135.5, 129.6, 128.2, 121.1, 119.2, 118.2, 117.5, 110.9, 103.6, 60.5, 33.5, 30.0, 29.9, 24.8, 
21.4, 13.8. Anal. Calcd. For. C, 76.30; H, 7.47; N, 4.94. Found: C, 76.00, 7.97, 4.95. 
 
Representative Procedure for syntheses of 3-substituted indoles using 
trichloroacetimidates. 
Procedure A: In dry toluene, 1.0 equivalent of the indole is dissolved to make a 0.25M 
solution. 2.0 Equivalents of imidate are then added. When a homogeneous mixture is 
ontained, 0.1 eq (10 mol %) of catalyst is added and the resulting mixture is heated to 
reflux. When no more nucleophile is observed by TLC, the mixture was allowed to cool, 
taken up in ethyl acetate (20 mL) and washed with saturated, aqueous sodium bicarbonate 
(3 x 20 mL). The organic layer was separated, dried over anhydrous sodium sulfate, 
concentrated and adsorbed over silica gel. Purification was then performed utilizing silica 
gel chromatography (solvent system is the same as TLC Rf reported). 
N
CO2Et
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Procedure B: In dry toluene, 1.0 equivalent of the indole is dissolved to make a 0.25M 
solution. 2.0 Equivalents of imidate are then added. When a homogeneous mixture is 
obtained, 0.1 eq (10 mol %) of catalyst is added and the resulting mixture is stirred at 
room temperature. When no more nucleophile is observed using TLC, the reaction 
mixture was taken up in ethyl acetate (20 mL), washed with saturated, aqueous sodium 
bicarbonate (3 x 20 mL), dried over anhydrous sodium sulfate, concentrated and then 
adsorbed on silica gel. Purification by silica gel chromatography (solvent system is the 
same as TLC Rf reported) then provides the reported product. 
3-[(3-nitrobenzyl)-2-methyl]indole 68. 
 
 
 
Appleton, J. E.; Dack, K. N.; Green, A. D.; Steele, J. A mild and selective C-3 reductive 
alkylation of indoles. Tetrahedron Lett. 1993, 34, 1529-1532. 
68. Prepared using representative procedure A from 2-methyl indole 34 and previously 
known imidate,95 compound 68 was purified using silica gel chromatography (70% 
hexanes/30% ethyl acetate). Orange solid (0.22 g, 84%); mp = 145-147 oC; TLC Rf = 
0.51 (90% hexanes/10% ethyl acetate); 1H NMR (300MHz, CDCl3) δ 8.08 (s, 1H), 8.00 
(d, J = 6.6 Hz, 1H), 7.92 (bs, 1H), 7.53 (d, J = 7.6 Hz, 1H), 7.39-7.28 (m, 3H), 7.14 (t, J 
= 7.5 Hz, 1H), 7.05 (t, J = 6.9 Hz, 1H), 4.16 (s, 2 H), 2.41 (s, 3H); 13C-NMR (75MHz, 
CDCl3) δ 149.5, 135.4, 135.1, 131.9, 131.0, 128.9, 127.9, 127.5, 125.6, 123.5, 119.1, 
118.4, 108.7, 107.6, 39.0, 12.4. 
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3-[(4-nitrobenzyl)-2-methyl]indole 69. 
 
 
 
Appleton, J. E.; Dack, K. N.; Green, A. D.; Steele, J. A mild and selective C-3 reductive 
alkylation of indoles. Tetrahedron Lett. 1993, 34, 1529-1532. 
69. Prepared using representative procedure A from 2-methyl indole 34 and previously 
known imidate,94 69 purified using silica gel chromatography (70% hexanes/30% ethyl 
acetate). Yellow solid (0.21 g, 81%); mp = 124-125 oC; TLC Rf = 0.39 (70% 
hexanes/30% ethyl acetate); 1H-NMR (300MHz, CDCl3) δ 8.08 (d, J = 8.5 Hz, 2H), 7.91 
(bs, 1H), 7.35-7.25 (m, 4H), 7.13 (t, J = 7.3, 1H), 7.04 (t, J = 7.3, 1H), 4.10 (s, 2H), 2.38 
(s, 3H); 13C-NMR (75MHz, CDCl3) δ 147.1, 137.9, 135.4, 131.0, 130.1, 127.5, 124.1, 
120.9, 119.3, 118.0, 108.6, 107.6, 38.9, 12.6. 
3-[(2-nitrobenzyl)-2-methyl]indole 70.  
 
 
 
Appleton, J. E.; Dack, K. N.; Green, A. D.; Steele, J. A mild and selective C-3 reductive 
alkylation of indoles. Tetrahedron Lett. 1993, 34, 1529-1532. 
70. Prepared using representative procedure A from 2-methyl indole 34 and previously 
known imidate,97 70 purified using silica gel chromatography (70% hexanes/30% ethyl 
acetate). Yellow solid (0.17 g, 69%); mp = 109-111 oC; TLC Rf = 0.42 (70% 
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hexanes/30% ethyl acetate); 1H-NMR (300MHz, CDCl3) δ 7.95 (bs, 1H), 7.91 (dd, J = 
7.8, 1.4 Hz, 1H) 7.39-6.99 (m, 8H), 4.10 (s, 2H), 2.38 (s, 3H). 
3-[(2-phthalimidomethyl)-2-methyl]indoles 71. 
 
 
 
71. Prepared using representative procedure B from 2-methyl indole 34 and previously 
known imidate,96 71 purified using silica gel chromatography (70% hexanes/30% ethyl 
acetate). White solid (0.23 g, 78%); mp = 181-185 oC; TLC Rf = 0.42 (70% hexanes/30% 
ethyl acetate); 1H-NMR (300MHz, CDCl3): δ 8.05 (bs, 1H), 7.83-7.89 (m, 1H), 7.70-7.80 
(m, 2H), 7.55-7.64 (m, 2H), 7.15-7.20 (m, 1H), 7.05-7.11 (m, 1H), 4.95 (s, 2H), 2.61 (s, 
3H); 13C-NMR (75MHz, CDCl3) δ 167.9, 136.4, 134.1, 133.9, 132.0, 127.7, 123.2, 
122.14, 119.3, 117.8, 111.1, 109.86, 54.3, 12.4. 
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Brønsted Acid Catalyzed Dearomatization of Indoles 
using Trichloroacetimidates 
 
Abstract 
Dearomatization reactions are a powerful tool that converts planar aromatic compounds 
into interesting highly functionalized three-dimensional structures. The reactions 
discussed herein include an alkylative dearomatization utilizing trichloroacetimidates for 
the syntheses of 2,3,3’-trisubstituted indolenine cores. Dearomatization/ cyclization 
cascade sequences that involve dearomatization as the key step useful in the syntheses of 
pyrroloindoline frameworks are also described in this chapter. 
Introduction 
Dearomatization reactions have been recognized as particularly attractive transformations 
in organic synthesis. Starting materials for dearomatization reactions are arenes that are 
robust and abundantly available. These reactions convert the inexpensive planar aromatic 
systems into significantly more complex three-dimensional molecules, thus providing 
direct access to compounds bearing quaternary carbon centers, polycycles and 
spirocycles in an efficient and straightforward manner.1-15  
C2C3-Fused indolines16-18 and 3,3’-disubstituted indolenines19 featuring all carbon 
stereogenic centers are frequently found in pharmaceuticals, biologically active natural 
products, biogenetic precursors to indole alkaloids and organic-based electronics. 
Dearomatization reactions of indoles represent a benchmark in technologies for the 
syntheses of indolines and indolenines. Shown below in Figure 3.1 are some 
representative natural products containing indoline and indolenine cores.11-13 
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Figure 3.1 Indolinine and Pyrroloindoline Natural Isolates 
Shown below in Figure 3.2 is the method of numbering indoles and its derivatives. This 
numbering system will be used in the text going forward in the discussion of the new 
dearomatization reactions. 
 
Figure 3.2. Numbering System for Indole and its Derivatives 
Woodward first used a dearomatization technique in 1954 for the synthesis of the ‘C’ ring 
of Strychnine.20 Magnus21 and Kuehne22 later demonstrated the efficiency of 
dearomatization strategies in syntheses of strychnos alkaloids. Since then, tremendous 
effort has been made in development of dearomatization reactions, which include 
oxidative dearomatizations/ Diels-Alder cycloaddition,23 nucleophilic addition reactions,8 
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organocatalytic dearomatization24 and transition metal catalyzed dearomatization 
reactions.25,26  
Background and Significance 
MacMillan and group demonstrated the use of chiral imidazolidinone catalyst in an 
indole alkylation pathway to allow cascade formation of pyrroloindoline cores.27 
Protected tryptamine 12 was added to the activated iminium ion arising from the catalyst 
14 and α, β-unsaturated aldehyde (see Scheme 2). A quaternary ‘C’ substituted indolium 
ion (18) was generated, with the formal positive charge at the 2-position of the indole 
stabilized by the adjacent nitrogen. The pendant Boc carbamate then reacted at the 2-
position of the indole furnishing tricyclic system. Subsequent hydrolysis of the enamine 
moiety 19 provided the required pyrroloindoline and regenerated the imidazolidinone 
catalyst. MacMillan and his group later developed several cascade reactions based on 
similar transformations. They were successful in executing elegant and concise syntheses 
of complex natural products like (–)-flustramine B27,28 3, (–)-debromoflustramine29  and 
minfiensine 7.30 
Scheme 3.1 
 
 
 
NBr
NHBoc
O
MeN
N
H
Ph
O
p-TSA
1)
2) NaBH4, MeOH NBr
NBoc
HO
H
90 % ee
78%yield
12
13
14
15 N
NMe
Br
16
H
(±)-Flustramine B
74	
	
 
Scheme 3.2: Pyrroloindoline Catalytic Cycle 
 
MacMillan and his group in recent years have developed a second type of 
dearomatization reaction where an aryl iodonium salt is used as the electrophile (Scheme 
3.3). A Cu-(I)-bisoxazolindoline catalyst renders this arylation/ cyclization cascade 
enantioselective. The enantioinduction from bidentate substrate co-ordination produces 
highly enantioenriched pyrroloindoline products.31 Reisman and co-workers 
demonstrated a similar operationally simple, copper-catalyzed arylation of N-
tosyltryptamines provides direct access to C3-aryl pyrroloindolines.32  
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Scheme 3.3 
 
 
Figure 3.3. Bidentate Co-ordination in the Dearomatization Reaction 
Antilla and his group demonstrated the use of methyl vinyl ketone (MVK) in the presence 
of chiral 1,1’-bi-2-naphthol (BINOL) phosphoric acid derivatives for the syntheses of 
pyrroloindolines. The phosphoric acid co-ordinates to the MVK, activating it for attack 
from the indole, accessing a similar mechanism to that shown in Scheme 3.2. The 
enantioinduction from co-ordination of the phosphoric acid produces the highly 
enantioenriched pyrroloindoline products.33  
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Scheme 3.4 
 
You and his group demonstrated dearomatization/ cyclization/ allylic amination reaction 
in presence of a ruthenium complex and TsOH.H2O.34 This transformation is rationalized 
by the formation of an electrophilic Ru π-allyl complex, which then reacts with the indole 
in a similar fashion as described in Scheme 2. 
Scheme 3.5 
 
Asymmetric construction of quaternary carbon center at the 3-position of indoles also 
poses an interesting synthetic challenge. The indolenine products are prevalent in large 
number of natural products as shown in Figure 3.1. To address this synthetic need, Trost 
and Quancard utilized an enantioselective C-3 allylation of 3-substituted indoles in 
presence of anthracene-derived ligand 33 (Scheme 3.6). DCM was used as the solvent as 
it provided higher selectivity to furnish corresponding 3,3’-disubstituted indolenines like 
Ar
Ar
O
O
P
O
OH
Ar = 2,4,6-(iPr)3C6H2
N
H
NHCO2Me
+
O
N
NCO2Me
H
O
O
27
25
26
Catalyst 27 (10 mol%)
4Å MS, -20oC
24 h
toluene/benzene
1:1
90 % yield, 93 % ee
28
N
H
NHCO2Me
+
OH
25
29
Catalyst 30 (5 mol %)
TsOH.H2O (10 mol %)
cyclohexane, rt
RuMeCN NCMeNCMe
PF6-
Catalyst 30
N
NCO2Me
31
97 % yield
77	
	
34. This method was used by Trost group to synthesize (-)-esermenthol and (-)-
phenserine.35 
Scheme 3.6 
 
 
Rawal and co-workers have also demonstrated benzylation and β-allylation of 2,3-
disubstituted indoles with allyl carbonates, which react at C3 of the indole in presence of 
a palladium catalyst (again, a π-allyl complex is rationalized as the intermediate). This 
methodology furnished indolenines possessing sterically and electronically diverse 
substituents and affords the C3-benzyl indolenine products in high yields.36,37 
Scheme 3.7 
 
Cook and group have also reported a similar efficient decarboxylative allylic 
rearrangement of alloc indoles (Scheme 3.8).38 In these reactions the alloc protecting 
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group was used as the source of the allyl group which is incorporated into the indole 
products. 
Scheme 3.8 
 
Bandini and his group recently demonstrated the synthesis of 3,3-disubstituted indolenine 
cores through a dearomatization/hydrogen transfer cascade sequence (Scheme 3.9). This 
provided a new synthetic shortcut toward highly enantiomerically enriched indolenines.39 
Scheme 3.9 
 
Results and Discussions 
In exploring the reactivity of indoles and electrophilic trichloroacetimidates we 
envisioned exploring similar reactivity as that described by other groups detailed above. 
Reacting trichloroacetimidates with 3-substitutes indoles as nucleophiles followed by 
intramolecular trapping of intermediate iminium species by nitrogen/ oxygen 
nucleophiles could provide a convergent cascade process for preparation of 
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architecturally complex pyrrolidino[2,3-b]indolines.40-42 A mechanism for this 
transformation is proposed in Figure 3.4. First the trichloroacetimidate reacts with CSA 
so that imidate is protonated, providing 48, which reacts with indole to form the kinetic 
product, the N-alkylated indole 51 and trichloroacetamide 50 leaves. This intermediate, in 
presence of acid, forms 54 through 1,3-shift. The tethered nucleophile (either a protected 
amine, alcohol or carboxylic acid) then attacks the 2-position, thus trapping the iminium 
intermediate resulting in the formation of pyrroloindoline 56. 
 
Figure 3.4: Proposed Mechanism for the Alkylation of 3-Substituted Indoles with 
Trichloroacetimidates	
These reactions were shown to provide pyrroloindolines as products with a number of 
different trichloroacetimidates (Scheme 3.10). With the more reactive allyl imidate 
alkylation of the indoline nitrogen was also observed to give 59. The more hindered 
imidates of 2-methyl-3-butyn-2-ol and tert-butanol gave corresponding products 60 and 
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61 only upon heating, which evidently is required for the 1,3-alkyl shift of bulky groups.  
This transformation is quite powerful, as it results in the tandem formation of a carbon-
carbon bond between two adjacent quaternary carbon centers along with formation of a 
pyrrolidine ring in a single step. The modularity of this route is also notable, as many 
different alkyl groups may be introduced at the C3-position of the pyrrolidinoindoline. 
Scheme 3.10 
	
 
The alkylation reactions of 2,3-disubstituted indoles with trichloroacetimidates were also 
explored (Scheme 3.11). Initially, this work was focused on N-alkylation reactions that 
occur in presence of only a catalytic amount of CSA, thus showing efficiency and cost 
effectiveness of this new methodology. Indole nitrogens are generally poor nucleophiles, 
as the nitrogen is not very nucleophilic and a strong base is required for N-alkylation. In 
contrast, N-alkylation of 2,3-disubstituted indoles occurs in excellent yield utilizing just 
catalytic amount of CSA with an imidate electrophile.  
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Scheme 3.11 
 
 
Using tetrahydrocarbazole, N-alkylation was typically observed (see Scheme 3.11), but 
with allyl imidate the C3-alkylation product 76 was also detected in small (2%) amounts. 
Direct access to a C3-benzyl system was also investigated by using more vigorous 
reaction conditions (Scheme 3.12).  Heating of carbazole 69 in refluxing toluene with 
CSA gave an excellent yield of the C3-benzyl system 78. Rearrangement to 78 must 
proceed through a 1,3-alkyl shift (Figure 3.3) or a free benzyl cation as a [3,3]-
sigmatropic rearrangement is not possible in this system. No migration was observed for 
any other groups in absence of CSA. This further demonstrates that acid-catalyzed 
alkylations in many cases allow for the preparation of both N- and C3-alkylated products 
from the same starting materials by simply choosing the proper reaction conditions 
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Scheme 3.12 
 
 
	
Summary and Future Work 
 
In this chapter the reactions of indoles with trichloroacetimidate electrophiles was further 
explored. We have observed a number of cases with unusual reactivity, such as selective 
N- or C2-alkylation with 3-substituted indoles, the rapid formation of pyrroloindolines 
and the N- or C3-alkylation of 2,3-disubstituted indoles. The current reaction features 
readily available starting materials, wide substrate scope, excellent yields, and mild 
reaction conditions.  
These reactions may be further developed, as an enantioselective variant of these using a 
chiral Lewis acid and/or Brønsted acid may be possible. Natural products containing 
pyrroloindoline skeleton are challenging targets and may also be accessed using this 
chemistry. By exploring modular approaches to constructing these polycyclic 
compounds, we envision that trichloroacetimidates would prove to be an indispensible 
technology for the preparation of densely functionalized tryptamines and fused 
heteroaromatic natural products. 
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Experimentals 
General Information. All anhydrous reactions were performed under a positive 
pressure of argon or nitrogen. All syringes, needles, and reaction flasks required for 
anhydrous reactions were dried in an oven and cooled under an N2 atmosphere or in a 
desiccator. Dichloromethane and THF were dried by passage through an alumina 
column following the method of Grubbs.43 Triethylamine was distilled from CaH2. 
All other reagents and solvents were purchased from commercial sources and used 
without further purification. 
Analysis and Purification. Analytical thin layer chromatography (TLC) was 
performed on precoated glass backed plates (silica gel 60 F254; 0.25 mm thickness). 
The TLC plates were visualized by UV illumination and by staining. Solvents for 
chromatography are listed as volume:volume ratios. Flash column chromatography 
was carried out on silica gel (40-63 µm). Melting points were recorded using an 
electrothermal melting point apparatus and are uncorrected. Optical rotations were 
measured at the sodium D line (589 nm) on a digital polarimeter and reported in 
reagent grade solvent. Enantiopurity was determined using chiral phase HPLC with 
an OD-H (0.46 × 25 cm) column. Elemental analyses were performed on an 
elemental analyzer with a thermal conductivity detector and 2 meter GC column 
maintained at 50 °C. 
Identity. Proton (1H NMR) and carbon (13C NMR) nuclear magnetic resonance 
spectra were recorded at 300 MHz and 75 MHz respectively. The chemical shifts are 
given in parts per million (ppm) on the delta (δ) scale. Coupling constants are 
reported in hertz (Hz). The spectra were recorded in solutions of deuterated 
89	
	
chloroform (CDCl3), with  residual chloroform (δ 7.26 ppm for 1H NMR, δ 77.23 
ppm for 13C NMR) as the internal reference. Data are reported as follows: (s = singlet; 
d = doublet; t = triplet; q = quartet; p = pentet; dd = doublet of doublets; dt = doublet 
of triplets; td = triplet of doublets; tt = triplet of triplets; ddd = doublet of doublet of 
doublets; brs = broad singlet). Where applicable, the number of protons attached to 
the corresponding carbon atom was determined by DEPT 135 NMR. Infrared (IR) 
spectra were obtained as thin films on NaCl plates by dissolving the compound in 
CH2Cl2 followed by evaporation. 
General Procedures for the Synthesis of Pyrroloindolines 
Method A 
In dry toluene, 1.0 equivalent of the indole was dissolved to make a 0.25M solution. 2.0 
Equivalents of imidate were added. When a homogeneous mixture is obtained, 0.1 eq/ 10 
mol % of catalyst is added and the resulting mixture is stirred at room temperature. When 
no more starting material is observed using TLC, the mixture is taken up in ethyl acetate 
and washed with saturated, aqueous sodium bicarbonate (3x). The organic layer was then 
dried over anhydrous sodium sulfate and concentrated. Purification of the residue by 
silica gel chromatography (solvent system is the same as TLC Rf reported) provided the 
reported product. 
Method B 
In dry toluene, 1.0 equivalent of the indole was dissolved to make a 0.25M solution. 2.0 
Equivalents of imidate were added. When a homogeneous mixture is obtained, 0.1 eq/ 10 
mol % of catalyst is added and the resulting mixture was heated to reflux. When no more 
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starting material is observed using TLC, the mixture was allowed to cool to room 
temperature, taken up in ethyl acetate and washed with saturated, aqueous sodium 
bicarbonate (3x). The organic layer was then dried over anhydrous sodium sulfate and 
concentrated. Purification of the residue by silica gel chromatography (solvent system is 
the same as TLC Rf reported) provided the reported product. 
N-allyl, 3a-(allyl)-1,2,3a,8,8a-hexahydropyrrolo[2,3-b]indole 61. 
 
López-Alvarado, P.; Caballero, E.; Avendaño, C.; Menéndez, J.C. Efficient Synthesis of 
N-Prenylpyrroloindoline and N-Prenylindole Alkaloids Based on a New Four-Reaction 
Anionic Domino Process. Org. Lett. 2006, 8, 4303-4306. 
61. Method A used. Yellow oil (141 mg, 45%); TLC Rf = 0.51 (90% ethyl acetate/10% 
petroleum ether); IR (neat) 3076, 3055, 2978, 2877, 1697, 1641, 1605, 1489, 1463, 1412, 
1379, 1328, 1308, 1264, 1246, 1207, 1159, 1105, 1086, 1032, 993, 914, 768, 739, 668 
cm-1; 1H NMR (300 MHz, CDCl3) δ 7.07 (td, J = 7.6, 1.53 Hz, 1H), 7.00 (d, J = 7.1 Hz, 
1H), 6.65 (t, J = 7.3 Hz, 1H), 6.36 (d, J = 7.7 Hz, 1H), 5.98-5.75 (m, 1H), 5.71-5.58 (m, 
1H), 5.44-5.02 (m, 4H), 4.16-3.67 (m, 5H), 3.13-3.00 (m, 1H), 2.56-2.37 (m, 2H), 2.10-
1.96 (m, 2H), 1.61-1.46 (m, 2H).13C NMR (75 MHz, CDCl3) 155.9, 154.5, 150.4, 134.7, 
134.6, 132.6, 128.7, 123.2, 118.8, 117.7, 116.1, 84.7, 61.7, 61.6, 57.3, 56.1, 49.0, 45.6, 
43.7, 43.8, 37.9, 37.6, 15.1, 14.6.  
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3a-(tert- butyl)-1,2,3a,8,8a-hexahydropyrrolo[2,3-b]indole 62. 
 
62. Method B used. Colorless oil (103 mg, 36%); TLC Rf = 0.51 (70% ethyl acetate/30% 
petroleum ether); 1H NMR (300 MHz, CDCl3) δ 7.04-6.96 (m, 2H), 6.66-6.62 (m, 1H), 
6.50 (d, J = 2.1 Hz, 1H), 5.19 (d, J = 17.1 Hz, 1H), 4.22-3.98 (m, 2H), 3.70-3.46 (m, 1H), 
2.91-2.83 (m, 1H), 2.29-2.15 (m, 1H), 1.97-1.93 (m, 1H), 1.45-1.13 (m, 4H), 0.3 (s, 9H). 
13C NMR (75 MHz, CDCl3) 155.3, 150.5, 131.0, 128.4, 125.1, 125.0, 118.7, 118.4, 
109.2, 65.1, 63.8, 61.5, 61.2, 46.3, 46.0, 35.3, 31.9, 31.7, 26.3, 15.1 14.9.  
3a-(1,1-Dimethylpropargyl)-1,2,3a,8,8a-hexahydropyrrolo[2,3-b]indole 63. 
	
	
Hino, T.; Hasumi, K.; Yamaguchi, H.; Taniguchi, M.; Nakagawa, M. Inverted 
prenylation of Nb-Methoxycarbonyltryptamine. Synthesis of 3a-(1,1 dimethylallyl) 
pyrrolo[2,3b]-indole and 2-(1,1-dimethylallyl)tryptamine derivatives. Chem. Pharm. Bull. 
1985, 33, 5202-5206. 
63. Method B used. Colorless oil (120 mg, 41%); TLC Rf = 0.43 (70% ethyl acetate/30% 
petroleum ether); 1H NMR (300 MHz, CDCl3) δ 7.08-7.00 (m, 2H), 6.66-6.51 (m, 1H), 
6.50 (d, J = 7.8 Hz, 1H), 5.38 (d, J = 15.5 Hz, 1H), 4.16-4.03 (m, 2H), 3.60-3.57 (m, 1H), 
2.93-2.91 (m, 1H), 2.56-2.53 (m, 1H), 2.13-2.08 (m, 2H), 1.30-1.01 (m, 9H). 
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3a-(allyl)-2-oxo-2,3,3a,8a-tetrahydro-8H-furo[2,3b]indole 64. 
 
64. Method A used. Colorless oil (111 mg, 52%); TLC Rf = 0.50 (70% ethyl acetate/30% 
petroleum ether); 1H NMR (300 MHz, CDCl3) δ 7.07 (td, J = 7.5, 1.5 Hz, 1H), 7.04-7.01 
(m, 2H), 6.78 (td, J = 7.3, 1.1 Hz, 1H), 5.70-5.53 (m, 3H), 5.11-4.85 (m, 3H), 2.83 (s, 
3H), 2.82-2.41 (m, 3H). 13C NMR (75 MHz, CDCl3) 179.9, 132.5, 131.4, 129.5, 124.1, 
120.7, 120.2, 120.1, 110.1, 98.5, 53.7, 51.1, 41.4, 40.0. 
N-prenyl, 3a-(prenyl)-1,2,3a,8,8a-hexahydropyrrolo[2,3-b]indole 65. 
 
Lopez-Alvarado, P.; Caballero, E.; Avendano, C.; Menendez, J. C. Efficient Synthesis of 
N-Prenylpyrroloindoline and N-Prenylindole Alkaloids Based on a New Four-Reaction 
Anionic Domino Process. Org. Lett. 2006, 8, 4303 – 4306. 
65. Method A used. Colorless oil (202.5 mg, 55%); TLC Rf = 0.53 (90% ethyl 
acetate/10% petroleum ether); 1H NMR (300 MHz, CDCl3) δ 7.05-6.96 (m, 2H), 6.70-
6.65 (m, 1H), 6.52 (t, J = 2.1 Hz, 1H), 5.40-5.11 (m, 2H), 4.15-4.02 (m, 2H), 3.67-3.53 
(m, 1H), 3.10-2.87 (m, 1H), 1.80-1.00 (m, 12H).13C NMR (75 MHz, CDCl3) 155.3, 
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150.7, 134.4, 134.1, 133.9, 128.8, 123.4, 122.1, 120.5, 118.0, 107.0, 84.9, 61.4, 57.0, 
46.0, 44.5, 37.7, 37.4, 26.3, 26.1, 18.6, 18.5, 15.3.  
General Method for N-Alkylation Reactions 
In dry CH2Cl2, 1.0 equivalent of the indole is taken to make a 0.25M solution. 2.0 
equivalents of imidate are added and the resulting mixture is stirred at room temperature. 
When no more starting material is observed using TLC, the mixture is taken up in ethyl 
acetate (20 mL) and washed with saturated, aqueous sodium bicarbonate (3 x 20 mL). 
The organic layer was separated, dried over anhydrous sodium sulfate and concentrated. 
Purification by silica gel chromatography (solvent system is the same as TLC Rf 
reported) then gave the reported products. 
9-(diphenylmethyl)-2,3,4,9-tetrahydro-1H-carbazole 68. 
 
68. Pink oil. (289 mg, 93%), TLC Rf = 0.60 (20% ethyl acetate/80% petroleum ether); 1H 
NMR (300 MHz, CDCl3) δ 7.52 (d, J = 7.9 Hz, 1H), 7.41-6.99 (m, 13H), 6.72 (s, 1H), 
4.10 (s, 3H), 3.69 (s, 3H). 
9-(1-(2-methylphenyl)ethyl)-2,3,4,9-tetrahydro-1H-carbazole 69. 
N
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69. Yellow oil,  (208 mg, 91%), TLC Rf = 0.73 (20% ethyl acetate/80% petroleum ether); 
1H-NMR (300MHz, CDCl3) δ 7.56 (d, J = 7.2 Hz, 1H), 7.45 (d, J = 6.0, 2.0 Hz, 1H),  
7.38-6.96 (m, 6 H), 5.68 (q, J = 7.0 Hz, 1H), 2.73-2.59 (m, 4H), 2.34-2.28 (m, 2H), 2.04-
1.28 (m, 8H). 
9-(1-(2-methylphenyl)ethyl)-2,3,4,9-1H-carbazole 70. 
 
70. Pink oil,  (213 mg, 75%), TLC Rf = 0.82 (20% ethyl acetate/80% petroleum ether);. 
1H-NMR (300MHz, CDCl3) δ 8.21 (d, J = 7.7 Hz, 2H), 7.88 (d, J = 7.7 Hz, 1H),  7.51-
7.19 (m, 11 H), 6.09 (q, J = 7.0 Hz, 1H), 2.05 (d, J = 7.0 Hz, 3H), 1.93 (s, 3H). 
9-(4-methoxy)-2,3,4,9-tetrahydro-1H-carbazole 71. 
 
N
N
N
O
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Nazaré, M.; Schneider,C.; Lindenschmidt, A.; and David, W. W. A Flexible, Palladium-
catalysed Indole Synthesis by Direct Annellation of Chloroanilines with Ketones. Angew. 
Chemie. Int. Ed. 2004, 43, 4526-4528.  
71. Yellow oil,  (265 mg, 91%), TLC Rf = 0.33 (20% ethyl acetate/80% petroleum ether);. 
1H-NMR (300MHz, CDCl3) δ 7.48-7.39 (m, 1H), 7.16-7.14 (m, 1H), 7.07-6.98 (m, 2H), 
6.89 (d, J = 8.8 Hz, 2H), 6.72 (d, J = 8.8, 2H), 5.12 (s, 2H), 2.69 (t, J = 5.9Hz, 2H), 2.58 
(t, J = 5.9Hz, 2H), 1.97-1.75 (m, 4H); 13C-NMR (75MHz,CDCl3) δ = 158.2, 136.0, 135.3, 
130.4, 127.6, 126.9, 120.2, 118.3, 117.3, 113.8, 109.2, 108.5, 54.9, 44.8, 22.7, 21.6, 20.6 
ppm.  
9-(phthalimido)-2,3,4,9-tetrahydro-1H-carbazole  
 
Yellow oil,  (250 mg,78%), TLC Rf = 0.71 (20% ethyl acetate/80% petroleum ether); 1H-
NMR (300MHz, CDCl3) δ 7.77-7.70 (m, 3H), 7.65-7.6-2 (m, 2H), 7.34 (d, J = 7.7 Hz, 
1H), 7.34 (td, J = 7.2, 1.1 Hz, 1H), 7.04-6.96 (m, 1H), 5.80 (s, 2H), 3.01 (t, J = 6Hz, 2H), 
2.64-2.60 (m, 2H), 1.95-1.77 (m, 4H). 
9-tert-butyl-2,3,4,9-tetrahydro-1H-carbazole 72. 
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Barluenga, J.; Jiménez-Aquino, A.; Aznar, F.; Valdés, C.  Modular Synthesis of Indoles 
from Imines and o-Dihaloarenes or o-Chlorosulfonates by a Pd-Catalyzed Cascade 
Process. J. Am. Chem. Soc. 2009, 131, 4031-4041. 
72. Clear oil, (141mg, 62%), TLC Rf = 0.60 (20% ethyl acetate/80% petroleum ether); 1H 
NMR (300 MHz, CDCl3) δ 7.71 (bs, 1H), 7.27 (dd, J = 6.5, 2.3 Hz, 1H), 7.00-6.93 (m, 
2H), 2.67 (td, J = 18.3, 6.3 Hz, 4H), 1.89-1.71 (m, 4H), 1.44 (s, 9H).13C NMR (CDCl3, 
75MHz) δ 136.2, 136.1, 128.7, 120.1, 118.0, 117.5, 113.9, 111.2, 58.3, 31.4, 28.0, 24.7, 
22.3, 21.6 ppm.  
9-allyl-2,3,4,9-tetrahydro-1H-carbazole 73. 
 
Bramely, R. K.; Caldwell, J.; and Grigg, R. Site Specificity of [3,3]Sigmatropic 
Rearrangements of 3-Allyl- and 3-(Prop-2-ynyl)-3H-indoles. J. Chem. Soc., Perkin 
Trans. 1, 1973, 1913-1921 
73. Yellow solid, (171 mg, 81%), TLC Rf = 0.17 (20% ethyl acetate/80% petroleum 
ether); m.p. 52-56 oC. 1H NMR (300 MHz, CDCl3) δ 7.50 (d, J = 7.6 Hz, 1H), 7.27-7.21 
(m, 2H), 7.11 (td, J = 7.4, 1.0 Hz, 1H), 5.16-5.02 (m, 1H), 5.08 (dd, J = 17 Hz, 1.2 Hz, 
N
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1H), 4.87 (dd, J = 17 Hz, 1.5 Hz, 1H), 4.60 (m, 2H), 2.59-2.74 (m, 4H), 1.81-1.92 (m, 
4H); 13C NMR (75 MHz, CDCl3) δ 135.6, 132.8, 132.4, 128.5, 122.3, 121.0, 118.2, 
117.9, 108.2, 48.3, 25.1, 23.3, 22.2, 21.6. 
2,3-dimethyl-1-benzyl-1H-indole 74. 
 
Saito, A.; Oda, S.; Fukaya, H.; Hanzawa, Y. Rhodium(I)-Catalyzed Synthesis of Indoles: 
Amino-Claisen Rearrangement of N-Propargyl Anilines. J. Org. Chem. 2009, 74, 1517–
1524. 
74. White solid,  (74 mg, 89%), TLC Rf = 0.80 (20% ethyl acetate/80% petroleum ether);  
Mp 42-43 oC (hexanes). 1H NMR (300 MHz, CDCl3) δ 7.55-7.62 (m, 1H), 7.19-7.30 (m, 
5H), 7.11-7.18 (m, 2H), 6.95-7.02 (m, 2H), 5.26 (s, 2H ), 2.33 (s, 3H ), 2.29 (s, 3H ), 13C 
NMR (75 MHz, CDCl3) δ 138.2, 136.4, 132.3, 127.1, 125.9, 120.7, 118.8, 117.9, 108.8, 
106.9, 46.4, 10.1, 8.8.  
2,3-dimethyl-1-allyl-1H-indole 75. 
 
N
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Bramely, R. K.; Caldwell, J.; and Grigg, R. Site Specificity of [3,3] Sigmatropic 
Rearrangements of 3-Allyl- and 3-(Prop-2-ynyl)-3H-indoles. J. Chem. Soc., Perkin 
Trans. 1, 1973, 1913-1921 
75. Yellow oil, (86 mg, 81%), TLC Rf = 0.60 (20% ethyl acetate/80% petroleum ether); 
1H NMR (300 MHz, CDCl3) δ 7.30-7.28 (m, 1H), 7.04-6.96 (m, 2H), 6.86-6.80 (m, 1H), 
6.15 (ddt, J =17.5, 9.6, 7.0 Hz, 1H), 4.94 (dd, J = 17.5, 2.0 Hz, 1H), 4.86 (dd, J = 10.1, 
0.8 Hz, 1H), 2.50 (s, 3H), 2.30 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 135.6, 134.2, 132.4, 
129.8, 122.4, 119.9, 117.9, 112.5, 109.7, 48.3, 11.9, 8.8. 
General Method for C3 migration of 2,3-disubstituted indoles 
In dry toluene, 1.0 equivalent of the N-substituted indole is dissolved to make a 0.25M 
solution. When a homogeneous mixture is obtained, 0.1 eq/ 10 mol % of catalyst is added 
and the resulting mixture is heated to reflux. When no more starting material is observed 
using TLC, the mixture is cooled and then taken up in ethyl acetate (20 mL) and washed 
with saturated, aqueous sodium bicarbonate (3 x 20 mL). The organic layer is the 
separated, dried over anhydrous sodium sulfate and concentrated. Purification by silica 
gel chromatography (solvent system is the same as TLC Rf reported) then provided the 
observed product. 
4a-(tert-butyl)-2,3,4,4a-tetrahydro-1H-carbazole 77. 
 
77. Clear oil, (27 mg, 32%), TLC Rf = 0.15 (20% ethyl acetate/80% petroleum ether); IR 
N
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(thin film) 2931, 2860, 1582, 1454, 752 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.72 (bs, 
1H), 7.28-7.25 (m, 1H), 7.01-6.96 (m, 2H), 2.71-2.61 (m, 4H), 1.89-1.79 (m, 4H), 1.44 
(s, 9H). 
4a-allyl-2,3,4,4a-tetrahydro-1H-carbazole 78. 
 
Montgomery, T. D.; Zhu, Y.; Kagawa, N.; Rawal, V. H. Palladium-Catalyzed 
Decarboxylative Allylation and Benzylation of N-Alloc and N-Cbz Indoles. Org. Lett. 
2013, 15, 1140-1143  
78. Yellow oil, (70.1 mg, 75%), Rf = 0.15; (40% ethyl acetate/60% petroleum ether); IR 
(thin film) 2931, 2860, 1582, 1454, 752 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.58 (d, J = 
7.70 Hz, 1H), 7.27-7.21 (m, 2H), 7.13-7.08 (m, 1H), 5.08 (ddt, J = 17.4, 9.7, 7.2 Hz, 1H), 
4.83 (dq, J = 17.0, 3.2, 1.4 Hz, 1H), 4.78 (dq, J =10.0, 1.85, 0.90, Hz, 1H), 2.84-2.78 (m, 
1H), 2.52 (m, 1H), 2.45 (dt, J=1.10, 6.70 Hz, 1H), 2.55-2.52 (m, 1H), 2.10 (dq, J = 14.0, 
5.7, 2.4 Hz, 1H), 2.10-2.09 (m, 1H), 1.77-1.68 (m, 1H), 1.64-1.62 (m, 1H), 1.38-1.31 (m, 
1H), 1.13 (td, J = 14.0, 4.2 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ 188.8, 154.9, 144.6, 
132.2, 127.6, 124.6, 121.9, 120.1, 117.9, 57.6, 37.6, 37.0, 30.2, 28.8, 21.1.  
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3-allyl-2,3-dimethyl-3H-indole 79. 
 
 
 
Montgomery, T. D.; Zhu, Y.; Kagawa, N.; Rawal, V. H. Palladium-Catalyzed 
Decarboxylative Allylation and Benzylation of N-Alloc and N-Cbz Indoles. Org. Lett. 
2013, 15, 1140-1143  
79. Clear oil, (85 mg, 79%), Rf  = 0.17 (20% ethyl acetate/80% petroleum ether); IR (thin 
film) 3076, 2975, 2912, 1640, 1578, 1451, 1270, 1198, 917, 715 cm-1; 1H-NMR 
(300MHz, CDCl3) δ 7.52 (d, J=7.65 Hz, 1H), 7.19 (td, J=1.20, 7.55 Hz, 1H), 7.06-6.99 
(m, 2H), 5.15 (ddt, J =17.5, 9.6,7 Hz, 1H), 4.94 (dd, J = 17.5, 2.0 Hz, 1H), 4.86 (dd, J = 
10.1, 0.8 Hz, 1H), 2.62 (m, 1H), 2.41 (m, 1H), 2.25 (s, 3H), 1.30 (s, 3H). 13C-NMR 
(75MHz, CDCl3) 186.2, 154.2, 143.0, 136.1, 129.4, 127.7, 127.6, 126.6, 124.5, 122.6, 
119.8, 58.4, 42.7, 21.9, 16.2.  
4a-(4-methoxybenzyl)-2,3,4,4a-tetrahydro-1H-carbazole 80. 
Lit. Ref. : Zhu, Y.; Rawal, V. H. Palladium-Catalyzed C3-Benzylation of Indoles. J. Am. 
Chem. Soc. 2012, 134, 111–114. 
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80. Yellow liquid, (133 mg, 91%), TLC Rf = 0.33 (50% ethyl acetate/50% petroleum 
ether); IR (neat) 3005, 2934, 2858, 1611, 1581, 1512, 1454, 1250, 1035, 832, 751 cm-1; 
1H NMR (300 MHz, CDCl3) δ 7.46 (d, J = 7.7 Hz, 1H), 7.27 (td, J = 7.7, 1.3 Hz, 1H), 
7.10 (m, J = 7.3, 0.5 Hz, 2H), 6.68 (d, J = 8.7 Hz, 2H), 6.60 (d, J = 8.7 Hz, 2H), 3.68 (s, 
3H), 3.15 (d, J = 13.7 Hz, 1H), 2.93-2.90 (m, 2H), 2.74 (td, J = 13.3, 5.6 Hz, 1H), 2.46-
2.40 (m, 1H), 2.27-2.23 (m, 1H), 2.00 (qt, J = 13.7, 3.7 Hz, 1H), 1.75 (ddd, J = 14.0, 3.7, 
2.4 Hz, 1H) 1.46-1.36 (m, 1H), 1.19-1.15 (m, 1H). 13C NMR (75 MHz, CDCl3) 188.7, 
158.2, 155.0, 144.4, 130.4, 128.2, 127.6, 124.3, 122.7, 120.1, 113.2, 58.8, 55.1, 38.3, 
36.9, 30.7, 29.2, 21.4.  
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Syntheses of Tryptamine-based SHIP Inhibitors 
Abstract 
Phosphatidylinositol 3’-kinase (PI3K) is an important component of an important 
signaling pathway which regulates cell growth and cell proliferation. The SH2 containing 
inositol 5'-phosphatase (SHIP) also plays a regulatory role in the PI3K signaling pathway. 
Inhibition of SHIP using small molecules has been shown to result in decreased cell 
growth in a number of cancer cell lines. Thus, SHIP inhibitors are being investigated as 
potential anti-cancer drugs. In this chapter, synthesis of a tryptaimine based SHIP 
inhibitor and some analogs is discussed. 
Background and Significance 
Eukaryotic cell membranes contain several different types of lipids, including 
phosphoinositide phosphates. Phosphoinositide phosphates (PIPn) are lipids attached to a 
myo-inositol group, which is decorated with phosphates. The inositol portions of these 
compounds are concentrated on cytosolic face of cell membranes. The pattern of 
phosphorylation on the inositol acts as a recognition element for many protein kinases 
and phosphatases, which are often involved in modulating signaling cascades between the 
cell membrane and the nucleus. These cascades often specifically regulate cell 
proliferation, survival, differentiation and migration.1,2 
Phosphatidyl inositol 3’-kinase (PI3K), phosphatase and tensin homolog protein (PTEN) 
and SH2 containing 5'-inositol phosphatase (SHIP) are examples of inositol kinases and 
phosphatases that metabolize phosphoinositols.3 PI3K has a widespread influence on 
cellular physiology,4 primarily due to its key role in the transformation of the inositol 
bisphosphate [PI(4,5)P2] into the inositol triphosphate [PI(3,4,5)P3].5 
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Phosphatidylinositol-3,4,5-triphosphate [PI(3,4,5)P3] exerts it's influence as a secondary  
messanger, recruiting and activating a variety of proteins including the key 
serine/threonine-specific protein kinase Akt, which can control cell migration and cell 
division. Misregulation of PI(3,4,5)P3 has been implicated in several disease states such 
as cancer diabetes, and cardiovascular disease.2  
 
Figure 4.1 PI3K/Akt/mTor Pathway6 
PI(3,4,5)P3 is usually mantained at low concentration in cells. However, PI3K can rapidly 
synthesize PI(3,4,5)P3 from phosphatidylinositol-4,5-diphosphate [PI(4,5)P2]. PI(3,4,5)P3 
levels are also governed by degradation of the triphosphate by the phosphatase and tensin 
homolog protein (PTEN), which facilitates a simple hydrolysis reaction of the 3'-
phospate, reversing the PI3K reaction. PTEN is known to be a to be a tumor supressor.7,8 
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Inhibiting PTEN has been linked to a wide variety of heriditary and non heriditary 
cancers.9,10 
The SH2 containing inositol 5'-phosphatase (SHIP) can also regulate the amount of 
PI(3,4,5)P3 present at the cell membrane by converting it to phosphatidylinositol-3,4-
diphosphate [PI(3,4)P2]. Unlike PI(4,5)P2, PI(3,4,5)P3 and PI(3,4)P2 are both signaling 
active, and both molecules may be required to promote a malignant state.11,12 In fact, 
PI(3,4)P2 levels are increased in lukemic cells.13 Thus SHIP inhibitors may promote 
apoptosis of cancer cell lines by inhibiting the formation of PI(3,4)P2 levels. There are 
three main forms of SHIP (SHIP1, SHIP2 and s-SHIP). SHIP1 is expressed in blood cells 
and other hematopoietic cells. SHIP2 is found ubiquitously in all other cells. 14-18 s-SHIP 
is a special form of SHIP present in stem cells that lacks the SH2 protein recognition 
domain.19 
 
Figure 4.2- Hydrolysis of PIP3 by PTEN and SHIP 
Recently, Kerr et al. found that SHIP1 knock-out mice accept mismatched bone marrow 
transplants without rejection or development of Graft-versus-Host disease (GvHD).11,20 
SHIP1 inhibitors also were found to promote apoptosis in human blood cancer cell lines.  
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Additionally, researchers at Purdue University found that SHIP2 is expressed in high 
levels inside breast cancer cell lines. Supporting a role for SHIP2 in cancer, SHIP2 
silencing leads to inhibition of in vivo tumor growth and lung metastasis.21 Thus, the 
available data support the hypothesis that SHIP1 and SHIP2 are clinically relevant anti-
cancer targets.  
Based on these results, small molecule inhibitors of SHIP1 and SHIP2 were desired. A 
library of small molecules from the NCI (the NCI diversity set) was screened utilizing a 
fluorescence polarization assay and some SHIP inhibitors were found. These inhibitors 
show biological activity against multiple myeloma and several other blood cancer cell 
lines.22-25 Further development of these molecules may lead to new therapeutics that 
enhance allogenic transplantation and reduce malignancies. 
One molecule which showed significant activity against SHIP1 and SHIP2 was the 
tryptamine analog NSC17383, 2-[1-(2-chlorobenzyl)-2-methyl-5-(methylmercapto)-1H-
3-yl] ethanamine 1. Tryptamine 1 and several analogues have been prepared and tested 
for inhibition of SHIP1 and SHIP2 using the malachite green assay which is a common 
method to test phosphatase activity and hence measure the activity of the inhibitor.26 
Selective inhibitors of SHIP1 and SHIP2 are of interest, as well as molecules that can 
inhibit both enzymes simultaneously.  These pan-SHIP inhibitors may not allow tumors 
to become resistant to inhibiton of one SHIP paralog by utilizing the other isoform in its 
place. Additionally, these studies will help define which portions of the tryptamine 
molecule are necessary for significant potency and selectivity. The analogues that are 
active will eventually be tested in cancer cell lines and, eventually, mice to evaluate their 
anti-tumor activity in several settings. 
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1  
Figure 4.3 (NSC17383) 
2-[1-(2-chlorobenzyl)-2-methyl-5-(methylmercapto)-1H-3-yl] ethanamine  
Results and Discussion 
The initial synthesis of tryptamine 1 was based on the convergent retrosynthetic scheme 
shown below. This route was an adaptation of the original literature synthesis performed 
at Sterling Drug Inc.26 Tryptamine 1 would be prepared from phthalimide protected 
indole 2. Indole 2 would come from Fischer indole reaction between phenyl hydrazine 3 
and ketone 4. The hydrazine 3 would be prepared from amine 5 through reduction of the 
corresponding N-nitroso amine. The amine 5 would come from reductive amination using 
4-methylthioaniline 6 and 2-chloro benzaldehyde 7. 
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O
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Cl
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S
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Figure 4.4 Initial Retrosynthetic Analysis 
The desired ketone N-phthalimido pentan-2-one 4 was prepared using a simple N-
alkylation method. Commercially available chloro ketone 8 and phthalimide 9 were 
heated in N,N-dimethylformamide in the presence of potassium carbonate for 18 h. The 
reaction mixture was simply poured into cold water to give tan precipitate of pure ketone 
4 in 86% yield.27  
Scheme 4.1 
O
Cl N
O
O
O
4
8
HN
O
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K2CO3
DMF, 80oC
18 h, 86%  
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The secondary amine 5 was prepared by Borch reduction (reductive amination) utilizing 
2-chlorobenzahdehyde 6 and aniline 7.28 The N-nitrosation reaction was then carried out 
using sodium nitrite and citric acid to provide 10 in 93 % yield.29 Reduction of the N-
nitroso compound 10 using zinc proved problematic and always resulted in significant 
conversion of the desired hydrazine back to amine 5.30 After several attempts, the 
secondary hydrazine was obtained in about 40% yield using zinc reduction under basic 
conditions [NH4OH and (NH4)2CO3].31 The Fischer indole process between 3 and 4 was 
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then attempted but no product was obtained in two attempts (EtOH, HCl reflux and 
TsOH, AcOH, 95 ºC).  
Scheme 4.3 
Cl
CHO
NH2
HN
N
Cl
N
ON H2N
NaBH(OAC)3
DCE, AcOH
rt 79 %
citric acid
sodium nitrite
wet silica
DCM, rt,  91 %
Zn, (NH4)2CO3
NH4OH, 
EtOH,  0oC
      48 %
Cl
6 11 12 13 14
Cl
 
In order to determine whether the hydrazine 3 or the ketone 4 was causing the difficulty 
in the synthesis, an attempt was made to synthesize the nor-SMe analogue of the 
compound. The secondary amine 12 was prepared by Borch reduction (reductive 
amination).27 The N-nitrosation reaction of amine 12 was carried out using sodium nitrite 
and citric acid.28 Reduction of the N-nitroso compound 13 using zinc reduction under 
basic conditions [NH4OH and (NH4)2CO3] furnished 14 in 48 % yield.30 The Fischer 
indole process was then attempted but no product was obtained in two attempts (EtOH, 
HCl reflux and TsOH, AcOH, 95 ºC).  
An alternative route was then devised where the product could be obtained by alkylation 
of indole 15 with 2-chlorobenzyl chloride 16. Indole 15 could be synthesized from known 
hydrazine 17 and ketone 4.  This route would avoid the low yields observed in the zinc 
reduction step and is actually one step shorter than the initial route, which was how the 
molecule was synthesized originally.31 
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Figure 4.5 Second Generation Retrosynthetic Analysis 
To determine good conditions for the Fischer Indole process the reaction was attempted 
using phenyl hydrazine 18 and ketone 4 using ethanol as solvent with added p-
toluenesulfonic acid (Scheme 2). Heating the reaction mixture for three hours furnished 
indole 19 in 83% yield.32 Fink’s protocol (Cs2CO3 as a base in CH3CN solvent) was used 
for N-alkylation of indole 19 using benzyl bromide 20.31 The reaction furnished alkylated 
indole 21. The phthalimide protecting group was removed using hydrazine hydrate in 
methanol at reflux to provide tryptamine 22 in  91%  yield.33 
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Scheme 4.4 
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With the core skeleton of the parent tryptamine successfully synthesized, several other 
analogues were investigated. In order to explore the synthesis of several 5-substituted 
tryptamine derivatives, corresponding hydrazine salts 25 a-d were prepared from 4-
substituted anilines via formation of the corresponding diazonium salt and in situ 
reduction using tin (II) chloride as shown in Table 1.34 
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Table 4.1: Synthesis of hydrazines from anilines 
HN
NH3+Cl-
RR
NH2
(1) NaNO2, HCl
(2) SnCl2, HCl
24 a-c 25 a-c  
Entry R= Isolated Yields % 
25a SMe 75 
25b I 86 
25c Br 66 
26d OMe 91 
 
The next step was the Fischer indole reaction. These reactions never seemed to reach 
completion, and even with long reaction times some starting hydrazine often remained. 
This may be due to the extremely low solubility of some hydrazine salts, especially the 
thiomethyl analogue. NMR analysis of the reaction mixture clearly showed the presence 
of excess ketone 4. Separation of the product from the ketone by silica gel column 
chromatography was very difficult as they often had similar mobility on silica gel. 
Attempts to force the reaction to completion with higher polarity solvents like acetic acid 
and ethylene glycol provided lower yields of the product. Use of p-toluene sulfonic acid 
in refluxing ethanol proved to be the best conditions, with the hydrazine being more 
soluble in the hot ethanol, and these conditions provided indole, 26a and 26c and 26d. 
Attempts to synthesize the 5-Iodoindole, 26b, provided no product under any conditions. 
Alternative routes to the synthesis of the 5-iodoindole analogue are discussed later in this 
chapter. 
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Table 4.2: Synthesis of indoles using Fischer conditions 
 
Entry R= Isolated Yields % Reaction 
Time 
26a SMe 75 36 h 
26b I 0 48 h 
26c Br 66 24 h 
26d OMe 68 12 h 
26e NO2 43 48 h 
 
It was envisaged that the iodoindole, once prepared, could be elaborated to several 
different groups using Suzuki couplings35 and Buchwald-Hartwig reactions.36,37 This 
would have been a flexible method to synthesize various analogues like 5-OMe, 5-OEt, 
5-Ph and 5-allyl. So, an iodination reaction of 19 was pursued using N-iodo 
succinimide.38,39 This reaction was carried out in the dark and at 0 oC. Crude 1H NMR did 
show some iodination. However, after purification, only starting material 19 was 
obtained. 
Scheme 4.5 
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4
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An aromatic Finkelstein reaction of 5-bromoindole 26c in presence of trans-1,2-
diaminocyclohexane, copper iodide and sodium iodide was also investigated.40 Only 19 
was obtained, however, and the synthesis of the 5-iodoindole was abandoned. 
Scheme 4.6 
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26c 26b  
In addtion the 5-methoxy and 5-nitro tryptamine analogs (26d and 26e, respectively) 
were also synthesized. In the future, the 5-nitro group would be reduced to 5-amino group 
which can later be converted to various amide or sulfonamide analogues. The 5-OMe 
analog, 26d may be deprotected with BBr3 and alkylated to form a variety of ether-based 
analogs without going through 5-iodoindole 26b. As shown before, N-alkylation of 
indoles in cesium carbonate using acetonitrile as the solvent is a very effective method. A 
number of analogues including the phthalimido-protected parent tryptamine were 
prepared in high yields using these conditions. 
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Table 4.3:  Alkylation of Indoles 
 
Entry R R1 R2 R3 X Yield 
27a H Cl H H Cl 87 
27b SMe H H H Br 77 
27c SMe Cl H H Cl 63 
27d SMe H Cl H Cl 78 
27e SMe H H Cl Cl 94 
27f SMe H H Br Br 62 
 
Deprotection of the phthalimde using the Ing-Manske procedure provided the required 
tryptamines in good yields. As these free amines proved unstable in some cases, they 
were immediately converted to their HCl salts. The yields reported in Table 4 are over 
two steps. 
R
N
H
NPhth
X
R1
R2
R3
Cs2CO3
CH3CN, 80 oC, 24h
R
N
NPhth
R1
R2
R3
26 a-c
27 a-f
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Table 4.4:  Deprotection of the phthalimide 
 
 
Entry R R1 R2 R3 Yield % 
29 a-i 
a H Cl H H 27 
b SMe H H H 14 
c SMe Cl H H 31 
d SMe H Cl H 34 
e SMe H H Cl 45 
f SMe H H Br 24 
g Br Cl H H 54 
        Note: Yields of 29 a-i are yields over two steps 
In order to test the importance of the benzyl group in the biological activity of these 
compounds, compounds without the benzyl group were also synthesized. Tryptamine 25a 
was treated with hydrazine hydrate to remove the phthalimide group. The HCl salt was 
then prepared providing tryptamine 31. 
R
N
NPhth
R1
R2
R3
27 a-f
R
N
NH2
R1
R2
R3
28 a-f
R
N
NH3+Cl-
R1
R2
R3
29 a-f
Hydrazine Hydrate
Methanol : THF
2:1
HCl in ether
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Scheme 4.7 
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The nor-SMe nor-chlorobenzyl compound was also synthesized using the same procedure 
as 31 as shown in Scheme 8. However, hydrochloride 33 failed to recrystallize, so it was 
tested as oil. 
Scheme 4.8 
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To understand the effect of substitution of the amino group on the activity of tryptamine 
based compounds, the amino group was alkylated. The parent tryptamine was first 
acylated in the presence of acetic anhydride and triethyl amine. The acylated amine was 
also sent for testing. The acylated tryptamine was then reduced in presence of lithium 
aluminium hydride to give N-ethyl tryptamine 35. 
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Scheme 4.9 
 
The parent tryptamine was also reacted with boc-anhydride in the presence of 
triethylamine to form the boc-protected tryptamine. The boc-protected tryptamine was 
then reduced in the presence of lithium aluminium hydride to give N-methyl tryptamine 
analogue 38. 
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The parent tryptamine was also converted into its tertiary amine to check its activity on 
SHIP enzyme. The parent tryptamine was subjected to reductive amination conditions 
with formalin in presence of sodium cyanoborohydride to give N,N dimethyl tryptamine 
40. 
Scheme 4.11 
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Changing the length of alkyl linker between the indole and the amine and then observing 
its effect on SHIP enzyme activity was also explored. So, a shorter chain ketone, 4-
phthalimido-2-butanone (as opposed to 4-phtalimido-2-pentanone in the parent 
compound) was synthesized using the 1,4-addition of phthalimide to methyl vinyl ketone. 
Fischer indole reaction with hydrazine 25a furnished indole 44. In the future, alkylation 
of the indole with 2-chloro benzylchloride would provide indole 45. De-protection of 
phthalimide would then be followed by conversion of the amine to its hydrochloric acid 
salt 47. 
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Scheme 4.12 
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In order to demonstrate the applicability of C-alkylation reactions of indoles with 
trichloroacetimidates, indole 48 was alkylated at 3-position. After the N-alkylation 
reaction, the nitro group was reduced and the hydrochloric acid salt was prepared. 
Derivative 53 will be sent to the Kerr lab at the Upstate Medical University to see if they 
are active to inhibit SHIP1/2 enzyme. 
Scheme 4.13 
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A number of these derivatives have been tested for their ability to inhibit the SHIP 
phosphatases. A colorimetric Malachite Green assay was used to evaluate SHIP 
activity,41 as this assay is less expensive. The results of the assay for some of the 
compounds are shown below in Table 5. 
Table 4.5: SHIP Inhibitory activities of Tryptamine 1 and its analogsa 
Entry Compound SHIP1 Inhibition SHIP2 Inhibition 
a 
 
85% nd 
b 
 
38% 30% 
c 
 
36% 19% 
d 
 
60% 42% 
e 
 
22% 39% 
N
NH3+Cl-
23
N
NH3+Cl-
29a
Cl
N
NH3+Cl-
MeS
29b
N
MeS
NH3+Cl-
Cl
29c
N
NH3+Cl-
MeS
29d
Cl
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f 
 
23% 30% 
g 
 
19% 42% 
h 
 
67% nd 
i 
 
42% 20% 
j 
 
77% nd 
k 
 
42% 20% 
aResults from the Malachite Green assay performed at 1 mM concentration.  
Tryptamines 29c, 39 and 41 showed inhibition of SHIP1/2. Tryptamines 29d and 29f 
demonstrated an especially strong inhibition of SHIP2. Tryptamines 39 and 42 on the 
N
NH3+Cl-
MeS
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Cl
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N
NH2+Cl-
MeS
Cl
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other hand show stronger inhibition of SHIP1. While it is too early to define any specific 
structure activity relationships (more data is needed), it appears the propensity of the 
inhibitors to inhibit either SHIP1 or SHIP2 may be controlled by the structural features 
on the tryptamine. 
Recently, Kerr Lab also investigated the role of SHIP2 enzyme in colorectal cancer. It 
was shown that SHIP2 expression and its enzymatic activity are enhanced in colorectal 
cancer tissue. Thus SHIP2 is a potential target to combat against this disease. The MTT 
(3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay was performed in 
two different epithelialcolorectal cancer cell lines (CRC), namely HCT116 and CACO-2 
cell lines. Two compounds, tryptamine 1 and 29f were found to be particularly effective. 
The cell viability versus doses of the tryptamines in µM is shown in figures 1.6 and 1.7. 
 
Tryptamine 1 (µM) 
Figure 4.6- Cell Viability versus concentration of Tryptamine 1 
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Tryptamine 29f (µM) 
Figure 4.7- Cell Viability versus concentration of Tryptamine 29f 
Both compounds induced a dose-dependent reduction in cell viability and induced cell 
death at low concentrations, however, both cell lines were more sensitive to the K149 
inhibitor. These initial results pave the way for a more complete study of these 
tryptamine based SHIP inhibitors. 
Conclusion 
A large number of tryptamine analogs have been prepared. These analogs include varying 
substitution on the indole, the appended phenyl ring and substitution on the basic 
nitrogen. The length of the carbon tether between the indole and the basic amine was also 
varied. These analogs are being tested in vitro and will provide information about the 
activities of these potential inhibitors. Future studies include the investigation of other 
tryptamine based inhibitors with different substitution patterns on the indole ring. 
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Experimental Section 
General Information. All anhydrous reactions were performed under a positive pressure 
of argon or nitrogen. All syringes, needles, and reaction flasks required for anhydrous 
reactions were dried in an oven and cooled under an N2 atmosphere or in a desiccator. 
Dichloromethane and THF were dried by passage through an alumina column following 
the method of Grubbs.43 Triethylamine was distilled from CaH2. All other reagents and 
solvents were purchased from commercial sources and used without further purification. 
Analysis and Purification. Analytical thin layer chromatography (TLC) was performed 
on precoated glass backed plates (silica gel 60 F254; 0.25 mm thickness). The TLC plates 
were visualized by UV illumination and by staining. Solvents for chromatography are 
listed as volume:volume ratios. Flash column chromatography was carried out on silica 
gel (40-63 µm). Melting points were recorded using an electrothermal melting point 
apparatus and are uncorrected. Optical rotations were measured at the sodium D line (589 
nm) on a digital polarimeter and reported in reagent grade solvent. Enantiopurity was 
determined using chiral phase HPLC with an OD-H (0.46 × 25 cm) column. Elemental 
analyses were performed on an elemental analyzer with a thermal conductivity detector 
and 2 meter GC column maintained at 50 °C. 
Identity. Proton (1H NMR) and carbon (13C NMR) nuclear magnetic resonance spectra 
were recorded at 300 MHz and 75 MHz respectively. The chemical shifts are given in 
parts per million (ppm) on the delta (δ) scale. Coupling constants are reported in hertz 
(Hz). The spectra were recorded in solutions of deuterated chloroform (CDCl3), with  
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residual chloroform (δ 7.26 ppm for 1H NMR, δ 77.23 ppm for 13C NMR) as the internal 
reference. Data are reported as follows: (s = singlet; d = doublet; t = triplet; q = quartet; p 
= pentet; dd = doublet of doublets; dt = doublet of triplets; td = triplet of doublets; tt = 
triplet of triplets; ddd = doublet of doublet of doublets; brs = broad singlet). Where 
applicable, the number of protons attached to the corresponding carbon atom was 
determined by DEPT 135 NMR. Infrared (IR) spectra were obtained as thin films on 
NaCl plates by dissolving the compound in CH2Cl2 followed by evaporation. 
 
 
N-(4-oxopentyl) phthalimide, 4 
Lit. Ref. : Bell, D. Process for preparation of Quinoline Derivatives. International Patent. 
03/093239 A2, Nov 13, 2003. 
Phthalimide (2.20 g, 15 mmol) and potassium carbonate (3.12 g, 22.5 mmol) were 
suspended in 15 mL of N,N-dimethylformamide and warmed to 80 ºC. 5-Chloro-2-
pentanone (3.54 ml, 3.62 g, 30 mmol) was added. After 24 h, the reaction mixture was 
poured into ice cold water (20 mL). After stirring for 20 min the mixture was filtered. 
The precipitate was dried under vacuum to give 2.98 g (86%) of 4 as tan powder. 
4. TLC Rf = 0.46 (70 % ethyl acetate : 30 % hexanes); mp = 55-57 ºC; IR (KBr) 3055, 
2988, 1774, 1714, 1422, 1265, 706 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.76-7.79 (m, 
2H), 7.63-7.66 (m, 2H), 3.64 (t, J = 6.0 Hz, 2H), 2.43 (t, J = 6.0 Hz, 2H), 2.07 (s, 3H), 
1.89 (p, J = 6.0 Hz, 2H). 
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N‐(2‐chlorobenzyl)‐aniline, 5 
To a stirred solution of 2-chlorobenzaldehye (6) (1.34 ml, 10.77 mmol) in 30 mL of 
dichloroethane was added aniline (7), (1.33 ml, 11.85mmol) and NaBH(OAc)3 (4.65 g, 
21.54 mmol). The mixture was stirred for 12 h. The reaction mixture was diluted with 
ethyl acetate (30 mL) and quenched with distilled water (15 mL). The resulting mixture 
was neutralized using saturated aqueous sodium bicarbonate. The organic layer was 
separated, dried over anhydrous Na2SO4 and filtered. The solvent from the filtrate was 
removed under reduced pressure. The crude product obtained was pre-absorbed on silica 
gel with ethyl acetate. Purification by silica gel column chromatography (5 % ethyl 
acetate/hexanes eluent) afforded 2.61 g (91%) of amine (5) in the form of thick oil. 
5. Rf = 0.85 in 10 % ethyl acetate/ 90 % hexanes; IR (film) 3381, 2942, 2873, 1660, 1319, 
1025, 764 cm‐1; 1H NMR (300 MHz, CDCl3) δ 7.32 (dd, 2H, J = 1.8, 5.1 Hz), 7.11‐7.19 
(m, 4H), 6.50, (app d, 2H, J = 2.1, 6.6 Hz), 4.35 (s, 2H), 4.15 (bs, 1H), 2.33 (s, 3H). 
N
Cl
S
NO
 
2‐chlorobenzyl‐(4‐methylmercapto)‐N‐nitrosoaniline, 10 
A suspension of amine (5) (1.00 g, 3.795 mmol), citric acid (0.48 g, 2.5 mmol), wet SiO2 
(50%, w/w), (1.2 g) and NaNO2 (0.523 g, 7.59 mmol) in dichloromethane (5 mL) was 
HN
SMe
Cl
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stirred at room temperature for 30 min (reaction progress was monitored by TLC) and 
then filtered. The solid residue was washed with dichloromethane (35 mL). Anhydrous 
Na2SO4 was added to the filtrate and then filtered off after 10 min. Dichloromethane was 
removed under reduced pressure. The crude product obtained was pre-absorbed on silica 
gel with ethyl acetate. Purification by silica gel column chromatography (5 ‐ 30% ethyl 
acetate/hexanes eluent) afforded 1.02 g (93%) of N‐nitroso compound (10) in the form of 
thick orange oil.  
10. TLC Rf = 0.85 in 10 % ethyl acetate/90 % hexanes; IR (film) 1495, 1137, 751, 820, 
1104, 1403 cm‐1. 1H NMR (300 MHz, CDCl3) 7.37 (app d, 2H, J = 6.0, 0.6 Hz), 7.31 (dd, 
1H, J = 8.1, 1.5 Hz), 7.22 (app d, 2H, J = 6.3, 1.8 Hz), 7.13 (ddd, 1H, J = 7.5, 6.0, 1.2. 
Hz), 7.07 (ddd, 1H, J = 7.5, 6.0, 1.5 Hz), 6.69 (app d, 1H, J = 7.8, 0.6 Hz), 5.23 (s, 2H), 
2.37 (s, 3H). 
N
Cl
S
NH2
 
2‐chlorobenzyl‐4‐methylmercaptophenyl hydrazine, 3 
To a stirred solution of N‐nitroso compound (10) (0.146 g, 0.5 mmol) in 2 mL of ethanol, 
0.2 g 
(NH4)2CO3 dissolved in a minimum amount of water was added and the mixture was 
maintained at 0 ᵒC. Concentrated aq. NH4OH (0.5 mL) was added very slowly. After 10 
min the orange color disappears upon which reaction was monitored by TLC until 
completion. The suspended solid was filtered off. The oil obtained is pre-absorbed on 
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silica gel and purified by silica gel column chromatography (5 ‐ 20% ethyl 
acetate/hexanes eluent) to afford 0.05g (39%) of hydrazine 3. 
3. Rf = 0.58 in 10 % ethyl acetate/hexanes; 1H NMR (300 MHz, CDCl3) δ 7.32‐7.38 (m, 
2H), 
7.13‐7.21 (m, 4H), 6.90, (app d, 2H, J = 6.9, 1.8 Hz), 4.63 (s, 2H), 3.65 (bs, 2H), 2.35 (s, 
3H). 
NH
Cl
 
N‐(2‐chlorobenzyl)‐aniline, 12 
To a stirred solution of aldehyde (6), (1.34 ml, 10.77 mmol) in 30 mL of dichloroethane, 
was added aniline (11), (1.33 ml, 11.85mmol) and NaBH(OAc)3 (4.65 g, 21.54 mmol) 
and AcOH (0.57 ml, 10 mmol). The reaction mixture was diluted with ethyl acetate (30 
mL) and quenched with distilled water (15 mL). The resulting mixture was neutralized 
using saturated sodium bicarbonate. The ethyl acetate layer was separated and dried over 
anhydrous Na2SO4. The solvent was removed under reduced pressure. The crude product 
obtained was pre-absorbed on silica gel with ethyl acetate. Purification by silica gel 
column chromatography (5% ethyl acetate/hexanes eluent) afforded 1.69 g (79%) of 
amine 12 in the form of thick oil. 
12. TLC Rf = 0.87 in 10 % ethyl acetate/ 90 % hexanes; IR (film) 3583, 3219, 1660, 
1025, 665 cm‐1; 1H NMR (300 MHz, CDCl3) δ 7.31‐7.38 (m, 2H,), 7.09‐7.19 (m, 4H), 
6.65‐6.71 (m, 1H), 6.56, (app d, 2H, J = 6.0 Hz), 4.36 (s, 2H), 4.08 (bs, 1H). 
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2‐chlorobenzyl phenyl‐N‐nitrosoaniline, 13 
A suspension of (12) (1.00 g, 3.795 mmol), citric acid (0.48 g, 2.5 mmol), wet SiO2 
(50%, w/w), 
(1.2 g) and NaNO2 (0.523 g, 7.59 mmol) in dichloromethane (5 mL) was stirred at room 
temperature for 30 min (reaction progress was monitored by TLC) and then filtered. The 
residue was extracted with CH2Cl2 (35 mL). The combined organic extracts were then 
dried with Na2SO4, filtered and concentrated. The crude product obtained was pre-
absorbed on silica gel with ethyl acetate. Purification by silica gel column 
chromatography (5 ‐ 30% ethyl acetate/hexanes eluent) afforded 1.08 g (96%) of 13 in 
the form of a thick orange oil. 
13. Obtained as an orange oil. TLC Rf = 0.85 in 10 % ethyl acetate/ 90 % hexanes; IR 
(film) 3064, 3030, 1472, 1444, 1120, 534 cm‐1. 1H NMR (300 MHz, CDCl3) 7.47 (app d, 
2H, J = 2.1, 9.6 Hz), 7.38 (app dd, 1H, J = 7.2, 1.5 Hz), 7.37‐7.27 (m, 2H) 7.24 (td, 2H, J 
= 8.0, 1.2 Hz), 7.06 (td, 2H, J = 8.0, 1.2 Hz), 6.69 ( d, 1H, J = 7.8 Hz), 5.23 (s, 2H). 
N NH2
Cl
 
2‐chlorobenzyl‐1‐phenyl hydrazine, 14 
To a stirred solution of (13) (0.146 g, 0.5 mmol) in ethanol (2mL), 0.2 g (NH4)2CO3 
dissolved in minimum amount of water was added and the mixture was agitated in an ice 
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bath. NH4OH (0.5 mL) was then added very slowly. After 3 h the orange color 
disappeared. The reaction showed completion by TLC. The reaction mixture was filtered 
and concentrated. The oil obtained was pre-absorbed on silica gel and purification by 
silica gel column chromatography (5 ‐ 20% ethyl acetate/hexanes eluent) afforded 0.06 g 
(48%) of 14. 
14. Rf = 0.66 in (10 % ethyl acetate/ 90 % hexanes); 1H NMR (300 MHz, CDCl3) δ 7.31‐
7.35 (m, 2H), 7.10‐7.20 (m, 4H), 6.80‐6.84, (m, 3H), 4.64 (s, 2H), 3.65 (bs, 2H). 
General Method for Fischer indole synthesis 
Corresponding phenyl hydrazine (1 eq, 1.52 mmol) and ketone 4 (0.9 eq, 1.36 mmol) 
were dissolved in 5 mL ethanol. TsOH•H2O (4 eq, 6.08 mmol) was added. The reaction 
mixture was heated to reflux for approximately 18 h. The reaction mixture was then 
cooled to room temperature and poured into 30 mL of 1M NaOH. The mixture was then 
extracted with dichloromethane (3 x 20 mL). The organic extracts were dried over 
Na2SO4, filtered and concentrated to give the required products. These indoles were 
purified using silica gel chromatography utilizing mixtures of ethyl acetate in hexanes as 
the eluent.  
Note: The stated TLC solvent system is used for purifying the indoles. 
 
Sosič, I. Anderluh, M.; Sova, M.; Gobec, M.; Mlinarič, R. I., Derouaux, A.; Amoroso, A.; 
Terrak. M.; Breukink. E.; Gobec. S. Structure-activity relationships of novel tryptamine-
based inhibitors of bacterial transglycosylase. J. Med. Chem. 2015, 58, 9712-9721. 
137	
	
1H-isoindole-1,3-dione-(2H), 2-[2-(2-methyl-1H-indol-3-yl)-ethyl]-, 19. 
19. Obtained as red solid. Yield = 83%. TLC Rf = 0.53 (30% ethyl acetate in hexanes); 
168-174 ºC IR (thin film) 3469, 3155, 2256, 1794, 1712, 1395, 950 cm-1; 1H NMR (300 
MHz, CDCl3) δ 8.00 (bs, 1H), 7.74-7.76 (m, 2H), 7.62-7.59 (m, 3H), 7.20-7.13 (m, 1H), 
7.02-6.99 (m, 2H),   3.85-3.79 (m, 2H), 3.02-2.96 (m, 2H), 2.30 (s, 3H). 13C NMR (75 
MHz, CDCl3) δ 167.9, 136.3, 132.1, 131.3, 128.8, 127.4, 122.2, 120.0, 118.6, 111.7, 
111.4, 108.3, 44.4, 20.2, 14.9, 12.4. 
N
H
N
O
O
S
 
2-(2-(2-methyl-5-(methylthio)-1H-indol-3-yl)ethyl)isoindoline-1,3-dione, 
26a
 
Sosič, I. Anderluh, M.; Sova, M.; Gobec, M.; Mlinarič, R. I., Derouaux, A.; Amoroso, A.; 
Terrak. M.; Breukink. E.; Gobec. S. Structure-activity relationships of novel tryptamine-
based inhibitors of bacterial transglycosylase. J. Med. Chem. 2015, 58, 9712-9721. 
26a. Obtained as a yellow solid. Yield = 75%. TLC Rf = 0.40 (30 % ethyl acetate in 
hexanes); mp = 179-184 oC IR (thin film) 3435, 2927, 1772, 1712, 1469, 1396, 651 cm-1; 
1H NMR (75 MHz, CDCl3) δ 8.00 (bs, 1H), 7.76-7.74 (m, 2H), 7.64-7.61 (m, 2H), 7.52 
(s, 1H), 7.18-7.10 (dd, J = 7.6, 1.8 Hz, 1H), 7.00-7.03 (dd, J = 7.6, 1.8 Hz, 2H), 3.83-3.78 
( m, 2H), 2.99-2.94 (m, 2H), 2.42 (s, 3H), 2.30 (s, 3H). 13C NMR (300 MHz, CDCl3) δ 
167.9, 132.3, 132.1, 131.3, 128.8, 127.6, 118.6, 111.7, 111.4, 108.3, 44.4, 20.2, 14.9, 
12.4. 
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N
H
N
O
O
Br
 
2-(2-(5-bromo-2-methyl-1H-indol-3-yl)ethyl)isoindoline-1,3-dione, 
26c
 
26c. Obtained as yellow oil. Yield = 66%. TLC Rf = 0.40 (30 % ethyl acetate in hexanes); 
IR (thin film) 3469, 3155, 2256, 1794, 1714, 1344, 950 cm-1; 1H NMR (300 MHz, 
CDCl3) δ 7.78 (bs, 1H), 7.71-7.74 (m, 2H), 7.60-7.57 (m, 3H), 7.20-7.13 (m, 1H), 7.02-
6.99 (m, 2H), 3.85-3.79 (m, 2H), 3.02-2.96 (m, 2H), 2.30 (s, 3H). 13C NMR (75 MHz, 
CDCl3) δ 169.0, 134.7, 132.5, 132.2, 128.9, 128.6, 123.1, 120.4, 118.6, 117.3, 110.4, 
106.8, 38.4, 23.3, 10.7. 
N
H
O
N
O
O
 
2-(2-(5-methoxy-2-methyl-1H-indol-3-yl)ethyl)isoindoline-1,3-dione, 
26d
 
Sosič, I. Anderluh, M.; Sova, M.; Gobec, M.; Mlinarič, R. I., Derouaux, A.; Amoroso, A.; 
Terrak. M.; Breukink. E.; Gobec. S. Structure-activity relationships of novel tryptamine-
based inhibitors of bacterial transglycosylase. J. Med. Chem. 2015, 58, 9712-9721. 
26d. Obtained as brown oil. Yield = 68%. TLC Rf = 0.40 (30 % ethyl acetate in hexanes); 
IR (thin film) 3430, 3003, 2956, 1712, 1549, 1395, 967 cm-1; 1H NMR (300 MHz, 
CDCl3) δ 7.78 (bs, 1H), 7.71-7.74 (m, 2H), 7.60-7.57 (m, 3H), 7.20-7.13 (m, 1H), 7.02-
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6.99 (m, 2H),  3.88 (s, 3H), 3.85-3.79 (m, 2H), 3.02-2.96 (m, 2H), 2.30 (s, 3H). 13C NMR 
(75 MHz, CDCl3) δ 167.0, 155.3, 132.3, 132.1, 131.3, 128.9, 128.5, 128.4, 127.6, 109.6, 
108.4, 101.8, 56.4, 45.3, 23.3, 12.7. 
N
H
N
O
O
O2N
 
2-(2-(5-nitro-2-methyl-1H-indol-3-yl)ethyl)isoindoline-1,3-dione, 26e
 
26c. Obtained as orange oil. Yield = 43%. TLC Rf = 0.60 (40 % ethyl acetate in hexanes); 
IR (thin film) 3469, 3155, 2256, 1732, 1315, 1506 cm-1; 1H NMR (300 MHz, CDCl3) δ 
10.1 (bs, 1H), 8.13 (d, J = 9.0 Hz, 1H), 8.11 (s, 1H), 7.71-7.74 (m, 2H), 7.60-7.57 (m, 
2H), 7.20 (d, J = 9.0 Hz, 1H), 3.85-3.79 (m, 2H), 3.02-2.96 (m, 2H), 2.96 (s, 3H). 13C 
NMR (75 MHz, CDCl3) δ  169.0, 142.3, 142.0, 132.5, 132.2, 127.9, 120.4, 114.6, 115.0, 
112.4, 106.8, 49.4, 20.3, 10.7. 
N
H
PhthN
S
 
2-((2-methyl-5-(methylthio)-1H-indol-3-yl)methyl)isoindoline-1,3-dione, 44  
44. Obtained as yellow oil. Yield = 83%. TLC Rf = 0.33 (30 % ethyl acetate in hexanes); 
IR (thin film) 3430, 3002, 2216, 1794, 1712, 903 cm-1; 1H NMR (75 MHz, CDCl3): δ 
7.78 (bs, 1H), 7.78-7.71 (m, 2H), 7.60-7.57 (m, 2H), 7.15-7.13 (m, 1H), 7.12-7.03 (m, 
2H), 4.86 (s, 2H), 2.58 (s, 3H), 2.48 (s, 3H). 13C NMR (300 MHz, CDCl3) δ 169.0, 134.7, 
132.5, 132.2, 128.9, 128.6, 123.1, 120.4, 118.6, 117.3, 110.4, 106.8, 38.4, 23.3, 10.7. 
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General Procedure for N-alkylation of indoles. 
The corresponding indole (1 eq, 0.33 mmol) was dissolved in 6 mL acetonitrile. Cesium 
carbonate (6 eq, 1.98 mmol) was added and the mixture was heated to 80 ºC. The 
corresponding benzyl halide was then added. The reaction mixture was maintained at 80 
ºC for 18 h. The reaction was quenched with water (10 mL), the organic layer separated, 
and the aqueous layer extracted with ethyl acetate (3 x 10 mL). The combined organic 
extracts were dried with Na2SO4, filtered, and concentrated. Purification by silica gel 
chromatography provided the required product. 
Note: The stated TLC solvent system is used for purifying the indoles. 
 
Sosič, I. Anderluh, M.; Sova, M.; Gobec, M.; Mlinarič, R. I., Derouaux, A.; Amoroso, A.; 
Terrak. M.; Breukink. E.; Gobec. S. Structure-activity relationships of novel tryptamine-
based inhibitors of bacterial transglycosylase. J. Med. Chem. 2015, 58, 9712-9721. 
1H-isoindole-1,3-dione-(2H), 2-[2-(2-methyl-N-benzyl indol-3-yl)-ethyl]-, 21. 
21. Obtained as white solid. TLC Rf = 0.76 (30 % ethyl acetate in hexanes); mp = 141-
147 ºC; IR (thin film) 3005, 2924, 1716, 1421, 1362, 1222, 1093 cm-1; 1H NMR (300 
MHz, CDCl3) δ 7.77-7.73 (m, 2H), 7.64-7.60 (m, 2H), 7.19-7.10 (m, 5H), 7.03-6.02 (m, 
2H), 6.86 (d, J = 7.0 Hz, 2H),  3.87-3.81 ( m, 2H), 3.08-3.02 (m, 2H), 2.30 (s, 3H). 13C 
NMR (75 MHz, CDCl3) δ 168.6, 138.1, 136.7, 135.4, 134.0, 133.8, 132.4, 132.0, 128.8, 
128.7, 127.6, 123.3, 121.3, 121.2, 119.6, 110.3, 109.2, 108.0, 46.4, 23.9, 11.9. 
N
NPhth
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1H-isoindole-1,3-dione-(2H), 2-[2-(2-methyl-N-(o-chloro)-benzyl indol-3-yl)-ethyl]-, 
27a 
Sosič, I. Anderluh, M.; Sova, M.; Gobec, M.; Mlinarič, R. I., Derouaux, A.; Amoroso, A.; 
Terrak. M.; Breukink. E.; Gobec. S. Structure-activity relationships of novel tryptamine-
based inhibitors of bacterial transglycosylase. J. Med. Chem. 2015, 58, 9712-9721. 
27a. Obtained as yellow oil. TLC Rf = 0.70 (30 % ethyl acetate in hexanes); IR (thin film) 
3005, 2924, 1716, 1421, 1362, 1222, 1093 cm-1; 1H NMR (75 MHz, CDCl3) δ 7.76-7.72 
(m, 2H), 7.63-7.60 (m, 3H), 7.32 (d, J = 6.0 Hz, 1H), 7.09 (t, J = 9 Hz, 2H), 6.97 (d, J = 
6.0 Hz, 1H), 6.95 (d, J = 9.0 Hz, 2H),  6.13 (d, J = 6.0 Hz), 4.71 (s, 2H) 3.89-3.84 (m, 
2H), 3.10-3.05 (m, 2H), 2.20 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 167.6, 137.3, 135.0, 
132.6, 132.3, 132.1, 130.5, 129.0, 127.7, 127.6, 127.2, 121.0, 120.3, 119.6, 111.3, 108.2, 
43.4, 20.9, 14.9, 10.1. 
N
NPhth
S
 
1H-isoindole-1,3-dione-(2H), 2-[2-(2-methyl-5-thiomethyl-N-benzyl indol-3-yl)-
ethyl]-, 27b 
Sosič, I. Anderluh, M.; Sova, M.; Gobec, M.; Mlinarič, R. I., Derouaux, A.; Amoroso, A.; 
Terrak. M.; Breukink. E.; Gobec. S. Structure-activity relationships of novel tryptamine-
based inhibitors of bacterial transglycosylase. J. Med. Chem. 2015, 58, 9712-9721. 
N
Cl
NPhth
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27b. Obtained as colorless oil. TLC Rf = 0.70 (30 % ethyl acetate in hexanes); IR (thin 
film) 3005, 1712, 1420, 1220, 1093, 735 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.76-7.72 
(m, 2H), 7.64-7.59 (m, 3H), 7.30 (d, J = 6.0 Hz, 2H), 7.19-6.94 (m, 3H), 6.83 (t, J = 6.0 
Hz, 2H), 5.18 (s, 2H) 3.88-3.83 (m, 2H), 3.09-3.04 (m, 2H), 2.54 (s, 3H) 2.32 (s, 3H). 13C 
NMR (75 MHz, CDCl3) δ 168.6, 136.1, 133.7, 132.7, 132.4, 132.0, 129.8, 128.7, 127.9, 
127.6, 125.3, 119.6, 110.3, 108.2, 53.0, 46.4, 20.9, 14.9, 10.1. 
N
NPhth
S
Cl  
1H-isoindole-1,3-dione-(2H), 2-[2-(2-methyl-5-thiomethyl-N-(o-chloro benzyl indol-
3-yl)-ethyl]-, 27c 
Sosič, I. Anderluh, M.; Sova, M.; Gobec, M.; Mlinarič, R. I., Derouaux, A.; Amoroso, A.; 
Terrak. M.; Breukink. E.; Gobec. S. Structure-activity relationships of novel tryptamine-
based inhibitors of bacterial transglycosylase. J. Med. Chem. 2015, 58, 9712-9721. 
27c. Obtained as yellow solid. TLC Rf = 0.68 (30 % ethyl acetate in hexanes); IR (thin 
film) 3001, 2990, 1716, 1650, 1363, 760 cm-1; 1H NMR (75 MHz, CDCl3) δ 7.73-7.72 
(m, 2H), 7.62-7.59 (m, 2H), 7.56 (s, 1H), 7.43-7.40 (dd, J = 6.0, 2.0 Hz, 1H), 7.33-7.28 
(m, 1H), 7.24-7.21 (m, 1H), 7.14-7.10 (m, 2H) 7.02-6.95 (m, 1H), 4.72 (s, 2H) 3.94-3.83 
(m, 2H), 3.09-3.04 ( m, 2H), 2.54 (s, 3H) 2.32 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 
168.6, 135.2, 134.5, 134.0, 132.3, 132.0, 129.5, 129.0, 128.9, 128.7, 127.9, 127.5, 127.1, 
123.3, 123.2, 118.6, 109.2, 108.2, 63.1, 44.6, 23.7, 12.3, 10.2. 
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N
NPhth
S
Cl  
1H-isoindole-1,3-dione-(2H), 2-[2-(2-methyl-5-thiomethyl-N-(m-chloro benzyl indol-
3-yl)-ethyl]-, 27d. 
27d. Obtained as green solid. TLC Rf = 0.69 (30 % ethyl acetate in hexanes); IR (thin 
film) 3004, 2999, 1716, 1600, 1363, 1232, 790 cm-1; 1H NMR (75 MHz, CDCl3) δ  7.75-
7.70 (m, 2H), 7.62-7.58 (m, 2H),  7.52-7.49 (m, 2H), 7.33-7.30 (d, J = 9.0 Hz, 1H), 7.24-
7.21 (m, 1H), 7.03-6.99 (m, 2H), 6.09-6.06 (m, 1H), 5.17 (s, 2H) 3.95-3.80 (m, 2H), 
3.07-3.00 ( m, 2H), 2.41 (s, 3H) 2.16 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 168.5, 140.0, 
135.2, 134.9, 134.4, 134.0, 132.3, 130.0, 128.9, 127.9, 127.8, 126.3, 124.3, 123.3, 123.2, 
118.7, 109.7, 108.2, 46.4, 38.6, 23.7, 18.3, 10.4. 
N
NPhth
S
Cl  
1H-isoindole-1,3-dione-(2H), 2-[2-(2-methyl-5-thiomethyl-N-(p-chloro benzyl indol-
3-yl)-ethyl]-, 27e. 
27e. Obtained as white solid. TLC Rf = 0.68 (30 % ethyl acetate in hexanes); IR (thin 
film) 3001, 2980, 1718, 1650, 1363, 1220, 1003, 850 cm-1; 1H NMR (75 MHz, CDCl3) δ 
7.73-7.71 (m, 2H), 7.63-7.60 (m, 2H), 7.55 (s, 1H), 7.19-7.14 ( m, 2H), 7.00-6.98 (m, 
2H), 6.77-6.74 (d, J = 9.0, 2H), 5.10 (s, 2H), 3.94-3.83 (m, 2H), 3.09-3.04 ( m, 2H), 2.42 
(s, 3H) 2.19 (s, 3H). 13C NMR (300 MHz, CDCl3) δ 168.5, 136.9, 135.2, 134.4, 134.0, 
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132.3, 132.1, 128.9, 127.9, 123.3, 123.2, 121.4, 118.8, 109.6, 108.3, 46.3, 38.6, 23.7, 
18.9, 10.3. 
N
NPhth
S
Br  
1H-isoindole-1,3-dione-(2H), 2-[2-(2-methyl-5-thiomethyl-N-(p-bromo benzyl indol-
3-yl)-ethyl]-, 27f. 
27f. Obtained as orange oil. TLC Rf = 0.61 (30 % ethyl acetate in hexanes); IR (thin film) 
3116, 2990, 1718, 1633, 1329, 1090, 880 cm-1; 1H NMR (75 MHz, CDCl3) δ  7.73-7.71 
(m, 2H), 7.63-7.61 (m, 2H), 7.60 (s, 1H), 7.31-7.29 (d, J = 6.0 Hz, 2H), 7.00-6.98 (m, 
2H), 6.70-6.68 (d, J = 6.0 Hz, 2H) (m, 1H), 5.12 (s, 2H) 3.84-3.82 (m, 2H), 3.09-3.04 (m, 
2H), 2.42 (s, 3H) 2.19 (s, 3H). 13C NMR (75MHz, CDCl3) δ 168.5, 136.9, 135.2, 134.4, 
134.0, 132.3, 132.1, 128.9, 127.6, 123.3, 123.2, 121.4, 109.6, 108.2, 46.3, 38.6, 23.7, 
18.9, 10.4. 
 
General Method for de-protection of phthalamido group and preparation of 
tryptamine salts. The phthalimide protected tryptamine (1 eq, 0.38 mmol) was dissolved 
in 5 mL methanol. Hydrazine hydrate (85%, 5 eq, 1.90 mmol) was then added. The 
reaction mixture was refluxed for 0.5 h. The reaction mixture was allowed to cool and 
concentrated. The resulting residue was dissolved in dichloromethane and purified by 
silica gel chromatography (90% dichloromethane: 9 % methanol: 1 % ammonium 
hydroxide). The corresponding tryptamine (1 eq, 0.40 mmol) was dissolved in 1 mL of 
1M ether-HCl. Et2O (10 eq, 4.0 mmol) was added. The reaction mixture was allowed to 
145	
	
stand for 20 minutes and then concentrated. Recrystallization from mixtures of ether, 
hexanes or methanol furnished the required products. 
N
NH3+Cl-
 
2-[1-benzyl-2-methyl-5-1H-3-yl] ethanaminium chloride, 23 
Sosič, I. Anderluh, M.; Sova, M.; Gobec, M.; Mlinarič, R. I., Derouaux, A.; Amoroso, A.; 
Terrak. M.; Breukink. E.; Gobec. S. Structure-activity relationships of novel tryptamine-
based inhibitors of bacterial transglycosylase. J. Med. Chem. 2015, 58, 9712-9721. 
23. Obtained as white solid. mp = 158-161oC (50% ether in hexanes). IR (thin film) 3420, 
2917, 2942, 2890, 1554, 1375, 1238 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.78 (s. 1H), 
7.62 (s, 1H),  7.47 (s, 1H), 7.17 (t, J = 6.0 Hz, 1H), 6.98 (d, J = 6.0 Hz, 1H), 6.13 (d, J = 
6.0 Hz), 2.89 (bs, 4H), 2.24 (s, 3H), 2.19 (s, 3H). 13C NMR (75 MHz, DMSO-d6) δ 139.1, 
136.8, 134.8, 134.6, 129.2, 127.8, 127.7, 126.9, 121.3, 119.6, 118.6, 110.3, 106.7, 46.3, 
33.5, 10.6. 
N
NH3+Cl-
Cl  
2-[1-(2-chlorobenzyl)-2-methyl-5-1H-3-yl] ethanaminium chloride, 29a. 
Sosič, I. Anderluh, M.; Sova, M.; Gobec, M.; Mlinarič, R. I., Derouaux, A.; Amoroso, A.; 
Terrak. M.; Breukink. E.; Gobec. S. Structure-activity relationships of novel tryptamine-
based inhibitors of bacterial transglycosylase. J. Med. Chem. 2015, 58, 9712-9721. 
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29a. Obtained as a yellow solid. mp = 161-169 oC (methanol). IR (thin film) 3466, 2988 
2942, 2910, 1561, 1448, 1375, 1242, 939 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.43-7.41 
(m, 1H), 7.39-7.31 (m, 1H), 7.29-7.27 (m, 2H),7.21-7.15 (m, 2H), 7.05-7.02 (m, 1H), 
6.93-6.85 (m, 1H),  5.28 (s, 2H), 3.36 (bs, 2H), 2.87-2.83 (m, 4H), 2.21 (s, 3H). 13C NMR 
(75 MHz, DMSO-d6) δ 136.7, 136.0, 134.8, 131.8, 130.1, 128.3, 127.9, 127.5, 121.6, 
119.8, 118.3, 110.0, 107.2, 44.5, 38.0, 22.7, 10.4. 
N
NH3+Cl-
S
 
2-[1-benzyl-2-methyl-5-(methylmercapto)-1H-3-yl] ethanaminium chloride, 29b 
Sosič, I. Anderluh, M.; Sova, M.; Gobec, M.; Mlinarič, R. I., Derouaux, A.; Amoroso, A.; 
Terrak. M.; Breukink. E.; Gobec. S. Structure-activity relationships of novel tryptamine-
based inhibitors of bacterial transglycosylase. J. Med. Chem. 2015, 58, 9712-9721. 
29b. Obtained as a white solid. mp = 178-189oC (40% ether in hexanes). IR (thin film) 
3001, 2990, 1716, 1650, 1363, 1222, 1093, 760 cm-1; 1H NMR (300 MHz, CDCl3) δ 
7.73-7.72 (m, 2H), 7.62-7.59 (m, 2H), 7.56 (s, 1H), 7.43-7.40 ( dd, J = 6.0, 2.0 Hz, 1H), 
7.33-7.28 (m, 1H), 7.24-7.21 (m, 1H), 7.14-7.10 (m, 2H) 7.02-6.95 (m, 2H), 4.72 (s, 2H) 
3.94-3.83 (m, 2H), 3.09-3.04 (m, 2H), 2.54 (s, 3H) 2.32 (s, 3H). 13C NMR (75 MHz, 
DMSO-d6) δ 138.9, 136.0, 135.8, 135.7, 135.4, 129.5, 127.7, 127.9, 127.5, 121.6, 119.8, 
118.3, 110.0, 107.2, 44.5, 38.0, 22.7, 10.4. 
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N
NH3+Cl-
Cl
S
 
2-[1-(2-chlorobenzyl)-2-methyl-5-(methylmercapto)-1H-3-yl] ethanaminium 
chloride, 29c/1 
Sosič, I. Anderluh, M.; Sova, M.; Gobec, M.; Mlinarič, R. I., Derouaux, A.; Amoroso, A.; 
Terrak. M.; Breukink. E.; Gobec. S. Structure-activity relationships of novel tryptamine-
based inhibitors of bacterial transglycosylase. J. Med. Chem. 2015, 58, 9712-9721. 
29c. Obtained as a tan solid. mp = 191-193oC (methanol). IR (thin film) 3400, 2908, 
2942, 2900, 1551, 1375, 1242 cm-1; 1H NMR (300 MHz, CDCl3) δ 8.05 (s. 1H), 7.58 (s, 
1H),  7.50 (d, J = 6.0 Hz, 1H), 7.29 (m, 2H), 7.03 (d, J = 6.0 Hz, 1H), 6.13 (t, J = 6.0 Hz), 
3.02-2.93 (m, 4H), 2.49 (bs, 3H), 2.24 (s, 3H). 13C NMR (75 MHz, DMSO-d6) δ 138.1, 
133.8, 132.6, 131.5, 130.1, 128.8, 128.3, 127.9, 126.8, 124.8, 122.3, 121.5, 118.1, 110.9, 
107.0, 106.0, 49.2, 46.6, 22.7, 19.2, 10.6. 
N
NH3+Cl-
S
Cl  
2-[1-(3-chlorobenzyl)-2-methyl-5-(methylmercapto)-1H-3-yl] ethanaminium 
chloride, 29d 
29d. Obtained as a black oil. TLC Rf = 0.50 (90% dichloromethane: 9 % methanol: 1 % 
ammonium hydroxide). mp = 198-203 °C. IR (thin film) 3430, 2910, 2790, 1543, 1375, 
824 cm-1; 13C NMR (75 MHz, DMSO-d6) δ δ  9.05 (s. 3H), 7.50 (s, 1H),  7.14 (d, J = 6.0 
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Hz, 1H), 7.29 (m, 1H), 6.93 (m, 1H), 6.13 (d, J = 6.0 Hz), 3.02-2.93 (m, 4H), 2.39 (bs, 
3H),  2.24 (s, 3H). 
N
NH3+Cl-
S
Cl  
2-[1-(4-chlorobenzyl)-2-methyl-5-(methylmercapto)-1H-3-yl] ethanaminium 
chloride, 29e 
29e. Obtained as brown solid. mp = 198-209oC (methanol). IR (thin film) 3433, 2997, 
2912, 2890, 1554, 1375, 1238 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.78 (s, 3H), 7.62 (s, 
1H),  7.47 (s, 1H), 7.17 (t, J = 6.0 Hz, 1H), 6.98 (d, J = 6.0 Hz, 1H), 6.13 (d, J = 6.0 Hz), 
2.89 (bs, 4H), 2.24 (s, 3H), 2.19 (s, 3H). 13C NMR (75 MHz, DMSO-d6): δ 136.4, 135.4, 
134.5, 133.3, 129.2, 129.0, 127.5, 123.3, 119.3, 109.8, 108.9, 46.3, 42.0, 27.9, 19.1, 10.6. 
N
S
NH3+Cl-
Br  
2-[1-(4-bromobenzyl)-2-methyl-5-(methylmercapto)-1H-3-yl] ethanaminium 
chloride, 29f 
29e. Obtained as yellow oil. IR (thin film) 3225, 2879, 2850, 1550, 1345, 1224 cm-1; 1H 
NMR (300 MHz, CDCl3) δ  7.78 (s, 3H), 7.62 (s, 1H),  7.47 (s, 1H), 7.17 (t, J = 6.0 Hz, 
1H), 6.98 (d, J = 6.0 Hz, 1H), 6.13 (d, J = 6.0 Hz), 2.89 (bs, 4H), 2.24 (s, 3H), 2.19 (s, 
3H). 13C NMR (75 MHz, DMSO-d6) δ 135.4, 133.7, 132.6, 131.6, 131.3, 129.0, 127.9, 
119.3, 111.8, 111.3, 108.0, 53.0, 40.3, 23.5, 14.1, 10.6. 
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N
H
NH3+Cl-
S
 
2-[2-methyl-5-(methylmercapto)-1H-3-yl] ethanaminium chloride, 31 
TLC Rf = 0.20 (90% dichloromethane: 9 % methanol: 1 % ammonium hydroxide); mp = 
116- 129 oC (50% ethyl acetate in hexanes). IR (thin film) 3400, 2908, 2942, 2900, 1551, 
1375, 1242 cm-1; 1H NMR (300 MHz, CDCl3) δ 10.58 (s. 1H) 7.30 (d, J = 6.0 Hz, 1H), 
7.12 (d, J = 6.0 Hz, 1H), 6.89-6.78 (m, 4H), 2.97 (bs, 4H),  2.21 (s, 3H). 
N
H
NH3+Cl-
 
2-[2-methyl-1H-indol-3-yl] ethanaminium chloride, 32. 
IR (thin film) 3400, 2908, 2942, 2900, 1551, 1375, 1242 cm-1; 1H NMR (300 MHz, 
CDCl3) δ  10.58 (s, 1H) 7.30 (d, J = 6.0 Hz, 1H), 7.12 (d, J = 6.0 Hz, 1H), 6.89-6.78 (m, 
4H), 2.97 (bs, 4H),  2.21 (s, 3H). 
N
NHAc
S
Cl  
N-(2-[2-(2-methyl-5-thiomethyl-N-(o-chloro benzyl indol-3-yl)-ethyl]) acetamide, 34 
To a cool solution of tryptamine 29c/1 dissolved in THF, acetic anhydride (1.1 eq, 0.38 
mmol, 31 µL) and pyridine (1.1 eq, 0.38 mmol, 36 µL) were added. Solution was allowed 
to warm to room temperature and then stirred for 2h. The solvent were evaporated and 
the residue was dissolved in ethyl acetate (10 mL). The reaction was then washed with 
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saturated NaHCO3 (3 x 10 mL). The organic layer was then concentrated and purified 
using silica gel chromatography (40% ethyl acetate in hexanes) to give quantitative yield 
(0.132 g) of the required product. 
34. Obtained as yellow oil. TLC Rf = 0.37 (40 % ethyl acetate in hexanes);  IR (thin film) 
3223, 2942, 2900, 1717, 1551, 1375, 1242 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.49 (s. 
1H) 7.32 (d, J = 9.0 Hz, 1H), 7.19 -  6.90 (m,  3H), 6.11 (d, J = 9.0 Hz, 1H), 5.83 (bs, 
1H), 5.23 (s, 2H) 3.44 (m, 2H), 2.88 (t, J = 6.0 Hz, 2H), 2.48 (s, 3H), 2.21 (s, 3H). 13C 
NMR (75 MHz, DMSO-d6) δ 170.5, 135.5, 135.2, 134.7, 132.1, 129.9, 128.9, 128.8, 
127.8, 127.7, 126.6, 123.3, 119.0, 109.9, 108.9, 44.6, 40.5, 24.7, 23.5, 19.0, 14.4, 13.9, 
10.3. 
N
NHEt
S
Cl  
2-[1-(2-chlorobenzyl)-2-methyl-5-(methylmercapto)-1H-3-yl]-N-ethylethanamine, 35 
Compound 34 (0.37 mmols, 150 mg) is dissolved in dry THF (5mL). Lithium aluminium 
hydride (1.92 mmols, 63 mg) was added while maintaining the reaction mixture at 0 oC. 
The reaction was allowed to warm to room temperature and then refluxed for 4h. The 
reaction mixture was then allowed to cool to room temperature and quenched using 0.1 
mL water, 0.1 mL, 15 % NaOH, followed by 0.3 mL water. Then the mixture was then 
filtered through a bed of celite. The solvent was then removed and the residue purified by 
a silica gel column (90% dichloromethane: 9 % methanol: 1 % ammonium hydroxide) to 
provide the product in 63% yield. 
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35. Obtained as yellow oil. TLC Rf = 0.40 (90% dichloromethane: 9 % methanol: 1 % 
ammonium hydroxide); IR (thin film) 3332, 2918, 2900, 1551, 1385, 1266 cm-1; 1H NMR 
(300 MHz, CDCl3) δ  7.54 (s. 1H) 7.33 (m, 1H), 7.18 (s, 1H), 7.12-6.91 (m, 4H), 6.11 (d, 
J = 9.0 Hz, 1H), 5.24 (s, 2H), 3.59 (bs, 1H), 3.03-2.86 (m, 4H), 2.72-2.65 (m, 2H), 2.51 
(s, 3H), 2.23 (s, 3H), 1.11-1.04 (t, 3H). 
N
NH2Et+Cl-
S
Cl  
2-[1-(2-chlorobenzyl)-2-methyl-5-(methylmercapto)-1H-3-yl]-N-ethylethanaminium 
chloride, 36. 
Obtained as a white solid.  mp = 196-198oC (methanol). IR (thin film) 3443, 2908, 2900, 
1551, 1375, 1242 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.54 (s. 1H) 7.33 (m, 1H), 7.18 (s, 
1H), 7.12-6.91 (m, 4H), 6.11 (d, J = 9.0 Hz, 1H), 5.24 (s, 2H), 3.59 (bs, 1H), 3.03-2.86 
(m, 4H), 2.72-2.65 (m, 2H), 2.51 (s, 3H), 2.23 (s, 3H), 1.11- 1.04 (t, 3H). 13C NMR (75 
MHz, DMSO-d6) δ 135.4, 135.2, 132.0, 129.6, 128.9, 127.9, 127.6, 126.9, 123.3, 118.6, 
109.7, 52.9, 46.6, 44.6, 29.9, 21.0, 19.0, 10.5. 
N
NHBoc
S
Cl  
tert-butyl-(2-[2-(2-methyl-5-thiomethyl-N-(o-chloro benzyl indol-3-yl)-ethyl]) 
carbamate, 37 
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To a cool solution of indole (0.53 mmol, 200 mg) dissolved in THF, triethylamine (0.52 
mmol, 81 µL), and boc-anhydride (1.1 eq, 0.57 mmol, 107.5 mg) were added. The 
solution was allowed to warm to room temperature and then stirred for 4 h. The solvents 
were then evaporated and the residue was dissolved in ethyl acetate (10 mL). The mixture 
was then washed with saturated NaHCO3 (3 x 10 mL). The organic layer was then dried 
(Na2SO4) concentrated. The residue was purified using a silica gel chromatography (10 % 
ethyl acetate in hexanes) to give quantitative yield (0.220 g) of the required product. 
37. Colorless oil. TLC Rf = 0.62 (60 % hexanes : 40 % ethyl acetate); IR (thin film) 2908, 
2942, 2900, 1765, 1551, 1375, 1242 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.52 (s. 1H) 
7.33 (d, J = 9.0 Hz, 1H), 7.19 -  6.92 (m,  3H), 6.14 (d, J = 9.0 Hz, 1H), 5.23 (s, 2H) 3.32 
(m, 2H), 2.88 (t, J = 6.0 Hz, 2H), 2.45 (s, 3H),  2.21 (s, 3H) 1.34 (s, 9H). 13C NMR (75 
MHz, DMSO-d6) δ 156.2, 135.4, 135.3, 134.8, 132.0, 129.6, 128.9, 128.8, 127.7, 127.6, 
126.9, 123.3, 119.0, 109.8, 109.0, 44.6, 41.5, 28.7, 25.2, 19.2, 10.3. 
N
NHMe
S
Cl  
2-[1-(2-chlorobenzyl)-2-methyl-5-(methylmercapto)-1H-3-yl]-N-methylethanamine, 
38 
Compound 37 (0.45 mmols, 200 mg) is dissolved in dry THF (5mL). Lithium aluminium 
hydride (1.92 mmols, 63 mg) is added while maintaining the reaction mixture at 0 oC. 
The reaction mixture was allowed to warm to room temperature and then refluxed for 4h. 
After cooling to room temperature, the reaction mixture was quenched using 0.1 mL 
water, 0.1 mL, 15 % NaOH, followed by 0.3 mL water. Then the mixture is filtered 
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through a bed of celite. The reaction mixture was then dried (Na2SO4) and concentrated. 
Purification by silica gel chromatography (90% dichloromethane: 9 % methanol: 1 % 
ammonium hydroxide) provided the product in 61% yield. 
38. Obtained as Yellow Oil. TLC Rf = 0.30 (90% dichloromethane: 9 % methanol: 1 % 
ammonium hydroxide); IR (thin film) 3400, 2908, 2942, 2900, 1551, 1375, 1242 cm-1; 1H 
NMR (300 MHz, CDCl3) δ 7.54 (s. 1H) 7.33 (m, 1H), 7.18 (s, 1H), 7.12-6.91 (m, 4H), 
6.11 (d, J = 9.0 Hz, 1H), 5.24 (s, 2H), 3.59 (bs, 1H), 3.03-2.86 (m, 4H), 2.72-2.65 (m, 
2H), 2.51 (s, 3H), 2.23 (s, 3H), 1.11- 1.04 (t, 3H). 13C NMR (75 MHz, DMSO-d6) d 
135.4, 135.3, 134.8, 132.0, 129.6, 128.9, 128.8, 127.7, 127.6, 126.9, 123.3, 119.0, 109.8, 
109.1, 52.8, 36.0, 19.2, 10.3. 
N
NH2+MeCl-
S
Cl     
2-[1-(2-chlorobenzyl)-2-methyl-5-(methylmercapto)-1H-3-yl]-N-
methylethanaminium chloride, 39 
39. Tan solid. mp = 206-219 oC. TLC Rf = 0.33 (90% dichloromethane: 9 % methanol: 1 
% ammonium hydroxide) IR (thin film) 3410, 2993, 2912, 2900, 1551, 1365, 1212 cm-1; 
1H NMR (300 MHz, CDCl3) δ 9.00 (bs, 3H), 7.54 (s. 1H) 7.33 (m, 1H), 7.18 (s, 1H), 
7.12-6.91 (m, 4H), 6.11 (d, J = 9.0 Hz, 1H), 5.30 (s, 2H), 2.97-2.86 (m, 4H), 2.39 (s, 6H), 
2.16 (s, 3H). 13C NMR (75 MHz, DMSO-d6) δ 135.9, 135.6, 135.3, 131.8, 130.1, 129.6, 
128.6, 128.3, 127.8, 127.3, 122.5, 118.1, 110.0, 106.0, 47.4, 44.5, 28.9, 21.6, 18.0, 11.7, 
10.3. 
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N
NHMe2+Cl-
S
Cl  
2-[1-(2-chlorobenzyl)-2-methyl-5-(methylmercapto)-1H-3-yl]-N,N-
dimethylethanaminium chloride, 41 
 Tryptamine 29c/1 (175 mg, 0.46 mmol) was dissolved in acetic acid (600µL). Sodium 
cyanoborohydride (10 eq, 4.6 mmol, 289 mg) was dissolved in 1 mL methanol and added 
to the tryptamine solution. Formalin (50 eq, 23mmol, 1.8 mL, 37%) was also added. The 
reaction mixture was agitated at room temperature for approximately 18 h. The solvents 
were evaporated and the residue was dissolved in dichloromethane (10 mL). The reaction 
mixture was then washed with saturated NaOH (1M, 3 x 10 mL). The organic layer was 
then concentrated and the residue purified using silica gel chromatography (90% 
dichloromethane: 9 % methanol: 1 % ammonium hydroxide) to give the required product. 
The dialkylated tryptamine (1 eq, 0.40 mmol) was dissolved in 1 mL of 1M ether-HCl. 
Et2O (10 eq, 4.0 mmol) was added. The reaction mixture was allowed to stand for 20 
minutes and then concentrated. Recrystallization from methanol furnished the required 
product (77 mg) in 40% yield over two steps. 
41. Obtained as brown solid. mp = 203-212 oC. TLC Rf = 0.36 (90% dichloromethane: 9 
% methanol: 1 % ammonium hydroxide) IR (thin film) 3420, 2891, 2900, 1551, 1360, 
1245 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.00 (bs, 3H), 7.33-7.30 (m, 1H), 7.19 (s, 1H), 
7.11-6.90 (m, 4H), 6.11 (d, J = 9.0 Hz, 1H), 5.22 (s, 2H), 2.97-2.86 (m, 4H), 2.39-2.57 
(m, 3H), 2.57 (s, 3H), 2.44 (s, 6H), 2.19 (s, 3H). 13C NMR (75 MHz, DMSO-d6) δ 136.0, 
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135.6, 135.3, 131.8, 130.1, 129.6, 128.5, 128.3, 127.8, 127.2, 122.5, 118.1, 110.0, 106.0, 
57.0, 44.5, 42.5, 20.0, 18.0, 10.4 
3-[(3-nitrobenzyl)-2-methyl]indole 50 
 
 
 
Appleton, J. E.; Dack, K. N.; Green, A. D.; Steele, J. A mild and selective C-3 reductive 
alkylation of indoles. Tett. Lett. 1993, 34, 1529-1532. 
50. Prepared using representative procedure as shown in chapter 2 from 2-methyl indole 
34 and previously known imidate,95 50 purified using silica gel chromatography (70% 
hexanes/30% ethyl acetate). 
46. Orange solid (0.22 g, 84%); mp = 145-147 oC; TLC Rf = 0.51 (90% hexanes/10% 
ethyl acetate); 1H-NMR (300MHz, CDCl3) δ 8.08 (s, 1H), 8.00 (d, J = 6.6 Hz, 1H), 7.92 
(bs, 1H), 7.53 (d, J = 7.6 Hz, 1H), 7.39-7.28 (m, 3H), 7.14 (t, J = 7.5 Hz, 1H), 7.05 (t, J = 
6.9 Hz, 1H), 4.16 (s, 2 H), 2.41 (s, 3H); 13C-NMR (75MHz, CDCl3) δ 149.5, 135.4, 
135.1, 131.9, 131.0, 128.9, 127.9, 127.5, 125.6, 123.5, 119.1, 118.4, 108.7, 107.6, 39.0, 
12.4. 
N-(4-chlorobenzyl)3-[(3-nitrobenzyl)-2-methyl]indole 53 
 
The indole 46 (88 mg, 1 eq, 0.33 mmol) was dissolved in 6 mL of acetonitrile. Cesium 
carbonate (0.65 g, 6 eq, 1.98 mmol) was added and the mixture was heated to 80 oC. The 
N
NO2
Cl
N
H
NO2
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corresponding benzyl halide was then added. The reaction mixture was maintained at 80 
°C for 18 h. The reaction was quenched with water (10 mL), the organic layer separated, 
and the aqueous layer extracted with ethyl acetate (3 x 10 mL). The combined organic 
extracts were dried with Na2SO4, filtered, and concentrated. Purification by silica gel 
chromatography provided the required product. 
53. Pale yellow solid (79 mg, 61%); mp  = 199-210 oC. Rf (70% hexanes/30% ethyl 
acetate) = 0.25, 1H-NMR (300MHz, CDCl3): δ 8.24 (d, J=8.22 Hz, 1H), 7.92 (s, 1 H), 
7.57 (d, J = 8.2 Hz, 1H), 7.55-7.47 (m, 4H), 7.41-7.41 (m, 3H), 7.00-7.34  (m, 2H), 5.30 
(s, 2H), 4.08 (s, 2 H), 2.38 (s, 3H); 13C-NMR (75MHz, CDCl3) δ 149.5, 139.5, 135.0, 
134.6, 130.8, 129.5, 128.9, 128.7, 128.6, 128.2, 126.9, 125.6, 123.5, 122.4, 121.0, 118.4, 
109.7, 108.6, 49.0, 39.0, 12.4. 
 
N-(2-chlorobenzyl)3-[(3-amine hydrochloride)-2-methyl]indole 54 
Tin chloride (5eq, 1.35 mmols, 304 mg) was dissolved in ethanol (5 mL) to which the 
nitro compound 53 (78 mg, 0.28 mmol) is added. The reaction mixture is refluxed for 3 
hrs. It is cooled and then poured in 15 mL, 2N NaOH. It is extracted with ethyl acetate. 
Organics are dried with sodium sulfate and then purified using silica gel chromatography. 
An ice-cold solution of acetyl chloride (5 eq, 5 mmols, 0.6 mL) and 10 mL ethanol is 
prepared. The product obtained is dissolved in 5 mL ethyl acetate, which is added to the 
acetyl chloride/ethanol solution. The mixture is stirred or 30 min. Solvent is evaporated 
and the solid obtained is recrystallized from ethyl acetate. 
N
NH3+Cl-
Cl
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59. Pink solid (77 mg 98%); mp  = 221-225 oC (ethyl acetate). 1H-NMR (300MHz, 
CDCl3) δ 10.1 (bs, 1H), 7.49 (d, J = 7.89 Hz, 1H), 7.41-7.30 (m, 2H), 7.26 (t, J = 7.80 
Hz, 3H), 7.18-7.10 (m, 3H), 7.02-6.91 (m, 2H), 6.13 (d, J = 8.2 Hz, 1H), 5.45 (s, 2H), 
4.10 (s, 2 H), 2.28 (s, 3H); 13C-NMR (75MHz, CDCl3) δ 144.6, 136.8, 136.2, 134.4, 
133.2, 131.8, 130.3, 130.1, 129.5, 128.5, 128.2, 128.0, 127.3, 124.0, 122.8, 121.6, 120.9, 
119.8, 118.7, 110.5, 109.9, 44.5, 30.1, 10.6. 
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Convenient Formation of DPM and PMB Esters Using Diphenylmethyl 
Trichloroacetimidate and 4-Methoxybenzyl-2,2,2-trichloroacetimidate  
Abstract 
 
This chapter discusses esterification of acids using trichloroacetimidates. We specifically 
discuss the protection of carboxylic acids converted to the corresponding 4-
methoxybenzyl (PMB) esters with 4-methoxybenzyl-2,2,2-trichloroacetimidate in the 
absence of an acid catalyst.  This operationally simple procedure is an effective method 
for the formation of PMB esters.  The reaction is promoted by the carboxylic acids 
themselves in excellent yields (78-99%).  No racemization is observed in the case of 
carboxylic acids bearing a α-stereocenter.   
 
Introduction 
Fabulous progress has been made in the field of synthetic methodology in organic 
chemistry. However, in the synthesis of complex molecules, such as biologically active 
substances having base- or acid- labile functionalities, it is important to be able to work 
under neutral conditions. Protecting groups render an otherwise reactive functional group 
inert to certain reaction conditions, buth can later be removed to reveal the desired 
functionality under mild conditions. On the downside, each protecting group 
manipulation lengthens the synthesis by at least two steps (attachment and removal). 
These transformations lead to an inevitable decrease in yield and increase in the cost of 
the synthesis. Despite this major drawback, the proliferation of protecting group 
technology is an acknowledgement that selectivity in functional group transformations is 
still a baffling problem. Greater control over the chemistry used in the building of 
nature’s architecturally beautiful and diverse molecular frameworks, as well as unnatural 
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structures, is needed when one considers the number of protection and deprotection steps 
involved in the synthesis of complex molecules. Thus, many protecting groups have been 
and are continuing to be developed to this end. A good protecting group must fulfill the 
following requirements.1,2  
• Must react easily and efficiently with the functional group to be protected under 
mild conditions.  
• Must be stable to wide range of reaction conditions after protection. 
• Must be stable to chromatography. 
• Must be inexpensive and easily available. 
• Must be easy to characterize and should not give rise to complications like the 
formation of new stereogenic centres as they tend to clutter NMR spectra with 
numerous added signals.  
• The protecting group should be able to be removed easily and efficiently under 
highly specific conditions. 
• Byproducts formed during deprotection should be easily removable from the 
substrate. 
General Esterification Protocols for Protection of Carboxylic Acids 
Esters remain the most popular method for protection of carboxy functionality during 
synthesis. Traditional methods of esterification involved reaction of carboxylic acids with 
alkyl halides under basic conditions. Alternatively acid chlorides or acid anhydrides may 
be reacted with alcohols in the prescence of an appropriate base. Acidic conditions may 
also produce esters, such as the reaction of a carboxylic acid and an alcohol in presence 
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of Lewis or Brønsted acids (the Fischer-Speier Esterification).3 Milder methods have also 
been developed, such as the  Steglich esterfication4 which is often used for sterically 
hindered and acid labile substrates. This protocol involves the use of 
dicyclohexylcarbodiimide 1 (DCC, Figure 5.1) which, when reacted with carboxylic acid, 
forms an O-acylisourea intermediate. This intermediate then reacts with an alcohol in the 
presence of catalytic amount of 4-dimethylaminopyridine (DMAP) 2, producing the ester 
and dicyclohexyl urea. More recent methods for the preparation of esters involves the 
conversion of a carboxylic acid to a mixed anhydride, followed by addition of alcohol. 
An alternative approach, developed by Vowinkel5 and Mathias,6 involves treatment of the 
carboxylic acid with isoureas like 3. Wang reported the use of a very similar reagent, 
N,N’-diisopropyl-O-(4-methoxybenzyl) isourea (also known as PMB isourea) 4.7 
Unfortunately, in all of the protocols using isoureas, it is necessary to separate the 
product from the urea sideproduct, which can be difficult. Yamaguchi esterification is yet 
another variation of esterification in which carboxylic acid is reacted with 2,4,6-
trichlorobenzoyl chloride (the Yamaguchi reagent) 5.8 The activated ester intermediate 
then reacts with an alcohol in presence of stoichiometric amounts of DMAP, furnishing 
the required ester. Mukaiyama has also employed pyridinium salt 6 for esterification.9 
Very recently, Dudley has published a number of papers involving use of 2-benzyloxy-1-
methylpyridinium triflate 7, which releases an electrophilic benzyl species upon 
warming.10-13 Mukaiyama’s reagent 6 inspires the design of benzyloxypyridinium salt 7. 
They have reported 7 and related reagents for esterification and alcohol etherification 
under seemingly mild conditions. However, reagent 7 and is very expensive (105$/g) and 
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requires several steps to synthesize in the laboratory. The synthesis of 7 also requires the 
use of methyl triflate, which is highly toxic. 
 
Figure 5.1 General Esterification Protocols 
An alternative to the use of isourea based and pyridinium based reagents is to use a 
trichloroactimidate electrophile and react these systems with a carboxylic acid. Schmidt 
has popularized the use of trichloroacetimidate donors in glycoside synthesis,14 however 
these electrophiles are reactive enough to form esters. A search of the literature revealed 
that in most cases esterification reactions with trichloroacetimidates require the presence 
of a stoichiometric or catalytic amount of a Brønsted or Lewis acid such as TMSOTf, 
BF3·OEt2, triflic acid.15,16 Several other trivalent lanthanide triflates such as Sm(OTf)3, 
Sc(OTf)3, Tb(OTf)3 and Yb(OTf)3 can also activate trichloroacetimidates.17-24 Once 
activated, imidates can undergo substitution by nucleophiles as shown below in Figure 
5.2. Recently there have been some reports of trichloroacetimidates reacting 
spontaneously with carboxylic acids to form esters. Hayashi demonstrated such a 
spontaneous ester formation using 4-methoxybenzyl trichloroacetimidate in the syntheses 
of Interleukin-1β (IL-1 β) converting enzyme (ICE) inhibitors.25,26 In the case of the 2-
NCl
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phenylisopropyl trichloroacetimidate27 and glycosyl imidates,28-31 the ester formations 
also occured spontaneously. Schmidt observed similar reactivity when glycosyl 
trichloroacetimidates reacted with phosphoric acids to form the phosphate esters.32 These 
results indicate that, at least in cases where the corresponding cation is highly stabilized, 
imidates can be employed to form esters without the need for a catalyst or promoter.  
Given that ester formation only occurs in cases where the corresponding cation is 
especially stabilized, an SN1 type reaction pathway may be implicated in the formation 
of these esters. 
 
Figure 5.2 Nucleophilic Substitution on an activated imidate 
 In cases where the reaction of carboxylic acids and trichloroactimidates is 
spontaneous, the protonation of the imidate by the carbxylate must be suffcient to activate 
the imidate for substitution. As shown above in the Figure 5.2, alkylation is driven by the 
loss of the imidate and formation trichloroacetamide. Rearrangement of the imidate to 
acetamide is thermodynamically favorable as the C=O bond is more stable than the C=N 
bond. 
 Esterification of Carboxylic Acids using Trichloroacetimidates 
Armed with this information, in our lab, the reaction of lauric acid with a wide variety of 
R O CCl3
NH
H
R O CCl3
NH2
R O CCl3
NH2
R
CH2
+ Cl3C NH2
ONu
R Nu
R = Benzyl, PMB,  t-butyl, allyl
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imidates (7 a-m) was explored.  Substrates were subjected to conditions in progression 
from A to D, method A being mildest while method D being the most drastic (Table 5.1). 
Any given imidate was first subjected to the mild conditions and the yields were reported 
if it furnished the ester. In case the imidate did not produce the ester, it was subjected to 
more drastic conditions. Method A: the acid and imidate were mixed in DCM at room 
temperature with no catalyst.  Method B: the acid and imidate were heated to reflux in 
toluene with no catalyst.  Method C: the acid and imidate were mixed in DCM at room 
temperature in presence of dry CSA (10 mol %). Method C: the acid and imidate were 
heated to reflux in toluene in presence of dry CSA (10 mol %).  
Table 5.1 Esterification of Acids using variety of imidates 
R
OH
O CCl3
NH
Cl3CCN
DBU (1 mol %)
CH2Cl2
HO
O
10
CH2Cl2
95% R
O
O
10
R
HN CCl3
O
10 a-m
ROR
7a-m 8a-m
9
1211
R
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4-Methoxybenzyl imidate (PMB,7a), diphenyl methyl imidate (DPM, 7b) methyl-(2-
methoxy benzyl)-trichloroacetimidate (7c) and phthalimidomethyl imidate (Pim, 7d) 
MethodEntry Ester formed
1
2
3
4
5
6
7
8
9
10
11
12
13
Isolated
Yield (%
O
O
10
MeO
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O
O
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Ph
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O
10N
O
O
c
d
A
A 78
92
O
O
10
O
O
10
e
f
A
A ComplexMixture
Complex
Mixture
O
O
10
O
O
10
O
O
10
g
h
i C
C
C ComplexMixture
61
Trace
Product
O
O
10Ph j C 49
O
O
10k
A/B/C/D No Product
O
O
10
Cl
ClCl l
A/B/C/D No Product
O
O
10m
A/B/C/D No Product
NO2
165	
	
produce carbocations stabilized through delocalization of positive charge. Thus, they 
easily undergo esterification easily and furnish products in good yields. 
Prenyl and tert-prenyl cation are interconvertible through delocalization as shown in 
Figure 5.3. Hence, prenyl imidate (7e) and tert-prenyl imidate (7f) produced an 
inseparable mixture of prenyl and tert-prenyl esters. 
 
Figure 5.3 Delocalization in prenyl and tert-prenyl carbocation 
 
 tert-Butyl imidate (7g), cyclopropyl methyl imidate (7h, Cpm), allyl imidate (7i)  
and benzyl imidate (7j) all lead to the formation of carbocations that are comparatively 
less stable than those derived from 7a-f. Thus they require more drastic conditions to 
promote the esterifications. They required the use of camphor sulfonic acid (CSA) as 
catalyst for the formation of the ester.  
 In case of ethyl imidate 7k produces a carbocation that is quite unstable, with only 
mildl stabilization through the inductive effect of the adjacent methyl group. Also, 3-
nitrobenzyl imidate 7l and 2,2,2-tricloroethyl trichloroacetimidate 7m are destabilized 
because of the presence of elecron withdrawing substituents. Thus, despite of using 
drastic conditions, no product was obtained. Evidently the formation of an ester through 
an SN2 pathway, which should still be possible, was not attained under these conditions. 
 Phthalimidomethyl imidate (Pim, 7l) reacted with lauric acid to produce ester in 
78% yield. The imidate is a stable solid at room temperature and several other acids were 
subjected to the same reaction conditions. While these reactions furnished esters in good 
yields, the products were often contaminated with other inseparable byproduct impurities 
A B
166	
	
like the trichloroacetamide, which was very difficult to separate from the more polar Pim 
esters. Diphenyl methyl imidate (DPM, 7h) and 4-methoxy benzyl imidate (PMB,7i) both 
furnished their respective esters in 95 and 89% yields respectively. Both of these 
trichloroactimidates are relatively stable with a long shelf life. The esterification reactions 
with these imidates do not require strong acids, toxic metal salts or powerful catalysts or 
promoters. Additionally these imidates react selectively with the carboxylic acid without 
disturbing other functionality in the molecule. Armed with this knowledge, we went on to 
develop the use of DPM imidate33 and PMB imidates34 as convenient methods for 
protection of carboxylic acids as their esters respectively. 
Esterification Reactions Using 4-Methoxybenzyl-2,2,2-trichloroacetimidate 
4-Methoxybenzyl (PMB) esters are common protecting groups for carboxylic acids,1,2 as 
their ability to be removed by hydrogenation35,36 or under acidic conditions25,26,37 nicely 
complements that of other esters. PMB ester formation that occurs under mild conditions, 
is compatible with polyfunctional complex molecules, and can be accessed from simple, 
inexpensive starting materials is therefore of interest to organic chemists. The 
information shown in the Table 5.1 indicate that the trichloroacetimidate 8i is a good 
choice of reagent for the formation of PMB esters and could serve as an excellent 
protecting group precursor since it is commercially available or easily synthesized from 
the inexpensive trichloroacetonitrile and 4-methoxybenzyl alcohol.38 An investigation 
into the generality of the ester formation with 4-Methoxybenzyl-2,2,2-
trichloroacetimidate was therefore initiated. 
 Initially we adopted the conditions of Hayashi, 25,26 where dichloromethane was 
used as the solvent at 0 °C with two equivalents of the trichloroacetimidate. No 
advantage was found in using cryogenic temperatures, so the use of an ice bath was 
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abandoned. Some of the esterifications were sluggish, so a reaction time of 24 h was 
adopted to ensure complete conversion of the starting material. Under these conditions 
benzoic acid was esterified in 89% yield after purification by silica gel column 
chromatography (Table 5.2, entry 1). Other benzoic acids possessing electron poor and 
electron rich substituents were also esterified in good yields under these conditions. As 
shown in the Table 5.2 (entry 5,6 and 7), alkyl, vinyl, alkenyl and alkynyl carboxylic 
acids furnished PMB esters in good to excellent yields. The yield of the esterification did 
depend on the steric bulk of the group next to the carboxylic acid (Table 5.2, entries 7, 8 
and 9). As the steric bulk increased, the yields of the reactions decreased. Protection of 
admantyl carboxylic acid proceeded despite the steric bulk and the hindered adamantyl 
ester was formed in a synthetically useful 78% yield. Moreover, several complex 
carboxylic acids were also protected with ease. Highly electrophilic groups (like the 
bromide in 11 and the ketoacid in 12) were quite compatible with the reaction conditions, 
providing the ester products in excellent yields. This method could not be successfully 
used for the protection of the carboxylic acid group in unprotected amino group, as was 
observed in the case of phenylalanine.  We have postulated that the carboxylic acid itself 
may act as a promoter in this esterification, which would explain the unreactive nature of 
phenylalanine, as the amino acid exists as a zwitterion with a significantly higher pKa 
than a typical carboxylic acid. Alternatively, the free carbamate N-H bond of Boc-
protected phenylalanine was well tolerated (Table 5.2, entry 13). The unprotected alcohol 
of mandelic acid (Table 5.2, entry 12) was also well tolerated. Picolinic acid also formed 
the PMB ester (Table 1, entry 14), demonstrating that heterocycles with basic 
functionality also participate in the esterification reaction.  
168	
	
Table 5.2 Esterification Reactions Using 4-Methoxybenzyl-2,2,2-
trichloroacetimidate 
 
 To test the hypothesis of self-promotion, the esterification reaction was attempted 
Ester Product Yield
Ph OPMB
O
OPMB
O
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OPMB
O
OAc
OPMB
O
Entry
Ph OPMB
O
OPMB
O
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O
O
O
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Ph
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RCO2H RCO2PMB
MeO
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169	
	
with benzoic acid in the presence of two equivalents of triethylamine. No ester formation 
was observed; leading to the conclusion that activation of the imidate by protonation with 
the carboxylic acid appears to be a necessary component of the reaction. The successful 
esterification with picolinic acid in Table 1 (entry 14) can be rationalized by the greater 
acidity of the pyridinium ion as opposed to the ammonium formed with triethylamine. 
 In order to determine the effectiveness of these esterification conditions on 
sensitive substrates some further studies were undertaken (Scheme 1). First the 
esterification was performed with the 92:8 cis:trans mixture of α,β-unsaturated ester 27, 
which was produced by Lindlar reduction of the corresponding alkyne.39 Similar systems 
are highly prone to isomerization with common esterification catalysts such as DMAP.42 
Treatment of acid 27 with two equivalents of the PMB imidate gave the corresponding 
ester in 72% yield after chromatography. No isomerization to the more stable trans 
isomer was detected in the 1H NMR of the purified product, which showed an unchanged 
92:8 ratio of products. Any protecting group strategy is rendered useless in complex 
natural product synthesis if it racemizes a well-established stereocenter. A chiral 
carboxylic acid bearing an α-stereocenter was therefore esterified with PMB imidate. 
Chiral naproxen 29 was chosen as a challenging substrate for this transformation, as the 
stereocenter is both benzylic and next to the carboxylic acid, which should allow for 
facile racemization. Treatment of (R)-naproxen with imidate PMB provided the PMB 
ester in 80% yield with no detectable racemization of the product as determined by chiral 
HPLC analysis (the product was compared to racemic material prepared by heating the 
chiral ester with DBU in toluene). These experiments highlight the effectiveness of these 
reaction conditions with regard to base sensitive substrates. 
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Scheme 1 
 
Conclusions 
In summary, a mild method for protecting carboxylic acids in high yields as their 
corresponding PMB esters using the commercially available 4-methoxybenzyl-2,2,2-
trichloroacetimidate has been explored. The methodology is noteworthy, as it does not 
require addition of Brønsted or Lewis acids to form the ester. The transformation is also 
highly selective for carboxylic acids, with unprotected alcohols and carbamates being 
unreactive. These esterification conditions have been shown to be compatible with 
sensitive systems such as α-chiral carboxylic acids and cis-α,β-unsaturated carboxylic 
acids, which form esters without racemization or isomerization, respectively. 
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Experimentals 
General Information. All anhydrous reactions were performed under a positive pressure 
of argon or nitrogen. All syringes, needles, and reaction flasks required for anhydrous 
reactions were dried in an oven and cooled under an N2 atmosphere or in a desiccator. 
Dichloromethane and THF were dried by passage through an alumina column following 
the method of Grubbs.43 Triethylamine was distilled from CaH2. All other reagents and 
solvents were purchased from commercial sources and used without further purification. 
Analysis and Purification. Analytical thin layer chromatography (TLC) was performed 
on precoated glass backed plates (silica gel 60 F254; 0.25 mm thickness). The TLC plates 
were visualized by UV illumination and by staining. Solvents for chromatography are 
listed as volume:volume ratios. Flash column chromatography was carried out on silica 
gel (40-63 µm). Melting points were recorded using an electrothermal melting point 
apparatus and are uncorrected. Optical rotations were measured at the sodium D line (589 
nm) on a digital polarimeter and reported in reagent grade solvent. Enantiopurity was 
determined using chiral phase HPLC with an OD-H (0.46 × 25 cm) column. Elemental 
analyses were performed on an elemental analyzer with a thermal conductivity detector 
and 2 meter GC column maintained at 50 °C. 
Identity. Proton (1H NMR) and carbon (13C NMR) nuclear magnetic resonance spectra 
were recorded at 300 MHz and 75 MHz respectively. The chemical shifts are given in 
parts per million (ppm) on the delta (δ) scale. Coupling constants are reported in hertz 
(Hz). The spectra were recorded in solutions of deuterated chloroform (CDCl3), with  
residual chloroform (δ 7.26 ppm for 1H NMR, δ 77.23 ppm for 13C NMR) as the internal 
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reference. Data are reported as follows: (s = singlet; d = doublet; t = triplet; q = quartet; p 
= pentet; dd = doublet of doublets; dt = doublet of triplets; td = triplet of doublets; tt = 
triplet of triplets; ddd = doublet of doublet of doublets; brs = broad singlet). Where 
applicable, the number of protons attached to the corresponding carbon atom was 
determined by DEPT 135 NMR. Infrared (IR) spectra were obtained as thin films on 
NaCl plates by dissolving the compound in CH2Cl2 followed by evaporation. 
General conditions for reactions of imidates with acids 
General Reaction Procedure A. The carboxylic acid is dissolved in DCM to form a 0.25 
M solution. 2.0 Equivalents of imidate are added and the resulting mixture is stirred at 
room temperature. When no more nucleophile is observed using TLC, the mixture is 
dissolved in ethyl acetate (20 mL) and washed with saturated, aqueous sodium 
bicarbonate (3 x 20 mL). The organic layer was then dried over anhydrous sodium sulfate 
and concentrated. Purification is then performed by silica gel chromatography (solvent 
system is the same as TLC Rf reported). 
General Reaction Procedure B. The carboxylic acid was dissolved in dry toluene to 
form a 0.25 M solution. 2.0 Equivalents of imidate are added and the resulting mixture is 
heated to reflux. The reaction was monitored by TLC. When no more carboxylic acid is 
observed, the mixture is cooled to rt, taken up in ethyl acetate (20 mL) and washed with 
saturated, aqueous sodium bicarbonate (3 x 20 mL). The organic layer was then dried 
over anhydrous sodium sulfate and concentrated Purification by silica gel 
chromatography (solvent system is the same as TLC Rf reported). 
General Reaction Procedure C. The carboxylic acid is dissolved in DCM to form a 0.25 
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M solution. 2.0 Equivalents of imidate are added. When a homogeneous mixture is 
obtained, 0.1 eq/ 10 mol % of dry CSA is added and the resulting mixture is stirred at 
room temperature. The reaction was monitored by TLC. When no more carboxylic acid is 
observed, the reaction was taken up in ethyl acetate (20 mL) and washed with saturated, 
aqueous sodium bicarbonate (3 x 20 mL). The organic layer was then dried over 
anhydrous sodium sulfate and concentrated Purification by silica gel chromatography 
(solvent system is the same as TLC Rf reported). 
General Reaction Procedure D. The carboxylic acid is dissolved in DCM to form a 0.25 
M solution. 2.0 Equivalents of imidate are added. When a homogeneous mixture is 
obtained, 0.1 eq/ 10 mol % of dry CSA is added and the resulting mixture was heated to 
reflux. The reaction was monitored by TLC. When no more carboxylic acid is observed, 
the mixture is cooled to rt, taken up in ethyl acetate (20 mL) and washed with saturated, 
aqueous sodium bicarbonate (3 x 20 mL). The organic layer was then dried over 
anhydrous sodium sulfate and concentrated Purification by silica gel chromatography 
(solvent system is the same as TLC Rf reported). 
Benzyl laurate (7g). 
Li, X.; Eli, W.; Li, G. Solvent-free synthesis of benzoic esters and benzyl esters in novel 
Brønsted acidic ionic liquids under microwave irradiation. Catal. Commun. 2008, 9, 
2264-2268. 
 Colorless oil, (0.45 g, 49%): Condition B used. TLC Rf = 0.90 (30 % ethyl acetate in 
hexanes); 1H NMR (300 MHz, CDCl3) δ 7.22 (d, 2H, J = 9.0 Hz), 6.81 (d, 2H, J = 9.0 
Hz), 4.97 (s, 2H), 2.25 (t, 3H, J = 9.0 Hz), 1.61-1.53 (m, 2 H), 1.30-1.10 (m, 17 H), 0.81 
(t, 3H, J = 6.0 Hz); 13C NMR (75 MHz CDCl3) δ 169.9, 160.8, 130.4, 127.6, 114.2, 67.6, 
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35.2, 32.1, 29.8, 29.7, 29.6, 29.1, 27.5, 22.9, 14.4. 
Diphenylmethyl dodecanoate (7h).  
Wang, M. F., Golding, B. T., Potter. G. A Convenient Preparation of p-Methoxybenzyl 
Esters. Synth. Comm. 2000, 30, 4197-4204. 
White solid (0.69 g, 95%): TLC Rf = 0.91 (10% ethyl acetate/90% hexanes); mp = 60-62 
°C; IR (neat) 2845, 2837, 1694, 1240, 900 cm-1; 1H NMR (300 MHz, CDCl3), δ 7.28-6.19 
(m, 10H), 6.83 (s, 1H), 2.35 (t, J = 9.0 Hz, 3H), 1.61-1.53 (m, 2H), 1.30-1.10 (m, 16H), 
0.82 (t, J = 6.0 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 173.1, 140.5, 129.0, 128.1, 127.6, 
35.2, 32.1, 29.8, 29.7, 29.6, 29.1, 27.5, 22.9, 14.4; Anal. Calcd for C25H34O2: C, 81.92; H, 
9.35. Found: C, 82.25; H, 9.12. 
General conditions for esterification using 4-methoxybenzyl 2,2,2-
trichloroacetimidate: The carboxylic acid (1.50 mmol) was dissolved in anhydrous 
CH2Cl2 (6 mL, to provide a 0.25M solution). 4-Methoxybenzyl 2,2,2-trichloroacetimidate 
(430 mg, 3.00 mmol, 2.0 equiv) was then added. After 24 h TLC indicated that all of the 
starting carboxylic acid had been consumed. The reaction mixture was taken up in ethyl 
acetate (20 mL) and washed with sodium bicarbonate (sat. aq., 3 x 20 mL). The organic 
layer was dried (Na2SO4), filtered and concentrated. The residue was adsorbed on silica 
gel and purified by silica gel chromatography to provide the corresponding PMB ester. 
4-Methoxybenzyl benzoate (13). 
	
Wang, M. F., Golding, B. T., Potter. G. A Convenient Preparation of p-Methoxybenzyl 
Esters. Synth. Comm. 2000, 30, 4197-4204. 
Ph OPMB
O
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 Colorless oil (530 mg, 89%): TLC Rf = 0.57 (20:80 ethyl acetate:hexanes); 1H NMR 
(300 MHz, CDCl3) δ 8.10-8.03 (m, 2H), 7.59-7.51 (m, 1H), 7.47-7.36 (m, 4H), 6.92 (d, J 
= 8.8 Hz, 2H), 5.31 (s, 2H), 3.82 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 166.7, 159.9, 
133.2, 130.5, 130.3, 129.9, 128.5, 128.4, 114.2, 66.7, 55.5.  
4-Methoxybenzyl 4-(trifluoromethyl)benzoate (14).  
 
White solid (415 mg, 85%): TLC Rf = 0.47 (15:85 ethyl acetate:hexanes); mp = 48-49 °C; 
IR (film) 3051, 3014, 2961, 2914, 2841, 1721 cm-1; 1H NMR (300 MHz, CDCl3) δ 8.16 
(d, J = 8.1 Hz, 2H), 7.69 (d, J = 8.1 Hz), 7.40 (d, J = 8.7 Hz, 2H), 6.93 (d, J = 8.7 Hz, 
2H), 5.33 (s, 2H), 3.82 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 165.4, 160.0, 135.2 (q, J = 
33 Hz), 130.4, 129.2, 127.8, 125.5 (q, J = 277 Hz), 125.4, 118.5, 114.2, 67.3, 55.5; Anal 
calcd for C16H13F3O3; C, 61.94, H, 4.22.  Found C, 61.94, H, 4.24. 
4-Methoxybenzyl 2-acetoxybenzoate (15).  
 
Colorless oil (534 mg, 80%): TLC Rf = 0.69 (25:75 ethyl acetate:hexanes); IR (neat) 
2957, 2837, 1769, 1720, 1610, 1515, 1248 1195 cm-1; 1H NMR (300 MHz, CDCl3) δ 8.04 
(d, J = 1.7 Hz, 1H), 7.54 (t, J = 9.0 Hz, 1H), 7.29-7.38 (m, 3H), 7.09 (d, J = 9.0 Hz, 1H), 
6.92 (d, J = 8.7 Hz, 2H), 5.24 (s, 2H), 3.81 (s, 3H), 2.13 (s, 3H); 13C NMR (75 MHz, 
CDCl3) δ 169.8, 164.6, 159.9, 150.7, 133.2, 132.1, 130.5, 127.7, 126.1, 123.9, 123.5, 
OPMB
O
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114.3, 67.0, 55.4, 20.8. Anal calcd for C17H16O5: C, 67.99; H, 5.37. Found: C, 67.60; H, 
5.17. 
4-Methoxybenzyl 4-methoxybenzoate (16).  
 
Rolfe, A.; Loh, J. K.; Maity, P. K.; Hanson, P. R. High-Load, Hybrid Si-ROMP 
Reagents. Org. Lett. 2011, 13, 4-7. 
Colorless oil (788 mg, 92%): TLC Rf = 0.56 (15:85 ethyl acetate:hexanes); 1H NMR (300 
MHz, CDCl3) δ 8.03 (d, J = 8.0 Hz, 2H), 7.41 (d, J = 8.5 Hz, 2H), 6.88-6.99 (m, 4H), 
5.18 (s, 2H), 3.87 (s, 3H), 3.84 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 165.8, 163.5, 
159.9, 132.0, 130.5, 129.6, 122.2, 113.5, 113.1, 65.8, 54.9, 54.8.  
4-Methoxybenzyl cinnamate (17).  
 
Rolfe, A.; Loh, J. K.; Maity, P. K.; Hanson, P. R. High-Load, Hybrid Si-ROMP 
Reagents. Org. Lett. 2011, 13, 4-7. 
White solid (508 mg, 94%): TLC Rf = 0.64 (20:80 ethyl acetate:hexanes); mp = 61-63 °C; 
1H NMR (300 MHz, CDCl3) δ 7.71 (d, J = 16.2 Hz, 1H), 7.55-7.48 (m, 2H), 7.41-7.33 
(m, 5H), 6.92 (d, J = 8.8 Hz, 2H), 6.47 (d, J = 16.2 Hz, 1H), 5.19 (s, 2H), 3.82 (s, 3H); 
13C NMR (75 MHz CDCl3) δ 167.0, 159.8, 145.1, 134.5, 130.4, 130.3, 129.0, 128.3, 
128.2, 118.1, 114.1, 66.3, 55.4. 
4-Methoxybenzyl propiolate (18).  
OPMB
O
16
MeO
Ph OPMB
O
17
183	
	
 
White solid (545 mg, 99%): TLC Rf = 0.84 (10:90 ethyl acetate:hexanes); IR (neat) 2956, 
2837, 2257, 1694, 1514, 1235 cm-1; mp = 141-146 °C; 1H NMR(300 MHz, CDCl3) δ 
7.50 (d, 2H, J = 9.0 Hz), 7.37-7.26 (m, 5H), 6.81 (d, 2H, J = 9.0 Hz), 5.13 (s, 3H), 3.73 
(s, 3H); 13C NMR (75 MHz CDCl3) δ 160.2, 154.2, 133.2, 130.9, 130.8, 128.8, 127.3, 
119.2, 114.3, 86.7, 80.9, 67.8, 55.5; Anal calcd for C17H14O3: C, 76.68; H, 5.30. Found: 
C, 76.60; H, 5.27. 
4-Methoxybenzyl dodecanoate (19).  
 
Colorless oil (954 mg, 89%): TLC Rf = 0.91 (10:90 ethyl acetate:hexanes); IR (neat) 
2956, 2837, 1694, 1514, 1235, 900 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.22 (d, 2H, J = 
9.0 Hz), 6.81 (d, 2H, J = 9.0 Hz), 4.97 (s, 2H), 3.79 (s, 3H), 2.25 (t, 3H, J = 9.0 Hz), 
1.61-1.53 (m, 2 H), 1.30-1.10 (m, 17 H), 0.81 (t, 3H, J = 6.0 Hz); 13C NMR (75 MHz 
CDCl3) δ 169.9, 160.8, 130.4, 127.6, 114.2, 67.6, 55.5, 35.2, 32.1, 29.8, 29.7, 29.6, 29.1, 
27.5, 22.9, 14.4; Anal calcd for C20H32O3: C, 74.96; H, 10.06.  Found: C, 74.96; H, 10.25.  
(±)-4-Methoxybenzyl 2-phenylpropionate (20). Colorless oil (464 mg, 86%): TLC Rf = 
0.51 (20:80 ethyl acetate:hexanes); IR (neat) 2956, 2837, 1734, 1514, 1235 cm-1; 1H 
NMR (300 MHz, CDCl3) δ 7.31-7.22 (m, 5H), 7.20 (d, 2H, J = 9.0 Hz), 6.82 (d, 2H, J = 
9.0 Hz), 5.04 (q, 2H, J = 6.0 Hz), 3.79-3.76 (m, 1H), 3.71 (s, 3H), 1.50 (d, 3H, J = 6.0 
Hz); 13C NMR (75 MHz CDCl3) δ 173.8, 160.0, 138.5, 130.2, 128.8, 128.7, 127.3, 126.9, 
OPMB
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114.2, 73.2, 67.8, 55.5;  Anal calcd for C17H18O3: C, 75.53; H, 6.71. Found: C, 75.41; H, 
6.65. 
4-Methoxybenzyl adamantine carboxylate (21).	
 
Rolfe, A.; Loh, J. K.; Maity, P. K.; Hanson, P. R. High-Load, Hybrid Si-ROMP 
Reagents. Org. Lett. 2011, 13, 4-7. 
Colorless oil (520 mg, 78%): TLC Rf = 0.65 (25:75 ethyl acetate:hexanes); IR (neat) 
2999, 2906, 2851, 1724, 1514, 1229 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.27 (d, J = 8.6 
Hz, 2H), 6.88 (d, J = 8.7 Hz, 2H), 5.03 (s, 2H), 3.81 (s, 3H), 1.71-2.00 (m, 15H); 13C 
NMR (75 MHz CDCl3) δ 177.6, 159.4, 129.5, 113.8, 65.6, 55.3, 38.8, 36.5, 27.9. 
4-Methoxybenzyl 2-bromodecanoate (22).  
 
Yellow oil (407 mg, 93%): TLC Rf = 0.65 (25:75 ethyl acetate:hexanes); IR (neat) 3001, 
2906, 2851, 1724, 1514, 1229 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.25 (d, 2H, J = 9.0 
Hz), 6.82 (d, 2H, J = 9.0 Hz), 5.07 (s, 3H), 4.15 (t, 1H), 3.73 (s, 3H), 1.98-1.91 (m, 2 H), 
1.30-1.10 (m, 16 H), 0.82 (t, 3H, J = 6.0 Hz); 13C NMR (75 MHz CDCl3) δ 170.0, 160.8, 
130.4, 127.6, 114.2, 67.6, 55.5, 46.4, 35.2, 32.1, 29.8, 29.7, 29.6, 29.1, 27.5, 22.9, 14.6; 
Anal calcd for C20H31BrO3: C, 60.16; H, 7.82. Found: C, 60.01; H, 7.52.  
4-Methoxybenzyl oxoethanoate (23).  
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Yellow oil (503 mg, 83%): TLC Rf = 0.85 (25:75 ethyl acetate:hexanes); IR (neat) 3010, 
2906, 1724, 1708, 1524, 1239 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.25 (d, 2H, J = 9.0 
Hz), 6.81 (d, 2H, J = 9.0 Hz), 5.12 (s, 3H), 3.67 (s, 3H), 2.35 (s, 3H); 13C NMR (75 MHz 
CDCl3) δ 192.0, 160.8, 160.2, 130.9, 126.8, 114.3, 68.1, 55.5, 26.9; Anal calcd for 
C11H12O4: C, 71.10; H, 5.22.  Found: C, 70.99; H, 5.35. 
4-Methoxybenzyl but-3-enoate (27). 
 
Feng, X.; Sun, A.; Zhang, S.; Yu, X.; Bao, M. Palladium-Catalyzed Carboxylative 
Coupling of Benzyl Chlorides with Allyltributylstannane: Remarkable Effect of 
Palladium Nanoparticles. Org. Lett. 2013, 15, 108-111. 
Colorless oil (389.4 mg, 93 % yield). Rf = 0.50 (5:95 ethyl acetate:hexanes); 1H NMR 
(300 MHz, CDCl3) δ 7.28 (d, J = 8.8 Hz, 2H), 6.87 (d, J = 8.8 Hz, 2H), 5.87–5.96 (m, 
1H), 5.12–5.17 (m, 2H), 5.05 (s, 2H), 3.78 (s, 3H), 3.10 (d, J = 6.8 Hz, 2H); 13C NMR (75 
MHz, CDCl3) δ 171.4, 159.7, 130.3, 130.1, 128.0, 118.6, 114.0, 66.3, 55.2, 39.1.  
(±)-4-Methoxybenzyl 2-hydroxy-2-phenylacetate (24). 
	
Wang, M. F., Golding, B. T., Potter. G. A Convenient Preparation of p-Methoxybenzyl 
Esters. Synth. Comm. 2000, 30, 4197-4204.	
 Colorless oil (495 mg, 79%): TLC Rf = 0.65 (30:70 ethyl acetate:hexanes). 1H NMR 
(300 MHz, CDCl3) δ 7.35-7.25 (m, 5H), 7.09 (d, 2H, J = 9.0 Hz), 6.78 (d, 2H, J = 9.0 
Hz), 5.11- 4.96 (m, 3H), 3.71 (s, 3H), 3.57 (d, 1H, J = 6.0 Hz); 13C NMR (75 MHz 
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CDCl3) δ 173.8, 160.0, 138.5, 130.2, 128.8, 128.7, 127.3, 126.9, 114.2, 73.2, 67.8, 55.5. 
4-Methoxybenzyl-(2S)-2-[(tert-butoxycarbonyl)amino]phenylpropionate (25).	
 
Zeggaf, C.; Poncet, J.; Jouin, P.; Dufour, M. N.; Castro, B. Isopropenyl chlorocarbonate 
(IPCC)1 in amino acid and peptide chemistry: esterification of N-protected amino acids; 
application to the synthesis of the depsipeptide valinomycin. Tetrahedron 1989, 45, 
5039-5050. 
Colorless oil (342 mg, 89%): TLC Rf = 0.61 (30:70 ethyl acetate:hexanes); 1H NMR (300 
MHz, CDCl3) δ 7.20-7.11 (m, 5H), 6.99-6.87 (m, 2H), 6.75 (d, 2H, J = 9.0 Hz), 5.03-4.97 
(m, 3H), 4.60-4.45 (m, 1H), 3.73 (s, 3H), 3.11-2.90 (m, 2H), 1.35 (s, 9H); 13C NMR (75 
MHz CDCl3) δ 173.5, 160.1, 155.5, 138.6, 132.3, 130.3, 129.5, 127.8, 127.5, 114.6, 80.2, 
67.1, 55.5, 54.0, 39.1, 28.5 
4-methoxybenzyl picolinate (26) Yellow oil (516 mg, 83%): TLC Rf = 0.30 (50:50 ethyl 
acetate:hexanes); IR (film) 3057, 3005, 2957, 2837, 1717 cm-1; 1H NMR (300 MHz, 
CDCl3) δ 8.76 (d, J = 7.2 Hz, 1H), 8.12 (d, J = 8.7 Hz, 1H), 7.85-7.79 (m, 1H), 7.48-7.42 
(m, 3H), 6.90 (d, J = 8.7 Hz, 2H), 5.40 (s, 2H), 3.81 (s, 3H); 13C NMR (75 MHz, CDCl3) 
δ 165.2, 159.8, 150.0, 148.2, 137.0, 130.6, 127.9, 127.0, 125.3, 114.0, 67.4, 55.3; Anal 
calcd for C14H13NO3: C, 69.12; H, 5.39; N, 5.76.  Found C, 69.52; H, 5.65; N, 5.73. 
4-Methoxybenzyl but-3-enoate (27). 
 
Feng, X.; Sun, A.; Zhang, S.; Yu, X.; Bao, M. Palladium-Catalyzed Carboxylative 
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Coupling of Benzyl Chlorides with Allyltributylstannane: Remarkable Effect of 
Palladium Nanoparticles. Org. Lett. 2013, 15, 108-111. 
 Colorless oil (389.4 mg, 93 % yield). Rf = 0.50 (5:95 ethyl acetate:hexanes); 1H NMR 
(300 MHz, CDCl3) δ 7.28 (d, J = 8.8 Hz, 2H), 6.87 (d, J = 8.8 Hz, 2H), 5.87–5.96 (m, 
1H), 5.12–5.17 (m, 2H), 5.05 (s, 2H), 3.78 (s, 3H), 3.10 (d, J = 6.8 Hz, 2H); 13C NMR (75 
MHz, CDCl3) δ 171.4, 159.7, 130.3, 130.1, 128.0, 118.6, 114.0, 66.3, 55.2, 39.1.  
 (Z)-4-Methoxybenzyl 3-phenylacrylate (28).  
 
Colorless oil (130 mg, 72%): TLC Rf = 0.80 (30:70 ethyl acetate:hexanes); IR (thin film) 
3002, 2990, 1738, 1623, 1550, 1229, 1090, 710 cm-1. 1H NMR (300 MHz, CDCl3) δ 7.52-
7.47 (m, 2H), 7.32-7.29 (m, 3H), 7.26 (d, J = 6.0 Hz 2H), 7.19-7.17 (m, 3H), 5.90 (d, J = 
9.4 Hz 1H), 5.24 (s, 2H), 3.72 (s, 3H); 13C NMR (75 MHz CDCl3) δ 166.6, 159.2, 145.2, 
134.0, 129.9, 129.0, 128.9, 128.5, 128.2, 115.7, 113.4, 66.9, 56.2; Anal calcd for 
C17H16O3: C, 76.10; H, 6.10.  Found: C, 76.01; H, 5.86.  
(R)-4-Methoxybenzyl 2-(6-methoxynaphthalen-2-yl)propanoate (30). White solid 
(426 mg, 80%): [α]D22 = -9.9 (c = 0.9 in CH2Cl2); mp = 120-122 °C. TLC Rf = 0.71 
(30:70 ethyl acetate:hexanes); IR (thin film) 3006, 2890, 1748, 1635, 1550, 1289, 1090, 
780 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.63-7.55 (m, 3H), 7.31 (d, 1H, J = 6.0 Hz), 
7.13-7.05 (m, 4H), 7.09 (d, 2H, J = 8.0 Hz), 6.75 (d, 2H, J = 6.0 Hz) 4.98 (q, 2H, J = 12.0 
Hz), 3.91 (s, 3H), 3.69 (t, 3H), 1.49 (d, 3H, J = 6.0 Hz); 13C NMR (75 MHz CDCl3) δ 
174.8, 159.9, 138.5, 136.5, 130.2, 129.9, 129.7, 128.8, 127.8, 127.5, 119.9, 114.1, 106.0, 
104.8, 66.9, 55.55, 55.49, 45.4, 19.9; Anal calcd for C22H22O4: C, 75.41; H, 6.33.  Found: 
C, 75.44; H, 6.33. 
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Racemization of Ester 30.  
 
 (-)-Ester 30 (0.14 mmol, 50 mg) was dissolved in 2 mL of THF. DBU was added (0.14 
mmol, 22µL) and the reaction mixture was warmed to 40 °C for 12 h. The reaction 
mixture was then cooled to room temp, taken up in ethyl acetate (20 mL), washed with 
1M HCl (3 x 20 mL), dried (Na2SO4), filtered and concentrated. The residue was 
adsorbed on silica gel and purified by silica gel chromatography using 30:70 ethyl 
acetate:hexanes to provide 48 mg (96%) of (±)-4-methoxybenzyl-2-(6-methoxy-2-
naphthyl)propanoate 30. The enantiomeric ratio was determined by HPLC using a chiral 
column (OD-H), n-hexane:i-PrOH = 90:10, 1 mL/min; (R)-enantiomer tR = 15.3 min, (S)-
enantiomer tR = 17.9 min. 
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Appendix A 
 
 
1H and 13C NMR Spectra Supplement to Chapter 2 
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Appendix B 
 
 
1H and 13C NMR Spectra Supplement to Chapter 3 
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Appendix C 
 
 
1H and 13C NMR Spectra Supplement to Chapter 4 
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Appendix D 
 
 
1H and 13C NMR Spectra Supplement to Chapter 5 
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! S42 
Chiral HPLC trace of (+)-20 
2.5 5.0 7.5 10.0 12.5 15.0 17.5
Minutes
-7
-6
-5
-4
-3
-2
mVolts
14
.3
95
Peak
No
Ret.
Time
(min)
Area
(counts)
Sep.
Code
Width
1/2
(sec)
Result
(Area%)
1 14.395 171739 BB 34.9 100.0000
 171739 100.0000
  
 
Chiral HPLC of (±)-20 
5 10 15 20
Minutes
-7
-6
-5
-4
-3
-2
mVolts
15
.3
87
17
.9
43
Peak
No
Ret.
Time
(min)
Area
(counts)
Sep.
Code
Width
1/2
(sec)
Result
(Area%)
1 15.387 245573 BB 52.8 49.3531
2 17.943 252011 BB 59.7 50.6469
 497584 100.0000
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